{"id":176,"date":"2021-08-05T10:16:22","date_gmt":"2021-08-05T01:16:22","guid":{"rendered":"https:\/\/www.med.niigata-u.ac.jp\/oph\/?page_id=176"},"modified":"2026-04-01T13:38:32","modified_gmt":"2026-04-01T04:38:32","slug":"achievement","status":"publish","type":"page","link":"https:\/\/www.med.niigata-u.ac.jp\/oph\/medical\/achievement\/","title":{"rendered":"\u7814\u7a76\u696d\u7e3e"},"content":{"rendered":"<p><\/p>\n<p><a href=\"#eibunronbun\">\u82f1\u6587\u8ad6\u6587<\/a>\u3000\u3000<a href=\"#wabunronbun\">\u548c\u6587\u8ad6\u6587<\/a>\u3000\u3000<a href=\"#kokusaigakkai\">\u56fd\u969b\u5b66\u4f1a\u767a\u8868<\/a>\u3000\u3000<a href=\"#kokunaigakkai\">\u56fd\u5185\u5b66\u4f1a\u767a\u8868<\/a><\/p>\n<h2 id=\"eibunronbun\">\u82f1\u6587\u8ad6\u6587<\/h2>\n<h3>2025\u5e74<\/h3>\n<ul>\n<li>Tadanobu Sato, Taro Kuramoto<br \/>\nDiagnostic Performance of ChatGPT-4o in Classifying Idiopathic Epiretinal Membrane Based on Optical Coherence Tomography.<br \/>\nJ Clin Med. 2025 Dec 30;15(1):292.<a href=\"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/292\" target=\"_blank\" rel=\"noopener\">https:\/\/www.mdpi.com\/2077-0383\/15\/1\/292<\/a>.<\/li>\n<li>Hasegawa Y, Ueki S.<br \/>Anisometropia in bilateral hyperopic refractive amblyopia requires eye patching. BMC Ophthalmol.2025 Nov 25;25(1):701. <a href=\"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04536-4\">doi: 10.1186\/s12886-025-04536-4.<\/a><\/li>\n<li><span class=\"authors-list-item \">Ueki S<span class=\"comma\">, <\/span><\/span><span class=\"authors-list-item \">Mashio T<span style=\"font-size: 11.6667px;\">. <br \/><\/span><\/span>Correlation between quantified magnetic resonance imaging (MRI) findings and \u201cMRI score\u201d in Graves\u2019 ophthalmopathy. Orbit. 2025 Jul 23:1-5. <a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/01676830.2025.2528979\">doi: 10.1080\/01676830.2025.2528979.<\/a><\/li>\n<li>Satoshi Ueki, Yukari Hasegawa, Tetsuhisa Hatase, Izumi Kawachi, Takeo Fukuchi.<br \/>Reconsideration of conversion to multiple sclerosis: one-year cerebral lesion appearance rate of Japanese aquaporin-4 antibody-negative optic neuritis patients.<br \/>Jpn J Ophthalmol. 2025 Jun 21. Online ahead of print.<a href=\"https:\/\/link.springer.com\/article\/10.1007\/s10384-025-01235-x\">doi: 10.1007\/s10384-025-01235-x.<\/a>\u00a0<\/li>\n<li>Ando T, Terashima H, Kobayashi N. <br \/>Coughing-induced Ocular Content Extrusion through a Perforating Corneal Injury. <br \/>Ophthalmol Retina. 2025 Feb;9(2):e15. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2468653024003257?via%3Dihub\">doi: 10.1016\/j.oret.2024.07.002.<\/a><\/li>\n<li>Satoshi Ueki; Yuji Suzuki<br \/>New Perspective on Aqueous Humor Circulation: Retina Takes the Lead<br \/>Int. J. Mol. Sci. 2025, 26(6), 2645. <a href=\"https:\/\/doi.org\/10.3390\/ijms26062645\" target=\"_blank\" rel=\"noopener\">doi:10.3390\/ijms26062645<\/a>.<\/li>\n<li>Nakano R, Igarashi R, Akagi T, Sakaue Y, Iikawa R, Tazawa A, Kamada K, Arimatsu M, Togano T, Fukuchi T.<br \/>Correlation between contrast sensitivity and national eye institute visual function questionnaire (NEI VFQ-25) Rasch scores in patients with open-angle glaucoma: A cross-sectional study.<br \/>BMC Ophthalmol. 2025 Feb 25;25(1):95. <a href=\"https:\/\/doi.org\/10.1186\/s12886-025-03928-w\" target=\"_blank\" rel=\"noopener\">doi:10.1186\/s12886-025-03928-w<\/a>.<\/li>\n<li>Sato T, Akagi T, Kobayashi D, Anraku A, Nozaki Y, Ando T, Yoshida H, Terashima H, Hasebe H, Fukuchi T.<br \/>Relationships of the Duration from Onset and Macular Morphology with Metamorphopsia After Surgery for Macula-Off Rhegmatogenous Retinal Detachment.<br \/>Clin Ophthalmol. 2025 Mar 30:19:1119-1128. <a href=\"https:\/\/doi.org\/10.2147\/OPTH.S512396\" target=\"_blank\" rel=\"noopener\">doi:10.2147\/OPTH.S512396<\/a>.<\/li>\n<li>Ando T, Terashima H, Fujii K, Yoshida H, Ueda E, Nozaki Y, Shiozaki N, Yaoeda K, Fukuchi T.<br \/>Risk factors for hypotony after transconjunctival sutureless vitrectomy.<br \/>PLoS One. 2025 Apr 28;20(4):e0321135. <a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0321135\" target=\"_blank\" rel=\"noopener\">doi:10.1371\/journal.pone.0321135<\/a>.<\/li>\n<li>Kobayashi D, Akagi T, Togano T, Iikawa R, Fukuchi T.<br \/>Ab interno removal of malpositioned ex-press glaucoma device combined with bleb needling.<br \/>Jpn J Ophthalmol. 2025 May 7. <a href=\"https:\/\/doi.org\/10.1007\/s10384-025-01203-5\" target=\"_blank\" rel=\"noopener\">doi:10.1007\/s10384-025-01203-5<\/a>. Online ahead of print.<\/li>\n<li>Akagi T, Fukuchi T, Higashide T, Udagawa S, Ohkubo S, Sugiyama K, Tanihara H, Araie M, Tomita G, Matsumoto C, Tomidokoro A, Hangai M, Kawata H, Inai M, Tanaka Y; SVF Prospector Study Group.<br \/>Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study.<br \/>Ophthalmol Glaucoma. 2025 Apr 23:S2589-4196(25)00077-8. <a href=\"https:\/\/doi.org\/10.1016\/j.ogla.2025.04.009\" target=\"_blank\" rel=\"noopener\">doi:10.1016\/j.ogla.2025.04.009<\/a>. Online ahead of print.<\/li>\n<\/ul>\n<h3>2024\u5e74<\/h3>\n<ul>\n<li>Akagi T, Togano T, Iikawa R, Igarashi R, Arimatsu M, Miyajima M, Sakaue Y, Fukuchi T. <br \/>A novel bleb revision technique: lining with tenon&#8217;s patch graft for treatment of large, ischemic, leaking blebs with severe conjunctival scarring after trabeculectomy. <br \/>Jpn J Ophthalmol. 2024 Jan;68(1):32-36. <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s10384-023-01037-z\" target=\"_blank\" rel=\"noopener\">doi:10.1007\/s10384-023-01037-z<\/a>.\u00a0<\/li>\n<li>Ando T, Terashima H, Yoshida H, Ueda E, Ochiai S, Fukuchi T. <br \/>Relationship between long-term visual function and the ratio of foveal avascular zone area in eyes with macular hole and healthy fellow eyes. <br \/>Graefes Arch Clin Exp Ophthalmol. 2024 Mar 6. <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06433-w\" target=\"_blank\" rel=\"noopener\">doi:10.1007\/s00417-024-06433-w<\/a>. Epub ahead of print.<\/li>\n<li>Mika Ichimura, Satoshi Ueki, Takeo Fukuchi.<br \/>Test-Retest of the Spot Vision Screener among Children with Ophthalmological Diseases including Strabismus.<br \/>Journal of Ophthalmology 2024 Online ahead of print. <a href=\"https:\/\/www.hindawi.com\/journals\/joph\/2024\/2173860\/\" target=\"_blank\" rel=\"noopener\">doi:10.1155\/2024\/2173860<\/a>.<\/li>\n<li>Igarashi R, Ochiai S, Akagi T, Miyamoto D, Sakaue Y, Iikawa R, Fukuchi T.<br \/>Author Correction: Parapapillary choroidal microvasculature dropout in eyes with primary open-angle glaucoma.<br \/>Sci Rep. 2024 Feb 19;14(1):4089. <a href=\"https:\/\/www.nature.com\/articles\/s41598-024-54133-6\" target=\"_blank\" rel=\"noopener\">doi:10.1038\/s41598-024-54133-6<\/a>.<\/li>\n<li>Arimatsu M, Akagi T, Suetake A, Sakaue Y, Iikawa R, Igarashi R, Togano T,<br \/>Ando T, Yoshida H, Terashima H, Fukuchi T. <br \/>Intrascleral intraocular lens fixation with ab interno trabeculotomy in patients with exfoliation glaucoma with lens subluxation. <br \/>Jpn J Ophthalmol. 2024 Apr 8. <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s10384-024-01059-1\" target=\"_blank\" rel=\"noopener\">doi:10.1007\/s10384-024-01059-1<\/a>. Epub ahead of print.<\/li>\n<li>Yohei Nitta, Jiro Osaka, Ryuto Maki, Satoko Hakeda-Suzuki, Emiko Suzuki, Satoshi Ueki, Takashi Suzuki, Atsushi Sugie. Drosophila model to clarify the pathological significance of OPA1 in autosomal dominant optic atrophy. eLife. Published online 2024 Aug 23. <a href=\"https:\/\/elifesciences.org\/articles\/87880\" target=\"_blank\" rel=\"noopener\">doi: 10.7554\/eLife.87880.<\/a><\/li>\n<li>Yohei Takahashi, Takeshi Kezuka, Keigo Shikishima, Akiko Yamagami, Hideki Chuman, Makoto Nakamura, Satoshi Ueki, Akiko Kimura, Masato Hashimoto, Sonoko Tatsui, Kimiyo Mashimo, Hitoshi Ishikawa<br \/>Usage status of biologics for the chronic treatment of optic neuritis in neuromyelitis optica spectrum disorders in Japan.<br \/>Japanese Journal of Ophthalmology. 2024 Oct 29. Online ahead of print. <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s10384-024-01129-4\" target=\"_blank\" rel=\"noopener\">doi:10.1007\/s10384-024-01129-4<\/a>.<\/li>\n<\/ul>\n<h3>2023\u5e74<\/h3>\n<ul>\n<li>Akagi T, Togano T, Iikawa R, Igarashi R, Arimatsu M, Miyajima M, Sakaue Y, Fukuchi T. <br \/>A novel bleb revision technique: lining with tenon&#8217;s patch graft for treatment of large, ischemic, leaking blebs with severe conjunctival scarring after trabeculectomy. Jpn J Ophthalmol. 2023 Dec 12. Epub ahead of print.<\/li>\n<li>Igarashi R, Ochiai S, Akagi T, Miyamoto D, Sakaue Y, Iikawa R, Fukuchi T.<br \/>Parapapillary choroidal microvasculature dropout in eyes with primary open-angle glaucoma. Sci Rep. 2023 Nov 23;13(1):20601.<\/li>\n<li>Ueki S, Suzuki Y, Nakamura Y, Igarashi H. Age-Dependent Changes in Regulation of Water Inflow Into the Vitreous Body. Invest Ophthalmol Vis Sci. 2023 Sep 1;64(12):22.<\/li>\n<li>Akagi T, Kato-Takano Y, Miyamoto D, Sakaue Y, Igarashi R, Iikawa R, Arimatsu M, Miyajima M, Togano T, Fukuchi T. Relationship between Inter-Eye Asymmetries in Corneal Hysteresis and Visual Field Severity in Patients with Primary Open-Angle Glaucoma J Clin Med. 2023 Jul 6;12(13):4514.<\/li>\n<li>Nakano H, Hasebe H, Murakami K, Nakamura Y, Fukuchi T. CHOROIDAL VASCULAR DENSITY IN DIABETIC RETINOPATHY ASSESSED WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY Retina. 2023 Jan 1;43(1):34-41.<\/li>\n<li>Satoshi Ueki, Yukari Hasegawa, Tetsuhisa Hatase, Takako Hanyu, Jun Egawa, Atsushi Miki, Takeo Fukuchi.Spasm of Near Reflex in a Patient with Autism Spectrum Disorder: A Case Report.Reports 2023, 6(3), 38<\/li>\n<li>Ochi H, Kurimoto T, Yamagami A, Goto K, Miki A, Kawai M, Ishikawa H, Matsuzaki M, Kondo M, Mochizuki Y, Kimura A, Maekubo T, Chuman H, Ueki S, Nakamura M. Structure-function relationship between magnetic resonance imaging lesion areas and visual field defects in initial optic neuritis with altitudinal hemianopsia. Jpn J Ophthalmol. 2023 Sep;67(5):618-627.<\/li>\n<li>Ueki S, Hasegawa Y, Hatase T, Kiyokawa M, Fukuchi T. One-year recurrence rate of Graves ophthalmopathy presenting as diplopia in the primary position after varied doses of intravenous methylprednisolone followed by oral prednisolone with dosing based on the magnetic resonance imaging findings. Jpn J Ophthalmol. 2023 Jan;67(1):91-96.<\/li>\n<\/ul>\n<h3>2022\u5e74<\/h3>\n<ul>\n<li>Ominato J, Oyama T, Cho H, Shiozaki N, Eguchi K, Fukuchi T. Evaluation of the postoperative course of East Asian eyelid reconstruction with free tarsoconjunctival graft transplantation: A Japanese single-centre retrospective study. JPRAS Open. 2022 28;33:6-16.<\/li>\n<li>Ando T, Seki M, Ueda E, Suetake A, Terashima H, Yoshida H, Hasebe H, Fukuchi T. A case of bilateral diffuse uveal melanocytic proliferation with secondary angle closure caused by ciliary body thickening. Am J Ophthalmol Case Rep. 2022 Oct 21;28:101729.<\/li>\n<li>Akiko Suga, Kazutoshi Yoshitake, Naoko Minematsu, Kazushige Tsunoda, Kaoru Fujinami, Yozo Miyake, Kazuki Kuniyoshi, Takaaki Hayashi, Kei Mizobuchi, Shinji Ueno, Hiroko Terasaki, Taro Kominami, Nobuhisa Nao, Go Mawatari, Atsushi Mizota, Kei Shinoda, Mineo Kondo, Kumiko Kato, Tetsuju Sekiryu, Makoto Nakamura, Sentaro Kusuhara, Hiroyuki Yamamoto, Shuji Yamamoto, Kiyofumi Mochizuki, Hiroyuki Kondo, Itsuka Matsushita, Shuhei Kameya, Takeo Fukuchi, Tetsuhisa Hatase, Masayuki Horiguchi, Yoshiaki Shimada, Atsuhiro Tanikawa, Shuichi Yamamoto, Yoshihiro Hotta, Koji Tanaka, Takeshi Iwata. Genetic characterization of 1210 Japanese pedigrees with inherited retinal diseases by whole-exome sequencing. Hum Mutat. 2022 Dec;43(12):2251-2264.<\/li>\n<li>Sotaro Mori, Masaki Tanito, Nobuyuki Shoji, Yu Yokoyama, Takanori Kameda, Takuhei Shoji, Shiro Mizoue, Yuta Saito, Kyoko Ishida, Toshihiko Ueda, Makoto Nakamura; TramTrac Study Group; Koji Namiguchi, Shiro Mizoue, Kyoko Ishida, Kenji Inoue, Yusuke Kono, Masayuki Kasahara, Nobuyuki Shoji, Sotaro Mori, Matsumiya Wataru, Nagai Takayuki, Makoto Nakamura, Takanori Kameda, Akagi Tadamichi, Toshihiko Ueda, Jun Makita, Takuhei Shoji, Michihiro Kono, Masaki Tanito, Kota Yokoyama, Yuta Saito, Kyoko Ishida, Yu Yokoyama, Toru Nakazawa. Noninferiority of Microhook to Trabectome: Trabectome versus Ab Interno Microhook Trabeculotomy Comparative Study (Tram Trac Study). Ophthalmol Glaucoma. 2022 Jul-Aug;5(4):452-461.<\/li>\n<li>Kido A, Miyake M, Akagi T, Ikeda HO, Kameda T, Suda K, Hasegawa T, Hiragi S, Yoshida S, Tsujikawa A, Tamura H, Kawakami K. Association between topical \u03b2-blocker use and asthma attacks in glaucoma patients with asthma: a cohort study using a claims database. Graefes Arch Clin Exp Ophthalmol. 2022 Jan;260(1):271-280.<\/li>\n<li>Okamoto Y, Akagi T, Kameda T, Suda K, Miyake M, Ikeda HO, Numa S, Tsujikawa A. Changes in the deep vasculature assessed using anterior segment OCT angiography following trabecular meshwork targeted minimally invasive glaucoma surgery. Sci Rep. 2022 12(1):17187.<\/li>\n<li>Omoto T, Asaoka R, Akagi T, Oishi A, Miyata M, Murata H, Fujino Y, Hirasawa K, Inoue T, Tanito M, Shoji N. The number of examinations required for the accurate prediction of the progression of the central 10-degree visual field test in glaucoma. Sci Rep. 2022 12(1):18843.<\/li>\n<li>Hanyu T, Ueki S, Hasegawa Y, Kiyokawa M, Fukuchi T. Posterior microphthalmos with achievement of good visual acuity and disappearance of papillomacular retinal folds: a case report. BMC Ophthalmol. 2022 22(1):424.<\/li>\n<\/ul>\n<h3>2021\u5e74<\/h3>\n<ul>\n<li>Satoshi Ueki, Tetsuhisa Hatase, Megumi Kiyokawa, Izumi Kawachi, Etsuji Saji, Osamu Onodera, Takeo Fukuchi, Hironaka Igarashi. Visual outcome of aquaporin-4 antibody-positive optic neuritis with maintenance therapy. Japanese Journal of Ophthalmology. 2021 65:699\u2013703.<\/li>\n<li>Satoshi Ueki, Yuji Suzuki, Megumi Kiyokawa, Takako Hanyu, Takeo Fukuchi. Hyperopic anisometropia with a shorter axial length ipsilateral to the ptotic eye in children with congenital ptosis. BMC Ophthalmology. 21: 358<\/li>\n<li>Terashima H, Okamoto F, Hasebe H, Matsuoka N, Ueda E, Yoshida H, Togano T, Fukuchi T. Evaluation of postoperative visual function based on the preoperative inner layer structure in the epiretinal membrane. 2021 259(11):3251-3259.<\/li>\n<li>Ueki S, Suzuki Y, lgarashi H. Retinal aquaporin-4 and regulation of water inflow into the vitreous body. Invest Ophthalmol Vis Sci, 2021;62(2):24.<\/li>\n<li>Kiyokawa M, Ueki S, Hatase T, Hanyu T, Fukuchi T. The prevalence of brain abnormalities in Japanese patients with optic nerve hypoplasia. Neuro-Ophthalmology. 2021 45(4):265-270.<\/li>\n<li>Imai K, Sawada H, Hatase T, Fukuchi T. Iridocorneal contact as a potentialcause of corneal decompensation following laser peripheral iridotomy. Jpn J Ophthalmol. 2021. Epub ahead of print.<\/li>\n<li>Terashima H, Okamoto F, Hasebe H, Ueda E, Yoshida H, Fukuchi T. Optical coherence tomography angiography and Humphrey field analyser for macular capillary non-perfusion evaluation in branch retinal vein occlusion. Sci Rep. 2021 25;11(1):4583.<\/li>\n<li>Horiguchi H, Suzuki E, Kubo H, Fujikado T, Asonuma S, Fujimoto C, Tatsumoto M, Fukuchi T, Sakaue Y, Ichimura M, Kurimoto Y, Yamamoto M, Nakadomari S. Efficient measurements for the dynamic range of human lightness perception. JpnJ Ophthalmol. 2021; 65(3):432-438.<\/li>\n<li>Doi A, Akagi T, Tsujikawa A. Successful Treatment of Post-Phacoemulsification Descemet\u2019s Membrane Detachment Assessed by Anterior Segment Optical Coherence Tomography: A Case Report. Case Rep Ophthalmol. 2021. 2021. 12(2):611-615.<\/li>\n<li>Kadomoto S, Uji A, Arichika S, Muraoka Y, Kido A, Nishijima K, Akagi T, Kawai K, Tsujikawa A. Macular Cone Abnormalities in Beh\u00e7et&#8217;s Disease Detected by Adaptive Optics Scanning Light Ophthalmoscope. Ophthalmic Surg Lasers Imaging Retina. 2021; 52(4):218-225.<\/li>\n<li>Nakano E, Miyake M, Hosoda Y, Mori Y, Suda K, Kameda T, Ikeda-Ohashi H, Tabara Y, Yamashiro K, Tamura H, Akagi T, Matsuda F, Tsujikawa A; Nagahama Study Group. Relationship between Intraocular Pressure and Coffee Consumption in a Japanese Population without Glaucoma: The Nagahama Study. Ophthalmol Glaucoma. 2021; 4(3):268-276.<\/li>\n<li>Kawai K, Uji A, Murakami T, Kadomoto S, Oritani Y, Dodo Y, Muraoka Y, Akagi T, Miyata M, Tsujikawa A. IMAGE EVALUATION OF ARTIFICIAL INTELLIGENCE SUPPORTED OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IMAGING USING OCT-HS100 DEVICE IN DIABETIC RETINOPATHY. Retina. 2021. 41(8):1730-1738.<\/li>\n<li>Suda K, Akagi T, Ikeda HO, Kameda T, Hasegawa T, Miyake M, Kido A, Nakano E, Tsujikawa A. Atopic dermatitis as a risk factor for severe visual field loss in youth-a retrospective cohort study of glaucoma under steroid treatment. Graefes Arch Clin Exp Ophthalmol. 2021; 259(1):129-136.<\/li>\n<li>Sakata R, Yoshitomi T, Araie M; for Lower Normal Pressure Glaucoma Study Members in Japan Glaucoma Society. The occurrence of optic disc haemorrhage in primary open-angle glaucoma eyes with lower normal pressure and its relating factors. Acta Ophthalmol. 2021; 99(1):e28-e35.<\/li>\n<\/ul>\n<h3>2020\u5e74<\/h3>\n<ul>\n<li>Yoshida H, Terashima H, Ueda E, Hasebe H, Matsuoka N, Nakano H, Fukuchi T. Relationship between morphological changes in the foveal avascular zone of the epiretinal membrane and postoperative visual function. BMJ Open Ophthalmol. 2020; 5(1):e000636.<\/li>\n<li>Yamada K, Suzuki Y, Ueki S, Watanabe M, Suzuki K, lgarashi H. Participant-driven simulation protocol with a mock scanner for pediatric scanner for pediatric magnetic resonance neuroimaging preparation without sedation. Clinical Simulation in Nursing 2020; 47:40-47.<\/li>\n<li>Nakano H, Hasebe H, Murakami K, Cho H, Kondo D, Iino N, Fukuchi T. Choroid structure analysis following initiation of hemodialysis by using swept-source optical coherence tomography in patients with and without diabetes. PLoS One. 2020; 15(9):e0239072.<\/li>\n<li>Higashide T, Ohkubo S, Udagawa S, Sugiyama K, Tanihara H, Araie M, Tomita G, Matsumoto C, Fukuchi T, Tomidokoro A, Hangai M, Kawata H, Inai M, Tanaka Y; SVF Prospector Study Group. Spatial and Temporal Relationship between Structural Progression and Disc Hemorrhage in Glaucoma in a 3-Year Prospective Study. Ophthalmol Glaucoma. 2020 21:S2589-4196(20)30220-9. Epub ahead of print.<\/li>\n<li>Nakano H, Togano T, Sakaue Y, Suetaka A, Iikawa R, Nakano R, Fukuchi T. Clinical Features of Patients with Exfoliation Glaucoma Requiring Surgical Intervention. J Ophthalmol.2020:9423756.<\/li>\n<li>Igarashi R, Ochiai S, Togano T, Sakaue Y, Suetake A, Iikawa R, Honma Y, Miyamoto D, Fukuchi T. Foveal Avascular Zone Measurement Via Optical Coherence Tomography Angiography and its Relationship With the Visual Field in Eyes With Open-angle Glaucoma. J Glaucoma. 2020; 29(6):492-497.<\/li>\n<li>Nakazawa T, Fukuchi T. What is glaucomatous optic neuropathy? Jpn J Ophthalmol. 2020; 64(3):243-249.<\/li>\n<li>Shirono Y, Takizawa I, Kasahara T, Maruyama R, Yamana K, Tanikawa T, Hara N, Sakaue Y, Togano T, Nishiyama T, Fukuchi T, Tomita Y. Intraoperative intraocular pressure changes during robot-assisted radical prostatectomy: associations with perioperative and clinicopathological factors. BMC Urol. 2020; 20(1):26.<\/li>\n<li>Iikawa R, Togano T, Sakaue Y, Suetake A, Igarashi R, Miyamoto D, Yaoeda K, Seki M, Fukuchi T. Estimation of the central 10-degree visual field using en-face images obtained by optical coherence tomography. PLoS One. 2020; 15(3):e0229867.<\/li>\n<li>Igarashi R, Yamashita SI, Yamashita T, Inoue K, Fukuda T, Fukuchi T, Kanki T. Gemcitabine induces Parkin-independent mitophagy through mitochondrial-resident E3 ligase MUL1-mediated stabilization of PINK1. Sci Rep. 2020; 10(1):1465.<\/li>\n<li>Okamoto Y, Akagi T, Suda K, Kameda T, Miyake M, Ikeda HO, Nakano E, Uji A, Tsujikawa A. Longitudinal changes in superficial microvasculature in glaucomatous retinal nerve fiber layer defects after disc hemorrhage. Sci Rep. 2020; 10(1):22058.<\/li>\n<li>Akagi T, Okamoto Y, Kameda T, Suda K, Nakanishi H, Miyake M, Ikeda HO, Yamada T, Kadomoto S, Uji A, Tsujikawa A. Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Human Eyes: A Pilot Study. J Clin Med. 2020; 9(12):4016.<\/li>\n<li>Morino MU, Akagi T, Miyata M, Tsujikawa A. Removal of a Baerveldt Glaucoma Implant and Fibrous Adhesion for Refractory Mechanical Strabismus: A Case Report. Case Rep Ophthalmol. 2020; 11(2):249-255.<\/li>\n<li>Hou H, Moghimi S, Zangwill LM, Proudfoot JA, Akagi T, Shoji T, Girkin CA, Liebmann JM, Weinreb RN. Association between Rates of Retinal Nerve Fiber Layer Thinning after Intraocular Pressure-Lowering Procedures and Disc Hemorrhage. Ophthalmol Glaucoma. 2020; 3(1):7-13.<\/li>\n<li>Hasegawa T, Ooto S, Akagi T, Kameda T, Nakanishi H, Ikeda HO, Suda K, Tsujikawa A. Expansion of retinal nerve fiber bundle narrowing in glaucoma: An adaptive optics scanning laser ophthalmoscopy study. Am J Ophthalmol Case Rep. 2020; 19:100732.<\/li>\n<li>Kadomoto S, Uji A, Muraoka Y, Akagi T, Tsujikawa A. Enhanced Visualization of Retinal Microvasculature in Optical Coherence Tomography Angiography Imaging via Deep Learning. J Clin Med. 2020; 9(5): 1322.<\/li>\n<li>Uji A, Sadda SR, Muraoka Y, Kadomoto S, Ooto S, Murakami T, Akagi T, Miyata M, Tsujikawa A. Effect of image averaging on optical coherence tomography angiography data in eyes with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2020; 258(8):1639-1648.<\/li>\n<li>Akagi T, Fujimoto M, Ikeda HO. Anterior Segment Optical Coherence Tomography Angiography of Iris Neovascularization after Intravitreal Ranibizumab and Panretinal Photocoagulation. JAMA Ophthalmol. 2020; 138(2): e190318.<\/li>\n<\/ul>\n<h3>2019\u5e74<\/h3>\n<ul>\n<li>Ominato J, Oyama T, Cho H, Shiozaki N, Umezu H, Takizawa J, Fukuchi T. The natural course of IgG4-related ophthalmic disease after debulking surgery: a single-centre retrospective study. BMJ Open Ophthalmol. 2019; 4(1):e000295.<\/li>\n<li>Huber VJ, lgarashi H, Ueki S, Terumitsu-Tsujita M, Nito C, Ohno K, Suzuki Y, Itoh K, Kwee IL, Nakada T. Visualizing the distribution of matrix metalloproteinases in ischemic brain using in vivo 19F-magnetic resonance spectroscopic imaging. Contrast Media Mol Imaging 2019; Jan 6:8908943.<\/li>\n<li>Chernyshova K, Inoue K, Yamashita SI, Fukuchi T, Kanki T. Glaucoma-Associated Mutations in the Optineurin Gene Have Limited Impact on Parkin-Dependent Mitophagy. Invest Ophthalmol Vis Sci. 2019; 60(10):3625-3635.<\/li>\n<li>Terashima H, Hasebe H, Okamoto F, Matsuoka N, Sato Y, Fukuchi T. COMBINATION THERAPY OF INTRAVITREAL RANIBIZUMAB AND SUBTHRESHOLD MICROPULSE PHOTOCOAGULATION FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION: 6-MONTH RESULT. Retina. 2019; 39(7):1377-1384.<\/li>\n<li>Hou H, Moghimi S, Zangwill LM, Proudfoot JA, Akagi T, Shoji T, Girkin CA, Liebmann JM, Weinreb RN. Association between Rates of Retinal Nerve Fiber Layer Thinning following Intraocular Pressure Lowering Procedures and Disc Hemorrhage. Ophthalmol Glaucoma. 2019; 3(1):7-13.<\/li>\n<li>Akagi T, Uji A, Okamoto Y, Suda K, Kameda T, Nakanishi H, Ikeda HO, Miyake M, Nakano E, Motozawa N, Tsujikawa A. Anterior Segment Optical Coherence Tomography Angiography Imaging of Conjunctiva and Intrasclera in Treated Primary Open-Angle Glaucoma. Am J Ophthalmol. 2019; 208:313-322.<\/li>\n<li>Kadomoto S, Uji A, Muraoka Y, Akagi T, Miyata M, Tsujikawa A. A novel strategy for quantification of panoramic en face optical coherence tomography angiography scan field. Graefes Arch Clin Exp Ophthalmol. 2019; 257(6):1199-1206.<\/li>\n<li>Akagi T, Okamoto Y, Tsujikawa A. Anterior Segment OCT Angiography Images of Avascular Bleb after Trabeculectomy. Ophthalmol Glaucoma. 2019;2(2):102.<\/li>\n<li>Hou H, Moghimi S, Zangwill LM, Shoji T, Ghahari E, Penteado RC, Akagi T, Manalastas PIC, Weinreb RN. Macula Vessel Density and Thickness in Early Primary Open Angle Glaucoma. Am J Ophthalmol. 2019; 199:120-132.<\/li>\n<\/ul>\n<h3>2018\u5e74<\/h3>\n<ul>\n<li>Ominato J, Fukuchi T, Sato A, Yamaguchi N, Kobayashi K, Cho H, Oyama T, Ajioka Y. The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan. Appl Immunohistochem Mol Morphol. 2018; 26(9):658-663.<\/li>\n<li>Huber VJ, lgarashi H, Ueki S, Kwee IL, Nakada T. Aquaporin-4 facilitator TGN-073 promotes interstitial fluid circulation within the blood-brain barrier:[170]H20 JJVCPE MRI study. Neuroreport 2018; 29:697-703.<\/li>\n<li>Takagi Y, Santo K, Hashimoto M, Fukuchi T. Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review. Clin Ophthalmol. 2018; 12:1837-1844.<\/li>\n<li>Yaoeda K, Fukushima A, Shirakashi M, Miki A, Fukuchi T. Factors associated with fluctuations in repeated measurements of intraocular pressure using the Goldmann applanation tonometer in Japanese patients with primary open-angle glaucoma. Clin Ophthalmol. 2018; 12:1473-1478.<\/li>\n<li>Terashima H, Okamoto F, Hasebe H, Matsuoka N, Fukuchi T. Vitrectomy for Epiretinal Membranes: Ganglion Cell Features Correlate with Visual Function Outcomes. Ophthalmol Retina. 2018; 2(11):1152-1162.<\/li>\n<li>Udagawa S, Ohkubo S, Iwase A, Susuki Y, Kunimatsu-Sanuki S, Fukuchi T, Matsumoto C, Ohno Y, Ono H, Sugiyama K, Araie M. The effect of concentric constriction of the visual field to 10 and 15 degrees on simulated motor vehicle accidents. PLoS One. 2018; 13(3):e0193767.<\/li>\n<li>Suda M, Nakanishi H, Akagi T, Murakami T, Suzuma K, Suda K, Kameda T, Morooka S, Ikeda HO, Tsujikawa A. Baerveldt or Ahmed glaucoma valve implantation with pars plana tube insertion in Japanese eyes with neovascular glaucoma: 1-year outcomes. Clin Ophthalmol. 2018; 12:2439-2449.<\/li>\n<li>Suda K, Akagi T, Nakanishi H, Noma H, Ikeda HO, Kameda T, Hasegawa T, Tsujikawa A. Evaluation of Structure-Function Relationships in Longitudinal Changes of Glaucoma using the Spectralis OCT Follow-Up Mode. Sci Rep. 2018; 8(1):17158.<\/li>\n<li>Akagi T, Saunders LJ, Shoji T, De Moraes CG, Skaat A, Manalastas PIC, Girkin CA, Liebmann JM, Zangwill LM, Weinreb RN. Association Between Rates of Retinal Nerve Fiber Layer Thinning and Previous Disc Hemorrhage in Glaucoma. Ophthalmol Glaucoma. 2018; 1(1):23-31.<\/li>\n<li>Numa S, Akagi T, Uji A, Suda K, Nakanishi H, Kameda T, Ikeda HO, Tsujikawa A. Visualization of the Lamina Cribrosa Microvasculature in Normal and Glaucomatous Eyes: A Swept-source Optical Coherence Tomography Angiography Study. J Glaucoma. 2018; 27(11):1032-1035.<\/li>\n<li>Akagi T, Uji A, Huang AS, Weinreb RN, Yamada T, Miyata M, Kameda T, Ikeda HO, Tsujikawa A. Conjunctival and Intrascleral Vasculatures Assessed Using Anterior-Segment Optical Coherence Tomography Angiography in Normal Eyes. Am J Ophthalmol. 2018; 196:1-9.<\/li>\n<li>Akagi T, Zangwill LM, Shoji T, Suh MH, Saunders LJ, Yarmohammadi A, Manalastas PIC, Penteado RC, Weinreb RN. Optic disc microvasculature dropout in primary open-angle glaucoma measured with optical coherence tomography angiography. PLoS One. 2018; 13(8):e0201729.<\/li>\n<li>Kido A, Uji A, Morooka S, Kuroda Y, Arichika S, Akagi T, Tsujikawa A. Outer Plexiform Layer Elevations as a Marker for Prior Ocular Attacks in Patients With Behcet&#8217;s Disease. Invest Ophthalmol Vis Sci. 2018; 59(7):2828-2832.<\/li>\n<li>Fujimoto M, Uji A, Ogino K, Akagi T, Yoshimura N. Lacrimal Canaliculus Imaging Using Optical Coherence Tomography Dacryography. Sci Rep. 2018; 8(1):9808.<\/li>\n<li>Yoshikawa M, Akagi T, Uji A, Nakanishi H, Kameda T, Suda K, Ikeda HO, Tsujikawa A. Pilot study assessing the structural changes in posttrabecular aqueous humor outflow pathway after trabecular meshwork surgery using swept-source optical coherence tomography. PLoS One. 2018;13(6):e0199739.<\/li>\n<li>Hosoda Y, Yoshikawa M, Miyake M, Tabara Y, Shimada N, Zhao W, Oishi A, Nakanishi H, Hata M, Akagi T, Ooto S, Nagaoka N, Fang Y; Nagahama Study group, Ohno-Matsui K, Cheng CY, Saw SM, Yamada R, Matsuda F, Tsujikawa A, Yamashiro K. CCDC102B confers risk of low vision and blindness in high myopia. Nat Commun. 2018; 9(1):1782.<\/li>\n<li>Suh MH, Zangwill LM, Manalastas PIC, Belghith A, Yarmohammadi A, Akagi T, Diniz-Filho A, Saunders L, Weinreb RN. Deep-Layer Microvasculature Dropout by Optical Coherence Tomography Angiography and Microstructure of Parapapillary Atrophy. Invest Ophthalmol Vis Sci. 2018; 59(5):1995-2004.<\/li>\n<li>Penteado RC, Zangwill LM, Daga FB, Saunders LJ, Manalastas PIC, Shoji T, Akagi T, Christopher M, Yarmohammadi A, Moghimi S, Weinreb RN. Optical Coherence Tomography Angiography Macular Vascular Density Measurements and the Central 10-2 Visual Field in Glaucoma. J Glaucoma. 2018; 27(6):481-489<\/li>\n<li>Akagi T, Zangwill LM, Weinreb RN. Rates of Local Retinal Nerve Fiber Layer Thinning before and after Disc Hemorrhage in Glaucoma. Reply. Ophthalmology. 2018; 125(3):e22-e23.<\/li>\n<li>Hou H, Shoji T, Zangwill LM, Moghimi S, Saunders LJ, Hasenstab K, Ghahari E, Manalastas PIC, Akagi T, Christopher M, Penteado RC, Weinreb RN. Progression of Primary Open Angle Glaucoma in Diabetic and Non-diabetic Patients. Am J Ophthalmol. 2018; 189:1-9.<\/li>\n<li>Nakanishi H, Suda K, Yoshikawa M, Akagi T, Kameda T, Ikeda HO, Yokota S, Kurimoto Y, Tsujikawa A. Association of Bruch&#8217;s membrane opening and optic disc morphology to axial length and visual field defects in eyes with primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2018; 256(3):599-610.<\/li>\n<li>Kinoshita-Nakano E, Nakanishi H, Ohashi-Ikeda H, Morooka S, Akagi T. Comparative outcomes of trabeculotomy ab externo versus trabecular ablation ab interno for open angle glaucoma. Jpn J Ophthalmol. 2018; 62(2):201-208.<\/li>\n<li>Manalastas PIC, Zangwill LM, Daga FB, Christopher MA, Saunders LJ, Shoji T, Akagi T, Penteado RC, Yarmohammadi A, Suh MH, Medeiros FA, Weinreb RN. The Association between Macula and ONH Optical Coherence Tomography Angiography (OCT-A) Vessel Densities in Glaucoma, Glaucoma Suspect and Healthy Eyes. J Glaucoma. 2018; 27(3):227-232.<\/li>\n<\/ul>\n<h3>2017\u5e74<\/h3>\n<ul>\n<li>Igarashi R, Ochiai S, Sakaue Y, Suetake A, Iikawa R, Togano T, Miyamoto F, Miyamoto D, Fukuchi T. Optical coherence tomography angiography of the peripapillary capillaries in primary open-angle and normal-tension glaucoma. PLoS One. 2017; 12(9):e0184301.<\/li>\n<li>Shimizu M, Suzuki Y, Yamada K, Ueki S, Watanabe M, lgarashi H, Nakada T. Maturational decrease of glutamate in the human cerebral cortex from childhood to young adulthood: a 1H-MR spectroscopy study. Pediatr Res. 2017; 82:749-752.<\/li>\n<li>Aihara M, Adachi M, Matsuo H, Togano T, Fukuchi T, Sasaki N; JAC Study group\u2020. Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients. Acta Ophthalmol. 2017; 95(8):e720-e726.<\/li>\n<li>Murata N, Miyamoto D, Togano T, Fukuchi T. Evaluating Silent Reading Performance with an Eye Tracking System in Patients with Glaucoma. PLoS One. 2017; 12(1):e0170230.<\/li>\n<li>Manalastas PIC, Zangwill LM, Saunders LJ, Mansouri K, Belghith A, Suh MH, Yarmohammadi A, Penteado RC, Akagi T, Shoji T, Weinreb RN. Reproducibility of Optical Coherence Tomography Angiography Macular and Optic Nerve Head Vascular Density in Glaucoma and Healthy Eyes. J Glaucoma. 2017; 26(10):851-859.<\/li>\n<li>Shoji T, Zangwill LM, Akagi T, Saunders LJ, Yarmohammadi A, Manalastas PIC, Penteado RC, Weinreb RN. Progressive Macula Vessel Density Loss in Primary Open-Angle Glaucoma: A Longitudinal Study. Am J Ophthalmol. 2017; 182:107-117.<\/li>\n<li>Iida Y, Akagi T, Nakanishi H, Ohashi Ikeda H, Morooka S, Suda K, Hasegawa T, Yokota S, Yoshikawa M, Uji A, Yoshimura N. Retinal Blood Flow Velocity Change in Parafoveal Capillary after Topical Tafluprost Treatment in Eyes with Primary Open-angle Glaucoma. Sci Rep. 2017; 7(1):5019.<\/li>\n<li>Akagi T, Zangwill LM, Saunders LJ, Yarmohammadi A, Manalastas PIC, Suh MH, Girkin CA, Liebmann JM, Weinreb RN. Rates of Local Retinal Nerve Fiber Layer Thinning before and after Disc Hemorrhage in Glaucoma. Ophthalmology.124(9):1403-1411, 2017<\/li>\n<li>Yoshikawa M, Nakanishi H, Yamashiro K, Miyake M, Akagi T, Gotoh N, Ikeda HO, Suda K, Yamada H, Hasegawa T, Iida Y, Yamada R, Matsuda F, Yoshimura N; Nagahama Study Group. Association of Glaucoma-Susceptible Genes to Regional Circumpapillary Retinal Nerve Fiber Layer Thickness and Visual Field Defects. Invest Ophthalmol Vis Sci. 58(5):2510-2519, 2017<\/li>\n<li>Yarmohammadi A, Zangwill LM, Diniz-Filho A, Saunders LJ, Suh MH, Wu Z, Manalastas PI, Akagi T, Medeiros FA, Weinreb RN. Peripapillary and Macular Vessel Density in Patients with Glaucoma and Single-Hemifield Visual Field Defect. Ophthalmology. 124(5):709-19, 2017<\/li>\n<\/ul>\n<h3>2016\u5e74<\/h3>\n<ul>\n<li>Kunimatsu-Sanuki S, Iwase A, Araie M, Aoki Y, Hara T, Fukuchi T, Udagawa S, Ohkubo S, Sugiyama K, Matsumoto C, Nakazawa T, Yamaguchi T, Ono H. The role of specific visual subfields in collisions with oncoming cars during simulated driving in patients with advanced glaucoma. Br J Ophthalmol. 2017; 101(7):896-901.<\/li>\n<li>Hokari M, Yokoseki A, Arakawa M, Saji E, Yanagawa K, Yanagimura F, Toyoshima Y, Okamoto K, Ueki S, Hatase T, Ohashi R, Fukuchi T, Akazawa K, Yamada M, Kaki ta A, Takahashi H, Nishizawa M, Kawachi I. Clinicopathological features in anterior visual pathway in neuromyelitis optica. Ann Neurol. 2016; 79: 605-624.<\/li>\n<li>Yaoeda K, Fukushima A, Shirakashi M, Fukuchi T. Comparison of intraocular pressure adjusted by central corneal thickness or corneal biomechanical properties as measured in glaucomatous eyes using noncontact tonometers and the Goldmann applanation tonometer. Clin Ophthalmol. 2016; 10:829-34.<\/li>\n<li>Hokari M, Yokoseki A, Arakawa M, Saji E, Yanagawa K, Yanagimura F, Toyoshima Y, Okamoto K, Ueki S, Hatase T, Ohashi R, Fukuchi T, Akazawa K, Yamada M, Kakita A, Takahashi H, Nishizawa M, Kawachi I. Clinicopathological features in anterior visual pathway in neuromyelitis optica. Ann Neurol. 2016; 79(4):605-24.<\/li>\n<li>Yoshino T, Fukuchi T, Togano T, Sakaue Y, Seki M, Tanaka T, Ueda J. Rate of progression of total, upper, and lower visual field defects in patients with open-angle glaucoma and high myopia. Jpn J Ophthalmol. 2016; 60(2):78-85.<\/li>\n<li>Nishisako M, Meguro A, Nomura E, Yamane T, Takeuchi M, Ota M, Kashiwagi K, Mabuchi F, Iijima H, Kawase K, Yamamoto T, Nakamura M, Negi A, Sagara T, Nishida T, Inatani M, Tanihara H, Aihara M, Araie M, Fukuchi T, Abe H, Higashide T, Sugiyama K, Kanamoto T, Kiuchi Y, Iwase A, Chin S, Ohno S, Inoko H, Mizuki N. SLC1A1 Gene Variants and Normal Tension Glaucoma: An Association Study. Ophthalmic Genet. 2016; 37(2):194-200.<\/li>\n<li>Hasebe H, Matsuoka N, Terashima H, Sasaki R, Ueda E, Fukuchi T. Restoration of the Ellipsoid Zone and Visual Prognosis at 1 Year after Surgical Macular Hole Closure. J Ophthalmol. 2016;2016:1769794.<\/li>\n<li>Yoshikawa M, Akagi T, Nakanishi H, Ikeda HO, Morooka S, Yamada H, Hasegawa T, Iida Y, Yoshimura N. Longitudinal change in choroidal thickness after trabeculectomy in primary open-angle glaucoma patients. Jpn J Ophthalmol. 61(1):105-12, 2016<\/li>\n<li>Tanaka D, Nakanishi H, Hangai M, Akagi T, Morooka S, Ikeda HO, Yoshimura N. Influence of high myopia on outcomes of trabeculectomy with mitomycin C in patients with primary open-angle glaucoma. Jpn J Ophthalmol. 60(6):446-53, 2016<\/li>\n<li>Akagi T, Yoshimura N. Microvascular Density in Glaucomatous Eyes with Hemifield Visual Field Defects: An Optical Coherence Tomography Angiography Study. Reply: Am J Ophthalmol. 2016;170:248-249.<\/li>\n<li>Hasegawa T, Ooto S, Takayama K, Makiyama Y, Akagi T, Ikeda HO, Nakanishi H, Suda K, Yamada H, Uji A, Yoshimura N. Cone Integrity in Glaucoma: An Adaptive-Optics Scanning Laser Ophthalmoscopy Study.Am J Ophthalmol. 2016;171:53-66.<\/li>\n<li>Akagi T, Nakanishi H, Yoshimura N. Morphological Changes after Trabeculectomy in Highly Myopic Eyes with High Intraocular Pressure using Swept-source Optical Coherence Tomography. Am J Ophthalmol Case Rep. 3: 54-60, 2016<\/li>\n<li>Nakanishi H, Akagi T, Suda K, Hasegawa T, Yamada H, Yokota S, Yoshikawa M, Iida Y, Ikeda HO, Morooka S, Ishihara K, Yoshimura N. Clustering of Combined 24-2 and 10-2 Visual Field Grids and Their Relationship With Circumpapillary Retinal Nerve Fiber Layer Thickness. Invest Ophthalmol Vis Sci. 57(7):3203-10, 2016<\/li>\n<li>Akagi T, Iida Y, Nakanishi H, Terada N, Morooka S, Yamada H, Hasegawa T, Yokota S, Yoshikawa M, Yoshimura N. Microvascular Density in Glaucomatous Eyes with Hemifield Visual Field Defects: An Optical Coherence Tomography Angiography Study. Am J Ophthalmol. 168: 237-49, 2016<\/li>\n<li>Akagi T, Uji A, Yoshimura N: Glaucoma Tube Changes After Suture Lysis Assessed by High-Resolution Anterior Segment Optical Coherence Tomography. JAMA Ophthalmol. 134(2): e153674, 2016<\/li>\n<li>Akagi T, Nakano E, Nakanishi H, Uji A, Yoshimura N. Transient Ciliochoroidal Detachment After Ab Interno Trabeculotomy for Open-Angle Glaucoma: A Prospective Anterior-Segment Optical Coherence Tomography Study. JAMA Ophthalmol. 134(3): 304-311, 2016<\/li>\n<li>Yamada H, Akagi T, Nakanishi H, Ikeda HO, Kimura Y, Suda K, Hasegawa T, Yoshikawa M, Iida Y, Yoshimura N. Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma. Ophthalmology. 123(3): 542-551, 2016<\/li>\n<li>Hasegawa T, Akagi T, Hangai M, Yamada H, Suda K, Kimura Y, Nakanishi H, Ikeda HO, Yoshimura N. Structural dissociation of optic disc margin components with optic disc tilting: a spectral domain optical coherence tomography study. Graefes Arch Clin Exp Ophthalmol. 2016 ;254(2):343-349.<\/li>\n<li>Nakanishi H, Akagi T, Hangai M, Kimura Y, Suda K, Hasegawa T, Yamada H, Yoshikawa M, Morooka S, Ikeda HO, Yoshimura N. Effect of Axial Length on Macular Ganglion Cell Complex Thickness and on Early Glaucoma Diagnosis by Spectral-Domain Optical Coherence Tomography. J Glaucoma. 2016; 25(5):e481-490.<\/li>\n<li>Kimura Y, Akagi T, Miyake M, Yamashiro K, Yoshikawa M, Yamada H, Hasegawa T, Suda K, Nakanishi H, Ikeda HO, Gotoh N, Hangai M, Moriyama M, Ohno-Matsui K, Yoshimura N. Association between the CDKN2B-AS1 gene and primary open angle glaucoma with high myopia in Japanese patients. Ophthalmic Genet. 37(2): 242-244, 2016<\/li>\n<\/ul>\n<h3>2015\u5e74<\/h3>\n<ul>\n<li>Matsuoka N, Hasebe H, Mayama T, Fukuchi T. Sub-Tenon Injections of Triamcinolone Acetonide Had Limited Effect on Cystoid Macular Edema Secondary to Nanoparticle Albumin-Bound-Paclitaxel (Abraxane). Case Rep Ophthalmol Med. 2015; 2015:181269.<\/li>\n<li>Suda K, Hangai M, Akagi T, Noma H, Kimura Y, Hasegawa T, Yamada H, Yoshikawa M, Nakanishi H, Ikeda HO, Yoshimura N. Comparison of Longitudinal Changes in Functional and Structural Measures for Evaluating Progression of Glaucomatous Optic Neuropathy. Invest Ophthalmol Vis Sci. 56(9): 5477-5484, 2015<\/li>\n<li>Akagi T, Yoshikawa M, Nakanishi H, Yoshimura N. A Case of WAGR Syndrome in Association with Developmental Glaucoma Requiring Bilateral Baerveldt Glaucoma Implants and Subsequent Tube Repositioning. Clin Ophthalmol. 15(9):1081-1084, 2015<\/li>\n<li>Hasegawa T, Akagi T, Yoshikawa M, Suda K, Yamada H, Kimura Y, Nakanishi H, Miyake M, Unoki N, Ikeda HO, Yoshimura N. Microcystic Inner Nuclear Layer Changes and Retinal Nerve Fiber Layer Defects in Eyes with Glaucoma. PLoS One. 10(6): e0130175, 2015<\/li>\n<li>Nakanishi H, Akagi T, Hangai M, Kimura Y, Suda K, Kumagai KK, Morooka S, Ikeda HO, Yoshimura N. Sensitivity and specificity for detecting early glaucoma in eyes with high myopia from normative database of macular ganglion cell complex thickness obtained from normal non-myopic or highly myopic Asian eyes. Graefes Arch Clin Exp Ophthalmol. 253(7): 1143-1152, 2015<\/li>\n<li>Horii T, Murakami T, Akagi T, Uji A, Ueda-Arakawa N, Nishijima K, Yoshimura N. Optical coherence tomographic reflectivity of cystoid spaces is related to recurrent diabetic macular edema after triamcinolone. Retina. 35(2): 264-71, 2015<\/li>\n<\/ul>\n<h3>2014\u5e74<\/h3>\n<ul>\n<li>Seki M, Fukuchi T, Yoshino T, Ueda J, Hasebe H, Ueki S, Oyama T, Fukushima A, Abe H. Secondary glaucoma associated with bilateral complete ring cysts of the ciliary body. J Glaucoma. 2014; 23(7):477-81.<\/li>\n<li>Sawada H, Yoshino T, Fukuchi T, Abe H. Assessment of the vision-specific quality of life using clustered visual field in glaucoma patients. J Glaucoma. 2014; 23(2):81-7.<\/li>\n<li>Igarashi R, Togano T, Sakaue Y, Yoshino T, Ueda J, Fukuchi T. Effect on intraocular pressure of switching from latanoprost and travoprost monotherapy to timolol fixed combinations in patients with normal-tension glaucoma. J Ophthalmol. 2014;2014:720385.<\/li>\n<li>Sakaue Y, Ueda J, Seki M, Tanaka T, Togano T, Yoshino T, Fukuchi T. Evaluation of the new digital goldmann applanation tonometer for measuring intraocular pressure. J Ophthalmol. 2014;2014:461681.<\/li>\n<li>Kimura Y, Akagi T, Hangai M, Takayama K, Hasegawa T, Suda K, Yoshikawa M, Yamada H, Nakanishi H, Unoki N, Ikeda HO, Yoshimura N. Lamina cribrosa defects and optic disc morphology in primary open angle glaucoma with high myopia. PLoS One. 9(12):e115313, 2014<\/li>\n<li>Hata M, Miyamoto K, Oishi A, Makiyama Y, Gotoh N, Kimura Y, Akagi T, Yoshimura N. Comparison of optic disc morphology of optic nerve atrophy between compressive optic neuropathy and glaucomatous optic neuropathy. PLoS One. 9(11): e112403, 2014<\/li>\n<li>Yamada H, Hangai M, Nakano N, Takayama K, Kimura Y, Miyake M, Akagi T, Ikeda HO, Noma H, Yoshimura N. Asymmetry analysis of macular inner retinal layers for glaucoma diagnosis. Am J Ophthalmol. 158(6):1318-1329.e3, 2014<\/li>\n<li>Sigal IA, Wang B, Strouthidis NG, Akagi T, Girard MJ. Recent advances in OCT imaging of the lamina cribrosa. Br J Ophthalmol. 98 Suppl 2:ii34-9, 2014<\/li>\n<li>Hosoda Y, Akagi T, Yoshimura N. Two cases of malignant glaucoma unresolved by pars plana vitrectomy. Clin Ophthalmol. 8:677-9, 2014<\/li>\n<li>Hangai M, Ikeda HO, Akagi T, Yoshimura N. Paracentral scotoma in glaucoma detected by 10-2 but not by 24-2 perimetry. Jpn J Ophthalmol. 58(2):188-96, 2014<\/li>\n<li>Yoshikawa M, Akagi T, Hangai M, Ohashi-Ikeda H, Takayama K, Morooka S, Kimura Y, Nakano N, Yoshimura N. Alterations in the neural and connective tissue components of glaucomatous cupping after glaucoma surgery using swept-source optical coherence tomography. Invest Ophthalmol Vis Sci. 55(1):477-84, 2014<\/li>\n<li>Nukada M, Hangai M, Mori S, Takayama K, Nakano N, Morooka S, Ikeda HO, Akagi T, Nonaka A, Yoshimura N. Imaging of Localized Retinal Nerve Fiber Layer Defects in Preperimetric Glaucoma Using Spectral-domain Optical Coherence Tomography. J Glaucoma. 23(3): 150-9, 2014<\/li>\n<\/ul>\n<h3>2013\u5e74<\/h3>\n<ul>\n<li>Fukuchi T, Yoshino T, Sawada H, Seki M, Togano T, Tanaka T, Ueda J, Abe H. The relationship between the mean deviation slope and follow-up intraocular pressure in open-angle glaucoma patients. J Glaucoma. 2013; 22(9):689-97.<\/li>\n<li>Seki M, Yamamoto S, Abe H, Fukuchi T. Modified ab externo method for introducing 2 polypropylene loops for scleral suture fixation of intraocular lenses. J Cataract Refract Surg. 2013; 39(9):1291-6.<\/li>\n<li>Ishii M, Seki M, Harigai R, Abe H, Fukuchi T. Reading performance in patients with glaucoma evaluated using the MNREAD charts. Jpn J Ophthalmol. 2013; 57(5):471-4.<\/li>\n<li>Shi D, Funayama T, Mashima Y, Takano Y, Shimizu A, Yamamoto K, Mengkegale M, Miyazawa A, Yasuda N, Fukuchi T, Abe H, Ideta H, Nishida K, Nakazawa T, Richards JE, Fuse N. Association of HK2 and NCK2 with normal tension glaucoma in the Japanese population. PLoS One. 2013; 8(1):e54115.<\/li>\n<li>Yoshino T, Fukuchi T, Togano T, Seki M, Ikegaki H, Abe H. Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases. Jpn J Ophthalmol. 2013; 57(2):172-8.<\/li>\n<li>Nishijima K, Murakami T, Hirashima T, Uji A, Akagi T, Horii T, Ueda-Arakawa N, Muraoka Y, Yoshimura N. HYPERREFLECTIVE FOCI IN OUTER RETINA PREDICTIVE OF PHOTORECEPTOR DAMAGE AND POOR VISION AFTER VITRECTOMY FOR DIABETIC MACULAR EDEMA. Retina. 34(4):732-40, 2013<\/li>\n<li>Muraoka Y, Murakami T, Nishijima K, Akagi T, Uji A, Horii T, Ueda-Arakawa N, Yoshikawa M, Tsujikawa A, Yoshimura N. ASSOCIATION BETWEEN RETINAL VENULAR DILATION AND SEROUS RETINAL DETACHMENT IN DIABETIC MACULAR EDEMA. Retina. 34(4): 725-31, 2013<\/li>\n<li>Kimura Y, Hangai M, Matsumoto A, Akagi T, Ikeda HO, Ohkubo S, Sugiyama K, Iwase A, Araie M, Yoshimura N. Macular structure parameters as an automated indicator of paracentral scotoma in early glaucoma. Am J Ophthalmol. 156(5): 907-917, 2013<\/li>\n<li>Takayama K, Hangai M, Kimura Y, Morooka S, Nukada M, Akagi T, Ikeda HO, Matsumoto A, Yoshimura N. Three Dimensional Imaging of the Lamina Cribrosa Defects in Glaucoma Using Swept-source Optical Coherence Tomography. Invest Ophthalmol Vis Sci. 54(7): 4798-807, 2013<\/li>\n<li>Nakano N, Hangai M, Noma H, Nukada M, Mori S, Morooka S, Takayama K, Kimura Y, Ikeda HO, Akagi T, Yoshimura N. Macular Imaging in Highly Myopic Eyes With and Without Glaucoma. Am J Ophthalmol. 156(3): 511-23, 2013<\/li>\n<li>Akagi T, Hangai M, Kimura Y, Ikeda HO, Nonaka A, Matsumoto A, Akiba M, Yoshimura N. Peripapillary Scleral Deformation and Retinal Nerve Fiber Damage in High Myopia Assessed with Swept-Source Optical Coherence Tomography. Am J Ophthalmol. 155(5): 927-936, 2013<\/li>\n<li>Takayama K, Ooto S, Hangai M, Ueda-Arakawa N, Yoshida S, Akagi T, Ikeda HO, Nonaka A, Hanebuchi M, Inoue T, Yoshimura N. High-Resolution Imaging of Retinal Nerve Fiber Bundles in Glaucoma Using Adaptive Optics Scanning Laser Ophthalmoscopy. Am J Ophthalmol. 155(5): 870-881, 2013<\/li>\n<li>Hirashima T, Hangai M, Nukada M, Nakano N, Morooka S, Akagi T, Nonaka A, Yoshimura N. Frequency-doubling technology and retinal measurements with spectral-domain optical coherence tomography in preperimetric glaucoma. Graefes Arch Clin Exp Ophthalmol. 251(1): 129-137, 2013<\/li>\n<\/ul>\n<p><a href=\"#\" class=\"pagetop\">\u30da\u30fc\u30b8\u30c8\u30c3\u30d7<\/a><\/p>\n<h2 id=\"wabunronbun\">\u548c\u6587\u8ad6\u6587<\/h2>\n<h3>2025\u5e74<\/h3>\n<ul>\n<li>\u6afb\u6fa4 \u6167, \u690d\u6728 \u667a\u5fd7, \u5bfa\u5cf6 \u6d69\u5b50, \u798f\u5730 \u5065\u90ce\uff1a\u80f8\u817a\u816b\u306b\u5408\u4f75\u3057\u305f\u60aa\u6027\u816b\u760d\u968f\u4f34\u7db2\u819c\u75c7\u306e1\u4f8b\uff0e \u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u96d1\u8a8c129(7):658-667, 2025.<\/li>\n<\/ul>\n<h3>2024\u5e74<\/h3>\n<ul>\n<li>\u5bae\u5cf6 \u8aa0, \u8d64\u6728 \u5fe0\u9053, \u7530\u4e2d \u91cc\u4f73, \u7530\u6ca2 \u7dbe\u5b50, \u938c\u7530 \u7d79\u5b50, \u798f\u5730 \u5065\u90ce\uff1a\u7d9a\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u3092\u8a8d\u3081\u305f\u8679\u5f69\u5206\u96e2\u75c7\u306e1\u4f8b\uff0e\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u96d1\u8a8c128(8):610-615, 2024<\/li>\n<\/ul>\n<ul>\n<li>\u98ef\u5ddd \u9f8d(\u65b0\u6f5f\u5927\u5b66 \u5927\u5b66\u9662\u533b\u6b6f\u5b66\u7dcf\u5408\u7814\u7a76\u79d1\u773c\u79d1\u5b66\u5206\u91ce), \u8d64\u6728 \u5fe0\u9053, \u6802\u91ce \u54f2\u54c9, \u5742\u4e0a \u60a0\u592a, \u4e94\u5341\u5d50 \u907c\u5b50, \u6709\u677e \u771f\u592e, \u798f\u5730 \u5065\u90ce\uff1a\u7dda\u7dad\u67f1\u5e2f\u5207\u9664\u8853\u5468\u8853\u671f\u306b\u304a\u3051\u308b\u6297\u83cc\u85ac\u4f7f\u7528\u304a\u3088\u3073\u8853\u91ce\u6d17\u6d44\u306b\u95a2\u3059\u308b\u591a\u65bd\u8a2d\u8abf\u67fb\uff0e\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u96d1\u8a8c128(7):525-532, 2024<\/li>\n<\/ul>\n<h3>2023\u5e74<\/h3>\n<ul>\n<li>\u5bae\u672c \u5927\u8f1d, \u5e02\u6751 \u7f8e\u9999, \u843d\u5408 \u7ae3, \u8d64\u6728 \u5fe0\u9053, \u798f\u5730 \u5065\u90ce\uff1a\u5e83\u7fa9\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30a2\u30a4\u30d5\u30ec\u30a4\u30eb\u30c1\u30a7\u30c3\u30af\u30ea\u30b9\u30c8\u306e\u6709\u7528\u6027\u306e\u691c\u8a0e\uff0e\u773c\u79d165(6):571-578, 2023<\/li>\n<\/ul>\n<h3>2022\u5e74<\/h3>\n<ul>\n<li>\u5b89\u85e4 \u62d3\u6d77, \u4e0a\u7530 \u6075\u7406\u5b50, \u6e21\u9089 \u822a\u592a, \u5bfa\u5cf6 \u6d69\u5b50, \u5409\u7530 \u535a\u5149, \u5bae\u5cf6 \u8aa0, \u798f\u5730 \u5065\u90ce\uff1a\u9ec4\u6591\u5186\u5b54\u7db2\u819c\u5265\u96e2\u306b\u81ea\u7136\u767a\u75c7\u3057\u305f\u4e0a\u8108\u7d61\u819c\u51fa\u8840\u306e1\u4f8b\uff0e\u81e8\u5e8a\u773c\u79d1 76(6):753-758, 2022<\/li>\n<li>\u98ef\u5ddd \u9f8d, \u6802\u91ce \u54f2\u54c9, \u5742\u4e0a \u60a0\u592a, \u672b\u6b66 \u4e9c\u7d00, \u798f\u5730 \u5065\u90ce\uff1a\u30c8\u30e9\u30d9\u30af\u30ec\u30af\u30c8\u30df\u30fc\u8853\u5f8c3\u65e5\u76ee\u306b\u773c\u5185\u708e\u3092\u751f\u3058\u305f1\u4f8b\uff0e\u3042\u305f\u3089\u3057\u3044\u773c\u79d1 39(4):529-532, 2022<\/li>\n<li>\u5b89\u6a02 \u6676\u5b50, \u5927\u6e4a \u7d62, \u5869\u5d0e \u76f4\u54c9, \u5f35 \u5927\u884c, \u798f\u5730 \u5065\u90ce, \u5927\u6a4b \u7460\u5b50, \u8c37 \u512a\u4f51\uff1a\u6e26\u9759\u8108\u6d78\u6f64\u304c\u307f\u3089\u308c\u305f\u3076\u3069\u3046\u819c\u60aa\u6027\u9ed2\u8272\u816b\u306e2\u4f8b. \u81e8\u5e8a\u773c\u79d176(9):1279-1285, 2022<\/li>\n<li>\u91ce\u5d0e \u8000\u5e73, \u677e\u7530 \u82f1\u4f38, \u9ed2\u6fa4 \u53f2\u9580, \u798f\u5730 \u5065\u90ce\uff1aNocardia arthritidis\u306b\u3088\u308b\u64ad\u7a2e\u6027\u30ce\u30ab\u30eb\u30b8\u30a2\u75c7\u306b\u5408\u4f75\u3057\u305f\u3068\u8003\u3048\u3089\u308c\u308b\u5185\u56e0\u6027\u7db2\u819c\u4e0b\u81bf\u760d\u306e1\u4f8b\uff0e\u81e8\u5e8a\u773c\u79d176(9):1233-1239, 2022<\/li>\n<\/ul>\n<h3>2021\u5e74<\/h3>\n<ul>\n<li>\u5409\u7530 \u535a\u5149, \u5bfa\u5cf6 \u6d69\u5b50, \u4e0a\u7530 \u6075\u7406\u5b50, \u5b89\u85e4 \u62d3\u6d77, \u9577\u8c37\u90e8 \u65e5, \u798f\u5730 \u5065\u90ce\uff1a\u7279\u767a\u6027\u9ec4\u6591\u5186\u5b54\u306b\u5bfe\u3059\u308b\u4e2d\u5fc3\u7aa9\u6e29\u5b58\u5185\u5883\u754c\u819c\u5265\u96e2\u8853\u5f8c\u306e\u8996\u6a5f\u80fd\u3068\u9ec4\u6591\u5f62\u614b\u306e\u8a55\u4fa1\uff0e\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c135(1-3):23-30, 2021<\/li>\n<li>\u4f50\u85e4 \u4f0a\u5c06, \u677e\u7530 \u82f1\u4f38, \u91ce\u5d0e \u8000\u5e73, \u9ed2\u6fa4 \u53f2\u9580, \u4f50\u3005\u6728 \u85cd\u5b63\u5b50, \u798f\u5730 \u5065\u90ce\uff1a10\u5e74\u5f8c\u306b\u50da\u773c\u306b\u767a\u75c7\u3057\u30a6\u30a4\u30eb\u30b9\u5b9a\u91cf\u3092\u884c\u3063\u305f\u6025\u6027\u7db2\u819c\u58ca\u6b7b\u306e1\u4f8b\uff0e\u81e8\u5e8a\u773c\u79d175(4):549-554, 2021<\/li>\n<li>\u6709\u677e \u771f\u592e, \u82b3\u91ce \u9ad8\u5b50, \u677e\u7530 \u82f1\u4f38, \u677e\u5ca1 \u5c1a\u6c17, \u9ed2\u6fa4 \u53f2\u9580, \u798f\u5730 \u5065\u90ce\uff1a\u751f\u6765\u5065\u5eb7\u306a\u82e5\u5e74\u8005\u306e\u7247\u773c\u306b\u767a\u75c7\u3057\u305f\u5185\u56e0\u6027\u7d30\u83cc\u6027\u773c\u5185\u708e\u306e1\u4f8b\uff0e\u81e8\u5e8a\u773c\u79d175(3):308-312, 2021<\/li>\n<li>\u8d64\u6728 \u5fe0\u9053, \u85e4\u672c \u96c5\u5927, \u5742\u4e2d \u514b\u884c, \u8fbb\u5ddd \u660e\u5b5d\uff1a\u8108\u7d61\u819c\u8840\u7ba1\u816b\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u7642\u6cd5\u3068\u7dd1\u5185\u969c\u306b\u5bfe\u3059\u308b\u30c1\u30e5\u30fc\u30d6\u30b7\u30e3\u30f3\u30c8\u624b\u8853\u3092\u8981\u3057\u305f\u30b9\u30bf\u30fc\u30b8\u30fb\u30a6\u30a7\u30fc\u30d0\u30fc\u75c7\u5019\u7fa4\u306e\uff11\u4f8b\uff0e\u65e5\u773c\u4f1a\u8a8c125(2):142-149,2021\uff0e<\/li>\n<\/ul>\n<h3>2020\u5e74<\/h3>\n<ul>\n<li>\u5409\u91ce \u79c0\u662d, \u5bae\u5cf6 \u8aa0, \u5742\u4e0a \u60a0\u592a, \u798f\u5730 \u5065\u90ce\uff1a\u5065\u8a3a\u3001\u30c9\u30c3\u30af\u53d7\u8a3a\u3092\u6a5f\u4f1a\u306b\u9b5a\u6cbc\u57fa\u5e79\u75c5\u9662\u773c\u79d1\u306b\u304a\u3044\u3066\u7dd1\u5185\u969c\u3068\u8a3a\u65ad\u3055\u308c\u305f\u75c7\u4f8b\u306e\u691c\u8a0e\uff0e\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c134(3):91-97, 2020<\/li>\n<li>\u5409\u91ce \u79c0\u662d, \u798f\u5730 \u5065\u90ce\uff1a\u6975\u4f4e\u51fa\u751f\u4f53\u91cd\u5150\u306e\u8840\u6f3f\u6210\u9577\u56e0\u5b50\u30fb\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u6fc3\u5ea6\u306e\u691c\u8a0e\uff0e\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c134(1)19-27, 2020<\/li>\n<li>\u9152\u4e95 \u611b, \u4e2d\u91ce \u91cc\u7d75\u5b50, \u677e\u7530 \u82f1\u4f38, \u9ed2\u6fa4 \u53f2\u9580, \u4f50\u3005\u6728 \u85cd\u5b63\u5b50, \u9152\u4e95 \u5eb7\u5f18, \u798f\u5730 \u5065\u90ce\uff1a\u65b0\u6f5f\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308b\u904e\u53bb12\u5e74\u9593\u306e\u6025\u6027\u7db2\u819c\u58ca\u6b7b\u75c7\u4f8b\u306e\u691c\u8a0e\uff0e\u81e8\u5e8a\u773c\u79d174(4):421-427, 2020<\/li>\n<li>\u9ed2\u6fa4 \u53f2\u9580, \u690d\u6728 \u667a\u5fd7, \u6e05\u6cb3 \u6148, \u7551\u702c \u54f2\u5c1a, \u798f\u5730 \u5065\u90ce\uff1a\u9ad8\u8840\u5727\u6027\u7db2\u819c\u75c7\u306b\u3088\u308b\u4e73\u982d\u816b\u8139\u3068\u9451\u5225\u3092\u8981\u3057\u305f\u7279\u767a\u6027\u982d\u84cb\u5185\u5727\u4ea2\u9032\u75c7\u306b\u3088\u308b\u3046\u3063\u8840\u4e73\u982d\u306e1\u4f8b\uff0e\u795e\u7d4c\u773c\u79d137(4):400-405, 2020<\/li>\n<li>\u7530\u6ca2 \u7dbe\u5b50, \u690d\u6728 \u667a\u5fd7, \u6e05\u6cb3 \u6148, \u7fbd\u5165 \u8cb4\u5b50, \u7551\u702c \u54f2\u5c1a, \u798f\u5730 \u5065\u90ce\uff1a\u773c\u7403\u904b\u52d5\u5236\u9650\u3092\u4f34\u308f\u306a\u3044\u5f37\u5ea6\u8fd1\u8996\u6027\u5185\u659c\u8996\u306b\u5bfe\u3057\u3066\u4e0a\u5916\u76f4\u7b4b\u7d50\u5408\u8853\u3092\u65bd\u884c\u3057\u8853\u5f8c\u7d046\u5e74\u9593\u7d4c\u904e\u89b3\u5bdf\u3092\u884c\u3063\u305f1\u4f8b\uff0e\u3000\u795e\u7d4c\u773c\u79d137(3):317-321, 2020<\/li>\n<li>\u98ef\u5ddd \u9f8d, \u798f\u5730 \u5065\u90ce\uff1a\u5149\u5e72\u6e09\u65ad\u5c64\u8a08\uff08OCT\uff09\u306een-face\u753b\u50cf\u3092\u7528\u3044\u305f\u4e2d\u5fc310\u00b0\u5185\u8996\u91ce\u306e\u63a8\u5b9a\uff0e\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c134(3):99-106, 2020<\/li>\n<\/ul>\n<h3>2019\u5e74<\/h3>\n<ul>\n<li>\u9577\u8c37\u5ddd \u53cb\u52a0\u91cc, \u5742\u4e0a \u60a0\u592a, \u690d\u6728 \u667a\u5fd7, \u98ef\u5ddd \u9f8d, \u4e2d\u91ce \u91cc\u7d75\u5b50, \u672b\u6b66 \u4e9c\u7d00, \u6802\u91ce \u54f2\u54c9, \u798f\u5730 \u5065\u90ce\uff1a\u6b63\u5e38\u773c\u5727\u7dd1\u5185\u969c\u306e\u7d4c\u904e\u4e2d\u306b\u8996\u4ea4\u53c9\u90e8\u816b\u760d\u5408\u4f75\u304c\u660e\u3089\u304b\u306b\u306a\u3063\u305f4\u4f8b\uff0e\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u96d1\u8a8c123(12):1101-1108, 2019<\/li>\n<li>\u843d\u5408 \u7ae3, \u77f3\u4e95 \u96c5\u5b50, \u5f35\u66ff \u6dbc\u5b50, \u798f\u5730 \u5065\u90ce\uff1a90\u6b73\u4ee5\u4e0a\u3067\u62e1\u5927\u8aad\u66f8\u5668\u3092\u65e5\u5e38\u7684\u306b\u4f7f\u7528\u3057\u3066\u3044\u308b\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u60a3\u8005\u306e2\u4f8b\uff0e\u65e5\u672c\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u5b66\u4f1a\u8a8c18:S11-S15, 2019<\/li>\n<li>\u8d64\u6728 \u5fe0\u9053\u3001\u9808\u7530\u8b19\u53f2\u3001\u4e80\u7530\u9686\u7bc4\u3001\u4e09\u5b85\u6b63\u88d5\u3001\u6c60\u7530\u83ef\u5b50\u3001\u8fbb\u5ddd\u660e\u5b5d\uff1a 2\u56de\u306e\u7dd1\u5185\u969c\u30a4\u30f3\u30d7\u30e9\u30f3\u30c8\u9732\u51fa\u306b\u5bfe\u3057\u3066\u30a4\u30f3\u30d7\u30e9\u30f3\u30c8\u6458\u51fa\u3068\u518d\u7559\u7f6e\u8853\u3092\u8981\u3057\u305f\u7d9a\u767a\u7dd1\u5185\u969c\u306e\uff11\u4f8b. \u81e8\u5e8a\u773c\u79d1 73(5), 573-580, 2019<\/li>\n<\/ul>\n<h3>2018\u5e74<\/h3>\n<ul><\/ul>\n<h3>2017\u5e74<\/h3>\n<ul>\n<li>\u6751\u7530 \u61b2\u7ae0, \u5bae\u672c \u3075\u3046\u5b50, \u6728\u4e0b \u76f4\u5f66, \u690d\u6728 \u667a\u5fd7, \u7551\u702c \u54f2\u5c1a, \u798f\u5730 \u5065\u90ce\uff1a\u8996\u7dda\u89e3\u6790\u88c5\u7f6e\u3092\u7528\u3044\u305f\u7db2\u819c\u8272\u7d20\u5909\u6027\u60a3\u8005\u306e\u8aad\u66f8\u8a55\u4fa1\uff0e\u65e5\u672c\u8996\u80fd\u8a13\u7df4\u58eb\u5354\u4f1a\u8a8c46:245-256, 2017<\/li>\n<li>\u672c\u9593 \u53cb\u91cc\u6075, \u6802\u91ce \u54f2\u54c9, \u5bae\u672c \u5927\u8f1d, \u5742\u4e0a \u60a0\u592a, \u4e94\u5341\u5d50 \u907c\u5b50, \u798f\u5730 \u5065\u90ce\uff1a\u5e83\u7fa9\u30fb\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u773c\u306e\u4e2d\u5fc3\u7aa9\u95be\u5024\u3068\u77ef\u6b63\u8996\u529b\u3001\u508d\u4e2d\u5fc3\u7aa9\u8996\u91ce\u611f\u5ea6\u95be\u5024\u306e\u76f8\u95a2\uff0e\u3042\u305f\u3089\u3057\u3044\u773c\u79d134(11):1617-1621, 2017<\/li>\n<li>\u6802\u91ce \u54f2\u54c9, \u5e73\u5cf6 \u307f\u307b, \u672b\u6b66 \u4e9c\u7d00, \u5742\u4e0a \u60a0\u592a, \u98ef\u5ddd \u9f8d, \u672c\u9593 \u53cb\u91cc\u6075, \u798f\u5730 \u5065\u90ce\uff1aHumphrey\u8996\u91ce\u8a0810-2\u30d7\u30ed\u30b0\u30e9\u30e0\u7570\u5e38\u70b9\u6570\u3068\u9ec4\u6591\u90e8\u7db2\u819c\u5185\u5c64\u539a\u30bb\u30af\u30bf\u30fc\u5224\u5b9a\u3068\u306e\u76f8\u95a2\uff0e \u3042\u305f\u3089\u3057\u3044\u773c\u79d134(10):1465-1469, 2017<\/li>\n<li>\u798f\u6b66 \u6148, \u5742\u4e0a \u60a0\u592a, \u6802\u91ce \u54f2\u54c9, \u4e94\u5341\u5d50 \u907c\u5b50, \u9577\u8c37\u90e8 \u65e5, \u798f\u5730 \u5065\u90ce\uff1aSoemmerring\u8f2a\u3092\u4f34\u3046\u7d9a\u767a\u9589\u585e\u9685\u89d2\u75c7\u306e2\u4f8b\uff0e\u3042\u305f\u3089\u3057\u3044\u773c\u79d134(7):1054-1059, 2017<\/li>\n<\/ul>\n<h3>2016\u5e74<\/h3>\n<ul>\n<li>\u677e\u7530 \u82f1\u4f38, \u9152\u4e95 \u5eb7\u5f18, \u798f\u5730 \u5065\u90ce\uff1a\u89d2\u819c\u30d1\u30fc\u30c4\u79fb\u690d\u3068\u518d\u751f\u533b\u7642\uff0e\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c 130(11):628-630, 2016.<\/li>\n<li>\u5bae\u672c \u5927\u8f1d, \u5742\u4e0a \u60a0\u592a, \u6802\u91ce \u54f2\u54c9, \u672b\u6b66 \u4e9c\u7d00, \u4f50\u3005\u6728 \u85cd\u5b63\u5b50, \u798f\u6b66 \u6148, \u672c\u9593 \u53cb\u91cc\u6075, \u798f\u5730 \u5065\u90ce\uff1a\u30de\u30a4\u30af\u30ed\u30c1\u30e5\u30fc\u30d6\u30b7\u30e3\u30f3\u30c8(\u30a8\u30af\u30b9\u30d7\u30ec\u30b9)\u3092\u7528\u3044\u305f\u6ffe\u904e\u624b\u8853\u5f8c\u306e\u89d2\u819c\u5185\u76ae\u7d30\u80de\u5909\u5316\uff0e\u3042\u305f\u3089\u3057\u3044\u773c\u79d133(11):1645-1650, 2016<\/li>\n<li>\u677e\u7530 \u82f1\u4f38, \u9152\u4e95 \u5eb7\u5f18, \u4e0a\u7530 \u6075\u7406\u5b50, \u798f\u5730 \u5065\u90ce\uff1a\u5185\u773c\u708e\u6240\u898b\u3092\u5408\u4f75\u3057\u305f\u591a\u767a\u6027\u5f8c\u6975\u90e8\u7db2\u819c\u8272\u7d20\u4e0a\u76ae\u75c7(MPPE)\u306e1\u4f8b\uff0e\u81e8\u5e8a\u773c\u79d170(5):681-687, 2016<\/li>\n<li>\u6751\u7530 \u61b2\u7ae0, \u77f3\u4e95 \u96c5\u5b50, \u5f35\u66ff \u51c9\u5b50, \u798f\u5730 \u5065\u90ce\uff1a\u65b0\u6f5f\u5927\u5b66\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u5916\u6765\u306b\u304a\u3051\u308b\u5f8c\u671f\u9ad8\u9f62\u8005\u306e\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u30b1\u30a2\uff0e\u65e5\u672c\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u5b66\u4f1a\u8a8c15:58-62, 2016<\/li>\n<li>\u516b\u767e\u679d \u6f54, \u798f\u5cf6 \u6df3\u5fd7, \u767d\u67cf \u57fa\u5b8f, \u6802\u91ce \u54f2\u54c9, \u5742\u4e0a \u60a0\u592a, \u672b\u6b66 \u4e9c\u7d00, \u798f\u5730 \u5065\u90ce\uff1a\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u773c\u306b\u304a\u3051\u308b\u4e2d\u5fc3\u89d2\u819c\u539a\u3068\u89d2\u819c\u751f\u4f53\u529b\u5b66\u7684\u7279\u6027\u306b\u3088\u308b\u773c\u5727\u5024\u306e\u88dc\u6b63\uff0e\u81e8\u5e8a\u773c\u79d170(3):323-329, 2016<\/li>\n<\/ul>\n<h3>2015\u5e74<\/h3>\n<ul>\n<li>\u677e\u5ca1 \u5c1a\u6c17, \u9577\u8c37\u90e8 \u65e5, \u5bfa\u5cf6 \u6d69\u5b50, \u4f50\u85e4 \u5f25\u751f, \u4e0a\u7530 \u6075\u7406\u5b50, \u4f50\u3005\u6728 \u4eae, \u798f\u5730 \u5065\u90ce\uff1a\u6297VEGF\u85ac\u306e\u785d\u5b50\u4f53\u5185\u6ce8\u5c04\u3068\u5f8c\u90e8\u785d\u5b50\u4f53\u5265\u96e2\u306e\u767a\u75c7\u983b\u5ea6\uff0e\u773c\u79d1\u81e8\u5e8a\u7d00\u89818(10):730-733, 2015<\/li>\n<li>\u516b\u767e\u679d \u6f54, \u798f\u5cf6 \u6df3\u5fd7, \u767d\u67cf \u57fa\u5b8f, \u6802\u91ce \u54f2\u54c9, \u798f\u5730 \u5065\u90ce\uff1a\u6e2c\u5b9a\u74b0\u5883\u306e\u5909\u5316\u306b\u4f34\u3046\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c(\u5e83\u7fa9)\u60a3\u8005\u306e\u773c\u5727\u5909\u52d5\uff0e\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u96d1\u8a8c119(7):451-456, 2015<\/li>\n<li>\u98ef\u5ddd \u9f8d, \u4e2d\u6751 \u88d5\u4ecb, \u5927\u77e2 \u4f73\u7f8e, \u5b89\u85e4 \u4f38\u6717\uff1a\u7db2\u819c\u9759\u8108\u5206\u5c90\u9589\u585e\u75c7\u306b\u4f34\u3046\u9ec4\u6591\u6d6e\u816b\u306b\u5bfe\u3059\u308b\u30e9\u30cb\u30d3\u30ba\u30de\u30d6\u6cbb\u7642\uff0e\u81e8\u5e8a\u773c\u79d1 69(5):693-697, 2015<\/li>\n<\/ul>\n<h3>2014\u5e74<\/h3>\n<ul>\n<li>\u4e2d\u91ce \u82f1\u4e4b, \u9577\u8c37\u90e8 \u65e5, \u677e\u5ca1 \u5c1a\u6c17, \u5bfa\u5cf6 \u6d69\u5b50, \u4f50\u3005\u6728 \u4eae, \u4e0a\u7530 \u6075\u7406\u5b50, \u4f50\u85e4 \u5f25\u751f, \u798f\u5730 \u5065\u90ce\uff1a\u7db2\u819c\u8272\u7d20\u7dda\u6761\u306b\u8108\u7d61\u819c\u65b0\u751f\u8840\u7ba1\u3092\u5408\u4f75\u3057\u305f\u5bb6\u65cf\u4f8b\uff0e\u81e8\u5e8a\u773c\u79d169(7):1057-1061, 2014<\/li>\n<li>\u5c3e\u5c71 \u5fb3\u79c0, \u5f35 \u5927\u884c, \u5927\u6e4a \u7d62, \u798f\u5730 \u5065\u90ce\uff1a\u773c\u7aa9\u58c1\u9aa8\u6298\u306e\u786c\u6027\u518d\u5efa\u306b\u5bfe\u3059\u308b\u56fa\u5b9a\u5b54\u306a\u3057\u30b7\u30fc\u30c8\u72b6\u5438\u53ce\u6027\u30d7\u30ec\u30fc\u30c8(LactoSorb)\u306e\u4f7f\u7528\u7d4c\u9a13\uff0e\u65e5\u672c\u5f62\u6210\u5916\u79d1\u5b66\u4f1a\u4f1a\u8a8c34(10):726-735, 2014<\/li>\n<li>\u5bfa\u5cf6 \u6d69\u5b50, \u9577\u8c37\u90e8 \u65e5, \u798f\u5cf6 \u6df3\u5fd7, \u4f50\u3005\u6728 \u4eae, \u677e\u5ca1 \u5c1a\u6c17, \u9ad8\u7530 \u5f8b\u5b50, \u4f50\u85e4 \u5f25\u751f, \u4e0a\u7530 \u6075\u7406\u5b50, \u798f\u5730 \u5065\u90ce\uff1a\u9ec4\u6591\u5265\u96e2\u3092\u4f34\u3046\u88c2\u5b54\u539f\u6027\u7db2\u819c\u5265\u96e2\u306e\u9577\u671f\u8996\u529b\u4e88\u5f8c\uff0e\u773c\u79d1\u624b\u885327(1):112-117, 2014<\/li>\n<li>\u4e2d\u91ce \u91cc\u7d75\u5b50, \u677e\u5ca1 \u5c1a\u6c17, \u677e\u7530 \u82f1\u4f38, \u9577\u8c37\u90e8 \u65e5, \u9152\u4e95 \u5eb7\u5f18, \u798f\u5730 \u5065\u90ce\uff1a\u65b0\u6f5f\u5927\u5b66\u306b\u304a\u3051\u308b\u6025\u6027\u7db2\u819c\u58ca\u6b7b\u75c7\u4f8b\u306e\u691c\u8a0e\uff0e\u81e8\u5e8a\u773c\u79d169(7):981-985, 2014<\/li>\n<\/ul>\n<h3>2013\u5e74<\/h3>\n<ul>\n<li>\u677e\u6d66 \u5c06\u4eba, \u77f3\u4e95 \u96c5\u5b50, \u5f35\u66ff \u6dbc\u5b50, \u798f\u5730 \u5065\u90ce\uff1a\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u30b1\u30a2\u306b\u3088\u3063\u3066\u5c31\u52b4\u7d99\u7d9a\u304c\u53ef\u80fd\u3067\u3042\u3063\u305f\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u306e1\u4f8b\uff0e\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c127(8):427-432, 2013<\/li>\n<li>\u5927\u6e4a \u7d62, \u5c3e\u5c71 \u5fb3\u79c0, \u5f35 \u5927\u884c, \u6c5f\u53e3 \u529f\u4e00, \u798f\u5730 \u5065\u90ce\uff1a\u539f\u767a\u6027\u4e0a\u76ae\u578b\u773c\u77bc\u90e8\u60aa\u6027\u816b\u760d\u306e\u5207\u9664\u5f8c\u306e\u518d\u5efa\u8853\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff0e\u81e8\u5e8a\u773c\u79d167(8):1295-1298, 2013<\/li>\n<li>\u5742\u4e0a \u60a0\u592a, \u798f\u5730 \u5065\u90ce, \u7530\u4e2d \u9686\u4e4b, \u95a2 \u6b63\u660e, \u6802\u91ce \u54f2\u54c9, \u4e0a\u7530 \u6f64, \u963f\u90e8 \u6625\u6a39\uff1a\u30c8\u30e9\u30d9\u30af\u30ec\u30af\u30c8\u30df\u30fc\u65e2\u5f80\u773c\u306e\u767d\u5185\u969c\u624b\u8853\u5f8c\u306e\u773c\u5727\u7d4c\u904e\uff0e\u773c\u79d1\u624b\u885326(4):637-642, 2013<\/li>\n<li>\u672c\u9593 \u53cb\u91cc\u6075, \u5f35\u66ff \u6dbc\u5b50, \u77f3\u4e95 \u96c5\u5b50, \u963f\u90e8 \u6625\u6a39, \u798f\u5730 \u5065\u90ce\uff1a\u65b0\u6f5f\u5927\u5b66\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u5916\u6765\u306b\u304a\u3051\u308b\u7dd1\u5185\u969c\u60a3\u8005\u306e\u53d7\u8a3a\u72b6\u6cc1\uff0e\u3042\u305f\u3089\u3057\u3044\u773c\u79d130(7):1029-1033, 2013<\/li>\n<\/ul>\n<p><a href=\"#\" class=\"pagetop\">\u30da\u30fc\u30b8\u30c8\u30c3\u30d7<\/a><\/p>\n<h2 id=\"kokusaigakkai\">\u56fd\u969b\u5b66\u4f1a\u767a\u8868<\/h2>\n<h3>2026\u5e74<\/h3>\n<p><u>FujiRetina 2026. Tokyo 2026.3.27\uff5e3.29<\/u><\/p>\n<ul>\n<li>Hiroko Terashima, et al : Emergency Pneumatic Retinopexy for Macula-off RRD in a Claustrophobic Patient<\/li>\n<li>Takumi Ando : Coughing-induced Ocular Content Extrusion through a Perforating Corneal Injury<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2025\u5e74<\/h3>\n<p><u>The 5th Asia Retina Congress 2025. Taiwan 2025.10.25\uff5e10.26<\/u><\/p>\n<ul>\n<li>Hiroko Terashima, et al : MP3-guided ILM Peeling for Glaucoma-associated Epiretinal Membrane<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>WGC 2025. Honolulu 2025.6.25\uff5e6.28<\/u><\/p>\n<ul>\n<li>Tadamichi Akagi, et al : Intraocular pressure in the anterior chamber and vitreous cavity of the porcine eye: Effect verification of Irido-zonulo-hyaloido-vitrectomy.<\/li>\n<li>Taro Kuramoto, et al : A case of primary angle-closure with shallow anterior chamber persisting after cataract surgery<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>ARVO 2025. Salt Lake City 2025.5.4\uff5e5.8<\/u><\/p>\n<ul>\n<li>Takumi Ando, et al : Retinal Age Gap in Unilateral Retinal Diseases Using Japanese Open-source Retinal Age Estimation AI Model.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>ASRS 2025. CA 2005.4.29\uff5e8.2<\/u><\/p>\n<ul>\n<li>Takumi Ando, et al : No More Holes: A Surgical Strategy for Macular Retinoschisis with Glaucoma<\/li>\n<li>Takumi Ando, et al : The Mystery of Unstoppable Iris Bleeding.<\/li>\n<li>Takumi Ando, et al : Risk Factors and Predictive Cutoff Values for New-Onset Microscotoma Following Vitrectomy for Epiretinal Membrane<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>FUJIRETINA 2025. Tokyo 2025.3.28\uff5e30<\/u><\/p>\n<ul>\n<li>Hiroko Terashima\uff1aTreatment of Hypotony Maculopathy Caused by Traumatic Cyclodialysis.<\/li>\n<li>Takumi Ando, et al\uff1aFovea-Involving Transient Chorioretinal Folds Worsens Visual Function and Ellipsoid Zone.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>2025 Vail meeting CO 2025.2.8\uff5e11<\/u><\/p>\n<ul>\n<li>Hiroko Terashima\uff1aMP3-guided ILM Peeling for Glaucoma-associated Macular Disease.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2024\u5e74<\/h3>\n<p><u>APAO 2024. Bali 2024.2.22\uff5e2.25<\/u><\/p>\n<ul>\n<li>Ryu Iikawa, et al.: Visual field areas affecting quality of vision in glaucoma patients.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>EUJI RETINA 2024, Tokyo 2024.3.22<\/u><u>\uff5e3.24<\/u><\/p>\n<ul>\n<li>Hiroko Terashima, et al : Retinal detachment causing massive expulsive hemorrhage.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>ARVO 2024. Seattle 2024.5.5<\/u><u>\uff5e5.9<\/u><\/p>\n<ul>\n<li>Takumi Ando, et al : Evaluation of ellipsoid zone defect and visual function caused by transient macular folding due to hypotony after vitrectomy.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>EURETINA 2024, Barcelona 2024.9.19<\/u><u>\uff5e9.22<\/u><\/p>\n<ul>\n<li>Hiroko Terashima, et al.: Retinal sensitivity and ganglion cell complex changes after vitrectomy for macular disease in high myopia.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>The 17<sup>th<\/sup> Meeting of Japan-Korea-China Ophthalmologists Tokyo 2024.11.9<\/u><\/p>\n<ul>\n<li>Takumi Ando, et al.: Impact of Transient Macular Folding due to Hypotony After Vitrectomy on Visual Function and Ellipsoid Zone Damage<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2023\u5e74<\/h3>\n<p><u>FLORETINA ICOOR 2023, Roma 2023.11.30<\/u><u>\uff5e12.3<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Hiroko Terashima, et al.: Macular structure and visual function changes in glaucoma-associated macular hole.<\/li>\n<li>Yohei Nozaki, et al.: A STUDY ON CLINICAL APPLICATION OF DETECTION OF IRIS NEOVASCULARIZATION BY ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>16th KCJ symposium 2023, Seoul 2023.11.24<\/u><u>\uff5e11.25<\/u><\/p>\n<p>\u30101) Imaging and Eye in the three countries\u3011<\/p>\n<ul>\n<li>Tadamichi Akagi, et al.: Evaluation of the Deep Structure and Vasculature of the Optic Disc in Glaucoma.<span>\u00a0<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>American Academy of Ophthalmology (AAO) 2023, San Francisco 2023.11.3<\/u><u>\uff5e6<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Yohei Nozaki, et al.: Staging and temporal monitoring of neovascularization of the iris using anterior segment optical coherence tomography angiography.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>EURETINA 2023, Amsterdam 2023.10.5\uff5e8<\/u><\/p>\n<p>\u3010video competition\u3011<\/p>\n<ul>\n<li>Takumi Ando: Intraocular contents extrusion in deep scleral rupture.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>10th World Glaucoma Congress (WGC) 2023, Tokyo 2023.3.25\uff5e26<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Tadamichi Akagi, et al.: Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: a 3-year Prospective Study.<\/li>\n<li>Ryoko Igarashi, et al.: Nna1 deficiency causes retinal degeneration and glaucoma in a pcd mouse model.<\/li>\n<li>Mao Arimatsu, et al.: Longitudinal Vascular Changes assessed using AS-OCTA in Different Conjunctival Incisions in Filtering Trabeculectomy Blebs: a Pilot Study<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>FUJIRETINA , Tokyo 2023.3.25<\/u><u>\uff5e26<\/u><\/p>\n<p>\u3010Science session (Surgical) 4\u300cMacular surgery : technique and imaging\u300d\u3011<\/p>\n<ul>\n<li>Hiroko Terashima, et al.: Macular structure and visual function changes in glaucoma-associated macular hole.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>Duke Advanced Vitreous Surgery Courses , Tokyo 2023.3.23\uff5e25<\/u><\/p>\n<ul>\n<li>Takumi Ando: Intraocular contents extrusion in deep scleral rupture.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2022\u5e74<\/h3>\n<p><u>FUJIRETINA , Tokyo 2022.4.23\uff5e24<\/u><\/p>\n<p>\u3010Science session (Surgical) 3 Macular surgery\u3011<\/p>\n<ul>\n<li>Hiroko Terashima, et al.: MP3 guided ILM peeling for glaucoma-associated macular disease.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2021\u5e74<\/h3>\n<p><u>21st EURETINA 2021 Virtual Congress , Web 2021.9.9\uff5e12<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Takumi Ando, et al.: Relationship between the foveal avascular zone and visual function before and after surgery for idiopathic macular hole.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>2nd International Ocular Circulation Sciety (IOCS) Kyoto, 2021.9.24\uff5e26<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Tadamichi Akagi, et al.: Short-Term Effects of Different Types of Anti-Glaucoma Eyedrop on the Sclero-Conjunctival Vasculature Assessed Using Anterior Segment OCTA in Normal Eyes: A Pilot Study<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>9th World Glaucoma Congress (WGC) 2021\u3000Web\u30002021.6.30\uff5e7.3<\/u><\/p>\n<p>\u3010Parallel Symposium13\u3011<\/p>\n<ul>\n<li>World Glaucoma Patient Association (WGPA) Symposium Takeo Fukuchi: Chair<\/li>\n<\/ul>\n<p>\u3010Course04\u3011<\/p>\n<ul>\n<li>Quality of life \/ Patient adherence Takeo Fukuchi: What is the key to improve adherence in NTG?<\/li>\n<\/ul>\n<p>\u3010Parallel Symposium14\u3011<\/p>\n<ul>\n<li>NTG Joint session with Japan Glaucoma Society Tadamichi Akagi: Imaging characteristics of NTG<\/li>\n<\/ul>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Yuta Sakaue, et al.: Trabeculectomy for open-angle glaucoma patients with visual field damage in the papillo-macular area<\/li>\n<li>Ryu Iikawa, et al.: Relationship between foveal threshold and quality of vision using the National Eye Institute Visual Function Questionnaire-25 in glaucoma patients.<\/li>\n<li>Yukiho Takano, et al.: Impact of Rock inhibitor eye drop on corneal endothelial cell counts as measured by specular microscopy.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2020\u5e74<\/h3>\n<p><u>14th European Glaucoma Society (EGS) Congress\u3000Web\u30002020.12.25\uff5e26<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Tetsuya Togano, et al.: Interpolation of visual sensitivity based on the retinal nerve fiber trajectory.<\/li>\n<li>Yuta Sakaue, et al.: The relationship between the mean deviation slope in the central 10 degrees of visual field and follow-up intraocular pressure in open-angle glaucoma.<\/li>\n<li>Satomi Aida, et al.: The relationship between the mean deviation slope of visual field and follow-up intraocular pressure in open-angle glaucoma.<\/li>\n<li>Yukiho Takano, et al.: Impact of Rock inhibitor eye drop on corneal endothelial cell counts as measured by specular microscopy.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>20th EURETINA Congress\u3000Web\u30002020.10.1\uff5e4<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Hiroko Terashima, et al.\uff1aEffect of internal limiting membrane peeling on macular visual function in patients with vitrectomy for epiretinal membrane in glaucomatous eyes.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2019\u5e74<\/h3>\n<p><u>123rd American Academy of Ophthalmology (AAO) 2019 San Francisco, 2019.10.12-15<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Takeo Fukuchi, et al.: Clustered Visual Field Progression of Primary Open-angle Glaucoma with Disc Hemorrhages in a Three-year Prospective Study, 2nd report.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>19th EURETINA 2019 Paris, 2019.9.5-8<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Hiruma Hasebe, et al.: Characteristics of irnprovernent of visual acuity in the eyes with good visual prognosis after surgical rnacular hole closure.<\/li>\n<li>Hiroko Terashima, et al.: Prediction of postoperative visual function based on inner layer structure of preoperative epiretinal membrane<\/li>\n<li>Naoki Matsuoka, et al.: Change of the Internal limiting membrane peeling area after Vitrectomy for Idiopathic macular hole.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>The Association for Research in Vision and Ophthalmology (ARVO) 2019, Vancouver, 2019.4.28\u20135.2<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Tadamichi Akagi, et al.: Anterior Segment Optical Coherence Tomography Angiography Imaging of Conjunctiva and Intrasclera in Treated Primary Open-Angle Glaucoma<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>8th World Glaucoma Congress (WGC) 2019, Melbourne, 2019.3.27\u201330<\/u><\/p>\n<p>\u3010Japan Glaucoma Society Symposium\u3011<\/p>\n<ul>\n<li>Hot topics of imaging for glaucoma diagnosis and management Tadamichi Akagi: Usefulness of OCT angiography in glaucoma diagnosis and management<\/li>\n<\/ul>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Yuta Sakaue, et al.: The effect of steep Trendelenburg positioning during robot-assisted laparoscopic radical prostatectomy on intraocular pressure and visual function.<\/li>\n<li>Ryu Iikawa, et al.: Relationship between swept-source OCT en-face image and foveal threshold in glaucoma patients.<\/li>\n<li>Kinuko Kamada, et al.: Developing a method to predict mean deviation of 10-2 test from 24-2 test in the standard automated perimetry.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2018\u5e74<\/h3>\n<p><u>122nd American Academy of Ophthalmology (AAO) 2018 Chicago, Illinois, 2018.10.27-30<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Takeo Fukuchi, et al.: Clustered Visual Field Progression of Primary Open-angle Glaucoma with Disc Hemorrhages in a Three-year Prospective Study.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>18th EURETINA 2018 Vienna, Austria, 2018.9.20-23<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Hasebe, et al.: Postoperative changes of foveal hyper reflective lesion in OCT images of surgically closed macular hole.<\/li>\n<li>Terashima Hiroko, et al.: Relationship between optical coherence tomography angiography and visual field sensitivity for macular non-perfusion in branch retinal vein occlusion.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>World Ophthalmology Congress (WOC) 2018 Barcelona Spain, 2018.6.16-19<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Naoki Matsuoka, et al.: Segmental Choroidal Thickness of Idiopathic Macular Hole and Epiretinal Membrane.<\/li>\n<li>Jun Ominato, et al.: Local recurrence and lymph node metastasis rates of primary sebaceous and squamous cell carcinoma of the eyelid: A retrospective single institution study.<\/li>\n<li>Shiozaki Naoya\uff1aEvaluation of the clinical course of binocular retinoblastoma cases: A retrospective single institution study.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>13th European Glaucoma Society (EGS) Congress 2018 Fortezza da Basso,Florence,Italy 2018.5.19-22<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Takeo Fukuchi, et al.: Correlation Among Foveal Avascular Zone (FAZ) Detected by OCT Angiography and Inner Retinal Thickness, and Visual Filed Defects in POAG\/NTG patients.<\/li>\n<li>Tetsuya Togano, et al.: Analyzing test-retest variability of cluster sensitivity incorporating the structure-function relationship.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>The Association for Research in Vision and Ophthalmology (ARVO) 2018\u3000Honolulu, Hawaii, 2018.4.29 \u2013 5.3<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Ryu likawa, et al.: Comparison between estimated central 10 degrees visual field from En-face imaging of Swept-Source optical coherence tomography and Humphrey 10-2 Visual Field.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>4th Asia-Pacific Glaucoma Congress. (APGC) 2018\u3000Busan, Korea, 2018.4.13-15<\/u><\/p>\n<p>\u3010Course 07\u3011<\/p>\n<ul>\n<li>Glaucoma Imaging in Clinical Practice Tadamich Akagi: Vascular imaging of optic nerve and retina using OCT-angiography<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2017\u5e74<\/h3>\n<p><u>The 33rd Korean glaucoma society, Seoul, Korea, 2017.11.18-19<\/u><\/p>\n<p>\u3010Oral presentation\u3011<\/p>\n<ul>\n<li>Tetsuya Togano\uff1aDevelopment of High Density integrated Visual Field Optimized for Evaluation of Vision Related Quality of Life.<\/li>\n<\/ul>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Yuta Sakaue, et al.: Intraocular pressure changes during robot-assisted laparoscopic radical prostatectomy in normal and glaucomatous eyes.<\/li>\n<li>Aki Suetake, et al.: Clinical Results of simultaneous trabeculotomy, extraction of lens and fixation of intraocular lens in eyes with subluxated lens and exfoliation glaucoma.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>121st American Academy of Ophthalmology. (AAO) New Orleans, USA, 2017.11.11-14<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Tadamichi Akagi, et al.: Optical Coherence Tomography Angiography Microvasculature Dropout inside the Optic Disc in Primary Open-angle Glaucoma Eyes<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>17th EURETINA CONGRESS BARCELONA, SPAIN, 2017.9.7-10<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Hiruma Hasebe, et al.: Binarization technique to investigate foveal hyper-reflective lesion in OCT image of surgically closed macular hole.<\/li>\n<li>Hiroko Terashima, et al.: Retinal Microstructures and Sensitivity after Vitrectomy and Internal Limiting Membrane Peeling for Epiretinal Membrane: Evaluation Using Swept Source Optical Coherence Tomography and Humphrey 10-2 Program.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>World Glaucoma Congress (WGC) 2017 Helsinki, Finland, 2017.6.28 -7.1<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Takeo Fukuchi, et al.: Flow density and disappeared angle of the peripapillary capillaries quantified by OCT angiography might be structural indexes in OAG eyes.<\/li>\n<li>Tetsuya Togano, et al.: Relationship Between Vfq25 Score And Mean Sensitivity Of Integrated Visual Field With Weighting Corresponding To The Location.<\/li>\n<li>Yuta Sakaue, et al.: The effect of steep Trendelenburg positioning during robot-assisted laparoscopic radical prostatectomy in glaucoma patients.<\/li>\n<li>Ryu Iikawa, et al.: Observation of retinal nerve fiber bundles of segmental optic nerve hypoplasia with swept-source OCT en-face imaging and comparison sith SD-OCT.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>The Association for Research in Vision and Ophthalmology (ARVO) 2017 Baltimore,United States, 2017.5.7\u201311<\/u><\/p>\n<p>\u3010Oral presentation\u3011<\/p>\n<ul>\n<li>Tadamichi Akagi, et al.: Rates of Local Retinal Nerve Fiber Layer (RNFL) Thinning before and after Disc Hemorrhage (DH) in Glaucoma Patients<\/li>\n<\/ul>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Sakaue Yuta, et al.: Correlation between structure and function each cluster of test points within the central 10 degrees inglaucoma.<\/li>\n<li>Ominato Jun, et al.: Evaluation of somatic mutations of KRAS, NRAS, and BRAF in Japanese patients with lacrimal gland epithelial tumors.<\/li>\n<li>Murata Noriaki, et al.: Relationship between Silent Reading Performance and Clustered Visual Field in Patients with Glaucoma.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>Retina World Congress 2017 Fort Lauderdale,United States, 2017.2.23-26<\/u><\/p>\n<ul>\n<li>Hiroko Terashima, et al.: Combination therapy of intravitreal ranibizumab and subthreshold micropulse photocoagulation for macular edema secondary to branch retinal vein occlusion\uff1a6 month Result.<\/li>\n<li>Jun Ominato, et al.: Course of lgG4-related ophthalmic disease following excisional biopsy.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>The Association for Research in Vision and Ophthalmology ARVO-Asia 2017 Brisbane, Australia, 2017.2.5-8<\/u><\/p>\n<p>\u3010Poster presentation\u3011<\/p>\n<ul>\n<li>Matsuoka Naoki, et al.: Correlation of visual acuity and segmental choroidal and retinal thickness change following vitrectomy in idiopathic epiretinal membrane.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"#\" class=\"pagetop\">\u30da\u30fc\u30b8\u30c8\u30c3\u30d7<\/a><\/p>\n<h2 id=\"kokunaigakkai\">\u56fd\u5185\u5b66\u4f1a\u767a\u8868<\/h2>\n<h3>2026\u5e74<\/h3>\n<p><u>\u7b2c130\u56de\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000\u6771\u4eac\u30002026.4.9\uff5e4.12<\/u><\/p>\n<p>\u3010\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u3000\u81e8\u5e8a\u7814\u7a76\u306e\u57fa\u672c\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u753b\u50cf\u691c\u67fb\u30c7\u30fc\u30bf\u306e\u89e3\u6790\u300d<\/li>\n<\/ul>\n<p>\u3010\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u3000\u773c\u79d1\u8a3a\u7642\u306bMRI\u306f\u5fc5\u8981\u3060!\u3011<\/p>\n<ul>\n<li>\u690d\u6728\u667a\u5fd7\uff1a\u6f14\u8005\u300cMRI \u306e\u539f\u7406\u3068\u3088\u304f\u7528\u3044\u3089\u308c\u308b\u64ae\u50cf\u65b9\u6cd5\u2014\u5165\u9580\u306e\u624b\u524d\u3067\u2014\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5b89\u85e4\u62d3\u6d77\uff0c\u4ed6\uff1a\u7db2\u819c\u524d\u819c\u8853\u5f8c\u65e9\u671f\u306b\u51fa\u73fe\u3059\u308b\u9ec4\u6591\u767d\u8272\u75c5\u5909\u306e\u7279\u5fb4\u3068\u81e8\u5e8a\u7684\u610f\u7fa9<\/li>\n<\/ul>\n<p><u>\u7b2c49\u56de\u65e5\u672c\u773c\u79d1\u624b\u8853\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u3000\u798f\u5ca1\u30002026.1.30\uff5e2.1<\/u><\/p>\n<p>\u3010\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u3000\u785d\u5b50\u4f53\u624b\u8853\u306e\u57fa\u672c\u624b\u6280\u3011<\/p>\n<ul>\n<li>\u5bfa\u5cf6\u6d69\u5b50\uff1a\u6f14\u8005\u300c\u819c\u5265\u96e2\uff08ERM, ILM\uff09\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c64\u56de\u65e5\u672c\u7db2\u819c\u785d\u5b50\u4f53\u5b66\u4f1a\u3000\u6771\u4eac\u30002025.12.5\uff5e12.7<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5bfa\u5cf6\u3000\u6d69\u5b50\uff0c\u4ed6\uff1a\u9ec4\u6591\u5186\u5b54\u306b\u5bfe\u3059\u308b\u5185\u5883\u754c\u819c\u5265\u96e2\u6cd5\u5225\u306eMicroperimetry \u306b\u3088\u308b\u6a5f\u80fd\u8a55\u4fa1<\/li>\n<li>\u5409\u7530\u3000\u535a\u5149\uff0c\u4ed6\uff1a\u8853\u524d\u8996\u529b\u826f\u597d\u306a\u7279\u767a\u6027\u7db2\u819c\u524d\u819c\u306b\u304a\u3051\u308b\u8853\u5f8c\u8996\u6a5f\u80fd\u306e\u691c\u8a0e<\/li>\n<li>\u5c0f\u6797\u3000\u5927\u609f\uff0c\u4ed6\uff1a\u8fd1\u8996\u6027\u9ec4\u6591\u727d\u5f15\u75c7\u5019\u7fa4\u306b\u5bfe\u3059\u308b\u785d\u5b50\u4f53\u624b\u8853\u6210\u7e3e<\/li>\n<li>\u5b89\u85e4\u3000\u62d3\u6d77\uff0c\u4ed6\uff1a\u9ec4\u6591\u524d\u819c\u8853\u5f8c\u306e\u65b0\u898f\u5fae\u5c0f\u6697\u70b9\u306e\u5371\u967a\u56e0\u5b50\u3068\u30ab\u30c3\u30c8\u30aa\u30d5\u5024<\/li>\n<li>\u91ce\u5d0e\u3000\u8000\u5e73\uff0c\u4ed6\uff1a\u88c2\u5b54\u539f\u6027\u7db2\u819c\u5265\u96e2\u3078\u306e\u785d\u5b50\u4f53\u624b\u8853\u306b\u304a\u3051\u308bPFCL\u4f75\u7528\u306e\u5b9f\u614b\u3068\u8996\u6a5f\u80fd\u30fb\u9ec4\u6591\u5f62\u614b\u3078\u306e\u5f71\u97ff<\/li>\n<\/li>\n<\/ul>\n<p><u>\u7b2c63\u56de\u65e5\u672c\u795e\u7d4c\u773c\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000\u5927\u962a\u30002025. 11.21\uff5e11.22<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3011<\/p>\n<ul>\n<li>\u690d\u6728\u3000\u667a\u5fd7\uff1a\u6f14\u8005\u300c\u8996\u795e\u7d4c\u708e\u30fb\u7532\u72b6\u817a\u773c\u75c7\u306e\u8a3a\u65ad\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u300d<\/li>\n<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u65e9\u5ddd\u3000\u967d\u592a\uff0c\u4ed6\uff1a\u8996\u795e\u7d4c\u3092\u542b\u3080\u4e2d\u67a2\u795e\u7d4c\u6d78\u6f64\u304b\u3089\u518d\u767a\u3092\u7591\u3044\u65e9\u671f\u306e\u5316\u5b66\u7642\u6cd5\u306b\u3088\u308a\u8996\u6a5f\u80fd\u304c\u6539\u5584\u3057\u305f\u6025\u6027\u30ea\u30f3\u30d1\u6027\u767d\u8840\u75c5\u306e1\u4f8b<\/li>\n<\/li>\n<\/ul>\n<p><u>\u7b2c66\u56de\u65e5\u672c\u8996\u80fd\u77ef\u6b63\u5b66\u4f1a\u3000\u5ca1\u5c71\u30002025.10.25\uff5e10.26<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5bae\u672c\u3000\u5927\u8f1d\uff0c\u4ed6\uff1a\u7dd1\u5185\u969c\u773c\u306b\u304a\u3051\u308b\u30a2\u30a4\u30e2vifa10-2\u4e21\u773c\u540c\u6642\u523a\u6fc0\u6cd5\u3068HFA10-2\u4e21\u773c\u91cd\u306d\u5408\u308f\u305b\u8996\u91ce\u306e\u6bd4\u8f03<\/li>\n<\/ul>\n<p><u>\u7b2c79\u56de\u65e5\u672c\u81e8\u5e8a\u773c\u79d1\u5b66\u4f1a\u3000\u5927\u962a\u30002025.10.9\uff5e10.12<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5b89\u85e4\u3000\u514b\u6d77\uff0c\u4ed6\uff1a\u81ea\u7136\u5bdb\u89e3\u3057\u305f\u7d50\u7bc0\u6027\u5f8c\u90e8\u5f37\u819c\u708e\u306e2\u4f8b<\/li>\n<\/ul>\n<p><u>\u7b2c36\u56de\u65e5\u672c\u7dd1\u5185\u969c\u5b66\u4f1a\u3000\u795e\u6238\u30002025.9.12\uff5e9.14<\/u><\/p>\n<p>\u3010\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u3000\u7dd1\u5185\u969c\u306e\u60a9\u307e\u3057\u3044\u8af8\u554f\u984c\uff1a\u4ed6\u75be\u60a3\u306e\u5408\u4f75\u3068\u4ed6\u75be\u60a3\u306b\u3088\u308b\u7dd1\u5185\u969c\u3011<\/p>\n<ul>\n<li>\u5bfa\u5cf6\u3000\u6d69\u5b50\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u5408\u4f75\u9ec4\u6591\u75be\u60a3\u306e\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\uff1a\u8a3a\u65ad\u3068\u624b\u8853\u306e\u5de5\u592b\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u98ef\u5ddd\u3000\u9f8d\uff0c\u4ed6\uff1a\u65e9\u671f\u7dd1\u5185\u969c\u60a3\u8005\u306e\u4e2d\u5fc310\u00b0\u5185\u8996\u91ce\u969c\u5bb3\u3068Quality of Vision\u306e\u95a2\u9023<\/li>\n<li>\u842c\u4ee3\u8d73\u53f2\uff0c\u4ed6\uff1a\u30c8\u30e9\u30d9\u30af\u30ec\u30af\u30c8\u30df\u30fc\u65bd\u884c\u60a3\u8005\u3068\u975e\u65bd\u884c\u60a3\u8005\u306eQuality-Of-Vision(QOV)\u30b9\u30b3\u30a2\u306e\u6bd4\u8f03<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c26\u56de\u65e5\u672c\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u5b66\u4f1a\u3000\u5e83\u5cf6\u30002025.5.23\uff5e5.25<\/u><\/p>\n<p>\u3010\u30dd\u30b9\u30bf\u30fc\u767a\u8868\u3011<\/p>\n<ul>\n<li>\u843d\u5408\u7ae3\uff0c\u4ed6\uff1aICT\u652f\u63f4\u304c\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u30b1\u30a2\u306b\u6709\u7528\u3067\u3042\u3063\u305f\u7dd1\u5185\u969c\u60a3\u8005\u306e1\u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c129\u56de\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u3000\u6771\u4eac\u30002025.4.17\uff5e4.20<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e015\u3000\u795e\u7d4c\u773c\u79d1\u75be\u60a3\u3092\u6cbb\u3059\uff01\u2015\u751f\u7269\u5b66\u7684\u88fd\u5264\u2015\u3011<\/p>\n<ul>\n<li>\u690d\u6728\u667a\u5fd7\uff1a\u6f14\u8005\u300cBiologics for Neuro-ophthalmological diseases -overview-\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e017\u3000\u773c\u816b\u760d\u306e\u6cbb\u7642\u6226\u7565\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3011<\/p>\n<ul>\n<li>\u5927\u6e4a\u3000\u7d62\uff1a\u6f14\u8005\u300cTreatment Strategies for Malignant Tumors of the Eyelid\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b5\u30d6\u30b9\u30da\u30b7\u30e3\u30ea\u30c6\u30a3\u30fc\u30b5\u30f3\u30c7\u30fc 1\u3000\u7dd1\u5185\u969c\u691c\u67fb\u306e\u6700\u524d\u7dda\u3011<\/p>\n<ul>\n<li>\u98ef\u5ddd\u3000\u9f8d\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u8996\u91ce\u691c\u67fb\u306e\u6700\u524d\u7dda\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5b89\u85e4\u3000\u62d3\u6d77\uff0c\u4ed6\uff1a\u773c\u5e95\u5e74\u9f62\u63a8\u5b9aAI\u30e2\u30c7\u30eb\u3092\u7528\u3044\u305f\u7db2\u819c\u75be\u60a3\u306eRetinal Age Gap<\/li>\n<li>\u5b89\u85e4\u3000\u514b\u6d77\uff0c\u4ed6\uff1a\u5206\u5c64\u5186\u5b54\u304a\u3088\u3073\u985e\u7e01\u75be\u60a3\u306b\u304a\u3051\u308b\u4e2d\u5fc3\u7aa9\u7121\u8840\u7ba1\u57df\u306e\u8853\u524d\u5f8c\u306e\u5909\u5316<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2024\u5e74<\/h3>\n<p><u>\u7b2c78\u56de\u65e5\u672c\u81e8\u5e8a\u773c\u79d1\u5b66\u4f1a\u3000\u4eac\u90fd\u30002024.11.14\uff5e11.17<\/u><\/p>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b97\uff1b03. \u7dd1\u5185\u969c\u3011<\/p>\n<ul>\n<li>\u798f\u5730\u3000\u5065\u90ce\uff1a\u6f14\u8005\u300c\u30c8\u30e9\u30d9\u30af\u30ec\u30af\u30c8\u30df\u30fc\u3092\u7406\u89e3\u3057\u3001\u8853\u5f8c\u7ba1\u7406\u3092\u6975\u3081\u308b\u300d<\/li>\n<\/ul>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b953\uff1b04. \u7db2\u819c\u30fb\u785d\u5b50\u4f53\u3011<\/p>\n<ul>\n<li>\u5bfa\u5cf6\u3000\u6d69\u5b50\uff1a\u6f14\u8005\u300c\u785d\u5b50\u4f53\u624b\u8853\u30af\u30a8\u30b9\u30c1\u30e7\u30f3\u30d0\u30f3\u30af\u3000\u3082\u3063\u3068\u898b\u3048\u308b\u9ec4\u6591\u524d\u819c\u3000\u7de8\u300d<\/li>\n<\/ul>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b910\uff1b06. \u659c\u8996\u30fb\u5f31\u8996\u30fb\u5c0f\u5150\u773c\u79d1\u30fb\u795e\u7d4c\u773c\u79d1\u3011<\/p>\n<ul>\n<li>\u690d\u6728\u3000\u667a\u5fd7\uff1a\u6f14\u8005\u300c\u3084\u3055\u3057\u3044\u795e\u7d4c\u773c\u79d1 vol \u2169\u2163\u3000-\u795e\u7d4c\u773c\u79d1\u3092\u660e\u65e5\u304b\u3089\u59cb\u3081\u3088\u3046-\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c35\u56de\u65e5\u672c\u7dd1\u5185\u969c\u5b66\u4f1a\u3000\u5175\u5eab\u30002024.9.20\uff5e9.22<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5742\u4e0a\u3000\u60a0\u592a\uff0c\u4ed6\uff1a\u6025\u6027\u539f\u767a\u9589\u585e\u9685\u89d2\u7dd1\u5185\u969c\u306e\u60a3\u8005\u80cc\u666f<\/li>\n<li>\u98ef\u5ddd\u3000\u3000\u9f8d\uff0c\u4ed6\uff1a\u30a2\u30fc\u30e1\u30c9\u7dd1\u5185\u969c\u30d0\u30eb\u30d6\u306e\u8853\u5f8c\u8996\u529b<\/li>\n<li>\u5c0f\u6797\u3000\u5927\u609f\uff0c\u4ed6\uff1aEx-PRESS\u306e\u629c\u53bb\u8853<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c41\u56de\u65e5\u672c\u773c\u816b\u760d\u5b66\u4f1a\u3000\u6771\u4eac\u30002024.9.28\uff5e9.29<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5927\u6e4a\u3000\u3000\u7d62\uff0c\u4ed6\uff1a\u653e\u5c04\u7dda\u7167\u5c04\u5f8c\u306b\u624b\u8853\u52a0\u7642\u3092\u884c\u3063\u305f\u773c\u77bc\u30e1\u30eb\u30b1\u30eb\u7d30\u80de\u764c\u306e\u7d44\u7e54\u6240\u898b\u3068\u8853\u5f8c\u7d4c\u904e\u306e\u691c\u8a0e<\/li>\n<li>\u5869\u5d0e\u3000\u76f4\u54c9\uff0c\u4ed6\uff1a\u4e0b\u773c\u77bc\u5186\u84cb\u90e8\u7d50\u819c\u6241\u5e73\u4e0a\u76ae\u764c\u306e 2 \u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c40\u56de\u65e5\u672c\u773c\u5faa\u74b0\u5b66\u4f1a\u3000\u90e1\u5c71\u30002024.7.19\uff5e7.20<\/u><\/p>\n<p>\u3010\u30b3\u30fb\u30e1\u30c7\u30a3\u30ab\u30eb\u306e\u305f\u3081\u306e\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u3000\u773c\u5e95\u75be\u60a3\u3000\u691c\u67fb\u306e\u30dd\u30a4\u30f3\u30c8 \u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u753b\u50cf\u691c\u67fb\u306e\u30dd\u30a4\u30f3\u30c8\u300d<\/li>\n<\/ul>\n<p>\u3010JIPS\u30b3\u30fc\u30c1\u30f3\u30b0\u30bb\u30df\u30ca\u30fc\u3000\u30b3\u30fc\u30b9 1\u3000\u8a3a\u65ad\u306e\u52d8\u6240\u3000\u3011<\/p>\n<ul>\n<li>\u690d\u6728\u3000\u667a\u5fd7\uff1a\u6f14\u8005\u300c\u691c\u67fb\u3092\u99c6\u4f7f\u3057\u3066\u898b\u9003\u3057\u3084\u3059\u3044\u75be\u60a3\u3092\u8a3a\u65ad\u3057\u3088\u3046\uff01\u300d<\/li>\n<\/ul>\n<p><strong>\u00a0<\/strong><\/p>\n<p><u>\u7b2c49\u56de\u65e5\u672c\u5c0f\u5150\u773c\u79d1\u5b66\u4f1a\u3000\u9759\u5ca1\u30002024.6.14\uff5e6.15<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 (JAPO) 2\u3000\u5c0f\u5150\u306e\u524d\u773c\u90e8\u75be\u60a3\u3068\u7dd1\u5185\u969c\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u5c0f\u5150\u306e\u7dd1\u5185\u969c\u624b\u8853\u300d<\/li>\n<\/ul>\n<p>\u3010\u65e5\u672c\u5f31\u8996\u659c\u8996\u5b66\u4f1a\u30fb\u65e5\u672c\u5c0f\u5150\u773c\u79d1\u5b66\u4f1a\u3000\u5408\u540c\u8b1b\u7fd2\u4f1a\u30000\u6b73\u304b\u3089100\u6b73\u307e\u3067\u306e\u659c\u8996\u3011<\/p>\n<ul>\n<li>\u690d\u6728\u3000\u667a\u5fd7\uff1a\u6f14\u8005\u300c\u9ad8\u9f62\u3092\u7406\u7531\u306b\u6cbb\u7642\u3092\u65ad\u3089\u308c\u305f\u659c\u8996\uff08\u773c\u904b\u52d5\u795e\u7d4c\u9ebb\u75fa\u306a\u3069\uff09\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c13\u56de\u65e5\u672c\u8996\u91ce\u753b\u50cf\u5b66\u4f1a\u3000\u65b0\u6f5f\u30002024.6.1\uff5e6.2<\/u><\/p>\n<p>\u3010\u30b3\u30fb\u30e1\u30c7\u30a3\u30ab\u30eb\u306e\u305f\u3081\u306e\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u3000\u773c\u5e95\u75be\u60a3\u3000\u691c\u67fb\u306e\u30dd\u30a4\u30f3\u30c8\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u753b\u50cf\u691c\u67fb\u306e\u30dd\u30a4\u30f3\u30c8\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u4f50\u85e4\u3000\u4f0a\u5c06\uff0c\u4ed6\uff1a\u9ec4\u6591\u525d\u96e2\u3092\u4f34\u3046\u88c2\u5b54\u539f\u6027\u7db2\u819c\u525d\u96e2\u306e\u8853\u5f8c\u5909\u8996\u91cf\u3068\u624b\u8853\u5f85\u6a5f\u671f\u9593\u3084\u8853\u5f8c\u9ec4\u6591\u5f62\u614b\u306e\u95a2\u4fc2<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c6\u56de\u65e5\u672c\u8fd1\u8996\u5b66\u4f1a\u3000\u6771\u4eac\u30002024.5.18\uff5e5.19<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff13\u3000\u8fd1\u8996\u3068\u7dd1\u5185\u969c\u306e\u60a9\u307e\u3057\u3044\u95a2\u4fc2\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u8fd1\u8996\u773c\u306b\u5bfe\u3059\u308b\u7dd1\u5185\u969c\u624b\u8853\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff12\u3000\u5f37\u5ea6\u8fd1\u8996\u3068\u7db2\u819c\u785d\u5b50\u4f53\u75be\u60a3\u00a0 \uff0d\u9032\u6b69\u3068\u8ab2\u984c\uff0d\u3011<\/p>\n<ul>\n<li>\u5bfa\u5cf6\u3000\u6d69\u5b50\uff1a\u6f14\u8005\u300c\u5f37\u5ea6\u8fd1\u8996\u306e\u9ec4\u6591\u75be\u60a3\u3068\u8996\u91ce\u7570\u5e38\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c94\u56de\u4e5d\u5dde\u773c\u79d1\u5b66\u4f1a\u3000\u718a\u672c\u30002024.5.24\uff5e5.26<\/u><\/p>\n<p>\u3010\uff08\u7b2c57\u56de\u773c\u79d1\u81e8\u5e8a\u75c5\u7406\u7d44\u7e54\u7814\u7a76\u4f1a\uff09\u3011<\/p>\n<ul>\n<li>\u5927\u6e4a\u3000\u7d62\uff1a\u6f14\u8005\u300c\u51e1\u4eba\u773c\u79d1\u533b\u306e\u773c\u816b\u760d\u533b\u3068\u3057\u3066\u306e\u3042\u3086\u307f\uff5e\u3053\u308c\u307e\u3067\u3068\u3053\u308c\u304b\u3089\u3068\uff5e\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c128\u56de\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u3000\u6771\u4eac\u30002024.4.18\uff5e4.21<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 15\u3000OCT\u304c\u5275\u308b\u773c\u79d1\u753b\u50cf\u8a3a\u65ad\u306e\u65b0\u6642\u4ee3\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u524d\u773c\u90e8OCTA\u3067\u898b\u3048\u3066\u304d\u305f\u3082\u306e\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b5\u30d6\u30b9\u30da\u30b7\u30e3\u30ea\u30c6\u30a3\u30b5\u30f3\u30c7\u30fc 9\u3000\u7db2\u8108\u7d61\u819c\u75be\u60a3\u30fb\u3076\u3069\u3046\u819c\u708e\uff1a\u6cbb\u7642\u306e\u3053\u3064\u3011<\/p>\n<ul>\n<li>\u5bfa\u5cf6\u3000\u6d69\u5b50\uff1a\u6f14\u8005\u300c\u9ec4\u6591\u75be\u60a3\uff1a\u8996\u6a5f\u80fd\u304b\u3089\u8003\u3048\u305f\u624b\u8853\u6cbb\u7642\u306e\u30b3\u30c4\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b5\u30d6\u30b9\u30da\u30b7\u30e3\u30ea\u30c6\u30a3\u30b5\u30f3\u30c7\u30fc 3\u3000\u8996\u795e\u7d4c\u75be\u60a3\u8a3a\u65ad\u30fb\u6cbb\u7642\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3011<\/p>\n<ul>\n<li>\u690d\u6728\u3000\u667a\u5fd7\uff1a\u6f14\u8005\u300c\u8996\u795e\u7d4c\u708e\u306e\u30b9\u30c6\u30ed\u30a4\u30c9\u6cbb\u7642\u30fc\u6025\u6027\u671f\u30fb\u6162\u6027\u671f\u30fc\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u3000\u5fe0\u9053\uff0c\u4ed6\uff1a\u6975\u7d30\u5727\u30bb\u30f3\u30b5\u30fc\u3092\u7528\u3044\u305f\u8c5a\u773c\u306e\u524d\u623f\u5185\u304a\u3088\u3073\u785d\u5b50\u4f53\u8154\u5185\u306e\u773c\u5727\u8a55\u4fa1<\/li>\n<li>\u5b89\u85e4\u3000\u62d3\u6d77\uff0c\u4ed6\uff1a\u7d4c\u7d50\u819c\u7121\u7e2b\u5408\u785d\u5b50\u4f53\u624b\u8853\u5f8c\u306e\u4f4e\u773c\u5727\u306b\u304a\u3051\u308b\u5371\u967a\u56e0\u5b50\u306e\u89e3\u6790<\/li>\n<li>\u677e\u6d66\u3000\u5c06\u4eba\uff0c\u4ed6\uff1a\u7dd1\u9d0e\u7ae0\u6027\u8996\u91ce\u969c\u5bb3\u3068\u30b3\u30f3\u30c8\u30e9\u30b9\u30c8\u611f\u5ea6\u3068\u306e\u95a2\u4fc2<\/li>\n<\/ul>\n<p>\u3010\u5b66\u8853\u5c55\u793a\u3011<\/p>\n<ul>\n<li>\u5009\u672c\u3000\u592a\u90ce\uff0c\u4ed6\uff1a\u6c34\u6676\u4f53\u5f8c\u65b9\u56e0\u5b50\u306e\u95a2\u4e0e\u304c\u5927\u304d\u304b\u3063\u305f\u539f\u767a\u9589\u585e\u9685\u89d2\u75c7\u306e1\u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2023\u5e74<\/h3>\n<p><u>\u7b2c61\u56de\u65e5\u672c\u795e\u7d4c\u773c\u79d1\u5b66\u4f1a\u3000\u6771\u4eac\u30002023.12.1\uff5e2<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u690d\u6728\u3000\u667a\u5fd7\uff0c\u4ed6\uff1aMRI\u6240\u898b\u306b\u3088\u308a\u6295\u4e0e\u91cf\u3092\u5909\u5316\u3055\u305b\u308b\u30b9\u30c6\u30ed\u30a4\u30c9\u6cbb\u7642\u3092\u884c\u3063\u305f\u8907\u8996\u3092\u5448\u3059\u308b\u7532\u72b6\u817a\u773c\u75c7\u306e1\u5e74\u9593\u306e\u518d\u767a\u7387<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c62\u56de\u7db2\u819c\u785d\u5b50\u4f53\u5b66\u4f1a\u3000\u6a2a\u6d5c\u30002023.11.24\uff5e26<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e03\u3000Women in Japan Retina\u3011<\/p>\n<ul>\n<li>\u5bfa\u5cf6\u3000\u6d69\u5b50\uff1a\u6f14\u8005\u300c\u7db2\u819c\u785d\u5b50\u4f53\u30b5\u30fc\u30b8\u30e3\u30f3\u3068\u3057\u3066\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5409\u7530\u3000\u535a\u5149\uff0c\u4ed6\uff1a\u8853\u524d\u8996\u529b\u826f\u597d\u306a\u7279\u767a\u6027\u7db2\u819c\u524d\u819c\u306b\u304a\u3051\u308b\u8853\u5f8c\u8996\u6a5f\u80fd\u306e\u8a55\u4fa1 \u5b89\u85e4\u3000\u62d3\u6d77\uff0c\u4ed6\uff1a\u785d\u5b50\u4f53\u8853\u5f8c\u4f4e\u773c\u5727\u306b\u3088\u3063\u3066\u751f\u3058\u305f\u9ec4\u6591\u90e8\u9112\u58c1\u306b\u3088\u308b\u7db2\u819c\u5916\u5c64\u969c\u5bb3\u3068\u8996\u6a5f\u80fd\u306e\u8a55\u4fa1<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c64\u56de\u65e5\u672c\u8996\u80fd\u77ef\u6b63\u5b66\u4f1a\u3000\u9999\u5ddd\u30002023.11.18\uff5e19<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u843d\u5408\u3000\u4fca\uff0c\u4ed6\uff1a\u30b4\u30fc\u30eb\u30c9\u30de\u30f3\u8996\u91ce\u8a08\u3067\u306e\u7dd1\u5185\u969c\u60a3\u8005\u306e\u8996\u91ce\u969c\u5bb3\u7b49\u7d1a\u306e\u691c\u8a0e<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c37\u56de\u65e5\u672c\u773c\u7aa9\u75be\u60a3\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3000\u5e83\u5cf6\u30002023.10.28<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5869\u5d0e\u3000\u76f4\u54c9\uff0c\u4ed6\uff1a\u4e21\u4e0a\u773c\u77bc\u306e\u77bc\u7d50\u819c\u5074\u3088\u308a\u767a\u751f\u3057\u305fIgG4\u95a2\u9023\u773c\u75be\u60a3\u306e2\u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c77\u56de\u65e5\u672c\u81e8\u5e8a\u773c\u79d1\u5b66\u4f1a\u3000\u6771\u4eac\u30002023.10.6\uff5e9<\/u><\/p>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b922\uff1b03. \u7dd1\u5185\u969c\u3011<\/p>\n<ul>\n<li>\u798f\u5730\u3000\u5065\u90ce\uff1a\u6f14\u8005\u300c\u4eca\u3053\u305d\u30c8\u30e9\u30d9\u30af\u30ec\u30af\u30c8\u30df\u30fc\u3092\u7406\u89e3\u3057\u3001\u8853\u5f8c\u7ba1\u7406\u3092\u6975\u3081\u308b\u300d<\/li>\n<\/ul>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b938\uff1b06. \u659c\u8996\u30fb\u5f31\u8996\u30fb\u5c0f\u5150\u773c\u79d1\u30fb\u795e\u7d4c\u773c\u79d1\u3011<\/p>\n<ul>\n<li>\u690d\u6728\u3000\u667a\u5fd7\uff1a\u6f14\u8005\u300c\u3084\u3055\u3057\u3044\u795e\u7d4c\u773c\u79d1 vol \u216b\u3000\uff0d\u795e\u7d4c\u773c\u79d1\u3092\u660e\u65e5\u304b\u3089\u59cb\u3081\u3088\u3046\uff0d\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5bfa\u5cf6 \u6d69\u5b50\uff0c\u4ed6\uff1a\u7dd1\u5185\u969c\u5408\u4f75\u9ec4\u6591\u5186\u5b54\u306b\u5bfe\u3059\u308b\u5185\u5883\u754c\u819c\u5265\u96e2\u8853\u5f8c\u306een face OCT\u8a55\u4fa1.<\/li>\n<li>\u91ce\ufa11 \u8000\u5e73\uff0c\u4ed6\uff1a\u524d\u773c\u90e8\u5149\u5e72\u6e09\u65ad\u5c64\u8840\u7ba1\u9020\u5f71\u306b\u3088\u308b\u8679\u5f69\u65b0\u751f\u8840\u7ba1\u691c\u51fa\u306e\u81e8\u5e8a\u5fdc\u7528\u306e\u691c\u8a0e.<\/li>\n<li>\u6afb\u6fa4\u3000 \u6167\uff0c\u4ed6\uff1a\u80f8\u817a\u816b\u306b\u5408\u4f75\u3057\u305f\u60aa\u6027\u816b\u760d\u968f\u4f34\u7db2\u819c\u75c7\u306e\u4e00\u4f8b.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c40\u56de\u65e5\u672c\u773c\u816b\u760d\u5b66\u4f1a\u3000\u5927\u962a\u30002023.9.23\uff5e24<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5927\u6e4a\u3000\u7d62\uff0c\u4ed6\uff1a\u5c02\u9580\u5916\u6765\u53d7\u8a3a\u307e\u3067\u306b\u6642\u9593\u3092\u8981\u3057\u305f\u9ad8\u9f62\u8005\u773c\u77bc\u60aa\u6027\u816b\u760d\u75c7\u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c34\u56de\u65e5\u672c\u7dd1\u5185\u969c\u5b66\u4f1a\u3000\u6771\u4eac\u30002023.9.8\uff5e10<\/u><\/p>\n<p>\u3010\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u3000\u5320\u306e\u6280\u2461\u3011<\/p>\n<ul>\n<li>\u300c\u60a3\u8005\u306eQOL\u300d<\/li>\n<li>\u798f\u5730\u3000\u5065\u90ce\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u60a3\u8005\u306eQOL\u300d<\/li>\n<\/ul>\n<p>\u3010\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u3000\u521d\u7d1a\u3000\u30af\u30eb\u30ba\u30b9\u30bb\u30df\u30ca\u30fc\u2460\u3011<\/p>\n<ul>\n<li>\u300c\u7dd1\u5185\u969c\u306b\u5fc5\u8981\u306a\u691c\u67fb\u3001\u8a3a\u65ad\u5b66\u306e\u304a\u3055\u3089\u3044\u300d<\/li>\n<li>\u4e94\u5341\u5d50\u3000\u907c\u5b50\uff1a\u6f14\u8005\u300c\u773c\u5e95\u691c\u67fb\uff08\u773c\u5e95\u5199\u771f\u30fb\u753b\u50cf\u89e3\u6790\uff09\u300d<\/li>\n<\/ul>\n<p>\u3010\u9808\u7530\u8cde\u5831\u544a\u3011<\/p>\n<ul>\n<li>\u98ef\u5ddd\u3000\u9f8d\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u60a3\u8005\u306e\u8996\u899a\u7684QOL\u63a8\u5b9a\u30e2\u30c7\u30eb\u306e\u69cb\u7bc9\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1\uff09\uff0e\u6709\u677e\u3000\u771f\u592e\uff0c\u4ed6\uff1aAS-OCTA\u3092\u7528\u3044\u305f\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u306b\u304a\u3051\u308b\u7e4a\u7dad\u67f1\u5e2f\u5207\u9664\u8853\u306e\u6ffe\u904e\u80de\u8840\u7ba1\u306e\u7d4c\u6642\u5909\u5316\u306e\u8a55\u4fa1<\/li>\n<li>2\uff09\uff0e\u9ad9\u6a4b\u590f\u5948\u5b50\uff0c\u4ed6\uff1a\u30c8\u30e9\u30d9\u30af\u30ec\u30af\u30c8\u30df\u30fc\u5f8c\u8840\u7ba1\u6ffe\u904e\u80de\u304b\u3089\u306e\u9045\u767a\u6027\u623f\u6c34\u6f0f\u51fa\u306b\u5bfe\u3059\u308b\u30c6\u30ce\u30f3\u30d1\u30c3\u30c1\u88cf\u6253\u3061\u6cd5\u306e\u8853\u5f8c\u6210\u7e3e<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c48\u56de\u65e5\u672c\u5c0f\u5150\u773c\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000\u4ed9\u53f0\u30002023.6.16\uff5e17<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u690d\u6728\u667a\u5fd7\uff0c\u4ed6\uff1a\uff1a\u5168\u56fd\u591a\u65bd\u8a2d\u30ec\u30b8\u30b9\u30c8\u30ea\u7814\u7a76\u306b\u53c2\u52a0\u3059\u308b\u3053\u3068\u3067\u30a2\u30eb\u30b9\u30c8\u30ec\u30e0\u75c7\u5019\u7fa4\u3068\u8a3a\u65ad\u3067\u304d\u305f1\u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c93\u56de\u4e5d\u5dde\u773c\u79d1\u5b66\u4f1a\u3000\u798f\u5ca1\u30002023.5.26\uff5e28<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5927\u6e4a\u3000\u7d62\uff0c\u4ed6\uff1a\u60aa\u6027\u9ed2\u8272\u816b\u304c\u7591\u308f\u308c\u305f\u773c\u7aa9\u5185\u306e\u708e\u75c7\u6027\u8089\u82bd\u816b\u306e\u4e00\u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c12\u56de\u65e5\u672c\u8996\u91ce\u753b\u50cf\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3000\u540d\u53e4\u5c4b\u30002023.5.20\uff5e21<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u98ef\u5ddd\u3000\u9f8d\uff0c\u4ed6\uff1a\u7dd1\u5185\u969c\u60a3\u8005\u306equality of vision(QOV)\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u8996\u91ce\u9818\u57df\u306e\u691c\u8a0e<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c127\u56de\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000\u6771\u4eac\u30002023.4.6\uff5e9<\/u><\/p>\n<p>\u3010\u30b5\u30d6\u30b9\u30da\u30b7\u30e3\u30ea\u30c6\u30a3\u30b5\u30f3\u30c7\u30fc3\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u5fe0\u9053\uff1a\u30e2\u30c7\u30ec\u30fc\u30bf\u30fc\u300c\u7dd1\u5185\u969c\u6cbb\u7642update\u3000-\u65b0\u305f\u306a\u8853\u5f0f\u3068\u6cbb\u7642\u6210\u7e3e-\u300d<\/li>\n<\/ul>\n<p>\u3010International Symposium1\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u5fe0\u9053\uff1a\u30aa\u30fc\u30ac\u30ca\u30a4\u30b6\u30fc\u300cWhat OCTA can tell us about glaucoma\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e05\u3011\u300c\u5185\u5883\u754c\u819c\uff08ILM\uff09\u5265\u96e2\u306e\u529f\u7f6a\u300d<\/p>\n<ul>\n<li>\u5bfa\u5cf6\u3000\u6d69\u5b50\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u5408\u4f75\u9ec4\u6591\u75be\u60a3\u75c7\u4f8b\u306b\u5bfe\u3059\u308b\u5185\u5883\u754c\u819c\u5265\u96e2\u8853\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u98ef\u5ddd\u3000\u9f8d\uff0c\u4ed6\uff1aAI\u3092\u7528\u3044\u305f\u7dd1\u5185\u969c\u60a3\u8005\u306eQOV\u63a8\u5b9a\u30e2\u30c7\u30eb\u306e\u69cb\u7bc9.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c<\/u><u>12<\/u><u>\u56de\u65e5\u672c\u8996\u91ce\u753b\u50cf\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3000\u540d\u53e4\u5c4b\u3000<\/u><u>2023.5.20<\/u><u>\uff5e<\/u><u>21<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u98ef\u5ddd\u3000\u9f8d\uff0c\u4ed6\uff1a\u7dd1\u5185\u969c\u60a3\u8005\u306equality of vision(QOV)\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u8996\u91ce\u9818\u57df\u306e\u691c\u8a0e<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2022\u5e74<\/h3>\n<p><u>\u7b2c63\u56de\u65e5\u672c\u8996\u80fd\u77ef\u6b63\u5b66\u4f1a\u3000\u5927\u962a\u30002022.10.22\uff5e23<\/u><\/p>\n<p>\u3010\u5b66\u8853\u5c55\u793a\u3011<\/p>\n<ul>\n<li>\u5e02\u6751\u3000\u7f8e\u9999\uff0c\u4ed6\uff1aIT\u30b5\u30dd\u30fc\u30c8\u3092\u7d99\u7d9a\u4e2d\u306e\u9ad8\u9f62\u8996\u899a\u969c\u5bb3\u80052\u4f8b<\/li>\n<li>\u6e05\u91ce\u3000\u6210\u7f8e\uff0c\u4ed6\uff1a\u9ad8\u9f62\u8996\u899a\u969c\u5bb3\u8005\u306e\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u30b1\u30a2\u20152012\u5e74\u30682021\u5e74\u306e\u6bd4\u8f03\u2015<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c76\u56de\u65e5\u672c\u81e8\u5e8a\u773c\u79d1\u5b66\u4f1a\u3000\u6771\u4eac\u30002022.10.13\uff5e16<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e015\u3011\u300c\u7d99\u627f\u3068\u5275\u9020\u3001\u305d\u3057\u3066\u672a\u6765\u3078\uff0d\u7dd1\u5185\u969c\u300d<\/p>\n<ul>\n<li>\u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u9032\u884c\u89e3\u6790\u306e\u73fe\u72b6\u3068\u672a\u6765\u300d<\/li>\n<\/ul>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b940\uff1b03. \u7dd1\u5185\u969c\u3011<\/p>\n<ul>\n<li>\u798f\u5730\u3000\u5065\u90ce\uff1a\u6f14\u8005\u300c\u4eca\u3053\u305d\u30c8\u30e9\u30d9\u30af\u30ec\u30af\u30c8\u30df\u30fc\u3092\u7406\u89e3\u3057\u3001\u8853\u5f8c\u7ba1\u7406\u3092\u6975\u3081\u308b\u300d<\/li>\n<\/ul>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b924\uff1b06. \u659c\u8996\u30fb\u5f31\u8996\u30fb\u5c0f\u5150\u773c\u79d1\u30fb\u795e\u7d4c\u773c\u79d1\u3011<\/p>\n<ul>\n<li>\u690d\u6728\u3000\u667a\u5fd7\uff1a\u6f14\u8005\u300c\u3084\u3055\u3057\u3044\u795e\u7d4c\u773c\u79d1 vol \u216b\u3000\uff0d\u795e\u7d4c\u773c\u79d1\u3092\u660e\u65e5\u304b\u3089\u59cb\u3081\u3088\u3046\uff0d\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5bfa\u5cf6\u3000\u6d69\u5b50\uff0c\u4ed6\uff1a\u7dd1\u5185\u969c\u5408\u4f75\u9ec4\u6591\u75be\u60a3\u306b\u5bfe\u3059\u308b\u8a08\u753b\u7684\u5185\u5883\u754c\u819c\u5265\u96e2\u6cd5.<\/li>\n<li>\u5927\u6e4a\u3000\u7d62\uff0c\u4ed6\uff1a\u773c\u7aa9\u5148\u7aef\u90e8\u8840\u7ba1\u5947\u5f62\u306e\uff12\u4f8b.<\/li>\n<li>\u91ce\ufa11\u3000\u8000\u5e73\uff0c\u4ed6\uff1a\u504f\u98df\u3068\u904e\u5ea6\u306e\u98f2\u9152\u306b\u3088\u308b\u6804\u990a\u6b20\u4e4f\u6027\u8996\u795e\u7d4c\u75c7\u306e\uff11\u4f8b.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c33\u56de\u65e5\u672c\u7dd1\u5185\u969c\u5b66\u4f1a\u3000\u6a2a\u6d5c\u30002022.9.16~18<\/u><\/p>\n<p>\u3010\u9808\u7530\u8a18\u5ff5\u8b1b\u6f14\u3011<\/p>\n<ul>\n<li>\u798f\u5730\u3000\u5065\u90ce\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u306e\u69cb\u9020\u304b\u3089\u6a5f\u80fd\u3078\u3001\u305d\u3057\u3066QOL\u3078\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e09\u3011\u300c\u6b21\u4e16\u4ee3\u753b\u50cf\u691c\u67fb\u3068\u7dd1\u5185\u969c\u8a3a\u7642\u300d<\/p>\n<ul>\n<li>\u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u524d\u773c\u90e8OCTA\u306e\u53ef\u80fd\u6027\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e013\u3011\u300c\u7dd1\u5185\u969c\u8996\u91ce\uff0d\u691c\u67fb\u3068\u8a55\u4fa1\u306e\u6700\u65b0\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\uff0d\u300d<\/p>\n<ul>\n<li>\u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u69cb\u9020\u306e\u8a55\u4fa1\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5742\u4e0a\u3000\u60a0\u592a, \u4ed6\uff1a\u4e73\u982d\u9ec4\u6591\u9818\u57df\u8996\u91ce\u969c\u5bb3\u306e\u3042\u308b\u5e83\u7fa9\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30c8\u30e9\u30d9\u30af\u30ec\u30af\u30c8\u30df\u30fc\u5f8c\u306e\u8996\u529b.<\/li>\n<li>\u5bae\u5cf6\u3000\u8aa0\uff0c\u4ed6\uff1a\u8f2a\u90e8\u57fa\u5e95\u7dda\u7dad\u67f1\u5e2f\u5207\u9664\u8853\u5f8c\u306e\u6ffe\u904e\u80de\u304b\u3089\u306e\u623f\u6c34\u6f0f\u51fa.<\/li>\n<li>\u5bae\u672c\u3000\u5927\u8f1d\uff0c\u4ed6\uff1a\u5e83\u7fa9\u539f\u767a\u958b\u653e\u7dd1\u5185\u969c\u60a3\u8005\u3078\u306e\u30a2\u30a4\u30d5\u30ec\u30a4\u30eb\u8abf\u67fb.<\/li>\n<\/ul>\n<p>\u3010\u5b66\u8853\u5c55\u793a\u3011<\/p>\n<ul>\n<li>\u6709\u677e\u3000\u771f\u592e\uff0c\u4ed6\uff1a\u843d\u5c51\u7dd1\u5185\u969c\u773c\u306b\u5bfe\u3059\u308b\u7dda\u7dad\u67f1\u5e2f\u5207\u958b\u8853\u4f75\u7528\u773c\u5185\u30ec\u30f3\u30ba\u5f37\u819c\u5185\u56fa\u5b9a\u8853\u306e\u624b\u8853\u6210\u7e3e.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c39<\/u><u>\u56de\u65e5\u672c\u773c\u816b\u760d\u5b66\u4f1a\u3000\u6771\u4eac\u30002022.9.17<\/u><u>\uff5e18<\/u><\/p>\n<ul>\n<li>\u5927\u6e4a\u7d62, \u4ed6\uff1a\u7de9\u548c\u7684\u773c\u7aa9\u5185\u5bb9\u9664\u53bb\u306b\u81f3\u3063\u305f\u6d99\u817a\u539f\u767a\u817a\u764c\u306e\u4e00\u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c38<\/u><u>\u56de\u65e5\u672c\u773c\u5faa\u74b0\u5b66\u4f1a\u3000\u5bcc\u5c71\u30002022.7.16<\/u><u>\uff5e17<\/u><\/p>\n<p>\u3010\u30df\u30cb\u30b7\u30f3\u30dd\u30b8\u30a6\u30e01\u3011\u300c\u7dd1\u5185\u969c\u306b\u304a\u3051\u308b\u4e73\u982d\u30fb\u4e73\u982d\u5468\u56f2\u30fb\u7db2\u8108\u7d61\u819c\u306e\u6df1\u90e8\u8840\u6d41\u300d<\/p>\n<ul>\n<li>\u8d64\u6728\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u8996\u795e\u7d4c\u4e73\u982d\u5468\u56f2\u8108\u7d61\u819c\u306e\u90e8\u5206\u7684\u8840\u6d41\u8131\u843d\u3068\u7be9\u72b6\u677f\u6b20\u640d\u306e\u95a2\u4fc2\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c11<\/u><u>\u56de\u65e5\u672c\u8996\u91ce\u753b\u50cf\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3000\u6a2a\u6d5c\u30002022.7.2~3<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e03\u3011<\/p>\n<ul>\n<li>\u300c\u7dd1\u5185\u969c\u6cbb\u7642\u9078\u629e\u3078\u306eFlow\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u306b\u304a\u3051\u308bOCT\u304a\u3088\u3073OCTA\u6240\u898b\u7dcf\u8ad6\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c126\u56de\u3000\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000\u5927\u962a\u30002022.4.14\uff5e17<\/u><\/p>\n<p>\u3010\u6559\u80b2\u30bb\u30df\u30ca\u30fc8\u3011<\/p>\n<ul>\n<li>\u300c\u7dd1\u5185\u969c-\u6b63\u3057\u304f\u8a3a\u65ad\u3001\u9032\u884c\u30fb\u60aa\u5316\u306e\u30b5\u30a4\u30f3\u3092\u898b\u9003\u3055\u306a\u3044\uff01\u300d <br \/>\uff11\uff09\u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u8a3a\u7642\u306bOCTA\u3092\u3069\u3046\u751f\u304b\u3059\uff1f\u300d <br \/>\uff12\uff09\u6802\u91ce\u3000\u54f2\u54c9\uff1a\u6f14\u8005\u300c\u9032\u5316\u3092\u7d9a\u3051\u308b\u9759\u7684\u8996\u91ce\u691c\u67fb\u300d<\/li>\n<\/ul>\n<p>\u3010\u6559\u80b2\u30bb\u30df\u30ca\u30fc9\u3011 \u300c\u7db2\u8108\u7d61\u819c\u753b\u50cf\u8a3a\u65ad\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u300d<\/p>\n<ul>\n<li>\u5bfa\u5cf6\u3000\u6d69\u5b50\uff1a\u6f14\u8005\u300c\u9ec4\u6591\u4e0a\u819c\u30fb\u9ec4\u6591\u5186\u5b54\u306e\u8996\u6a5f\u80fd\u3068\u69cb\u9020\u3068\u306e\u95a2\u9023\u6027\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b5\u30d6\u30b9\u30da\u30b7\u30e3\u30ea\u30c6\u30a3\u30b5\u30f3\u30c7\u30fc7\u3011<\/p>\n<ul>\n<li>\u300c\u8996\u8def\u75be\u60a3\uff1a\u8a3a\u65ad\u3068\u6cbb\u7642\u306e\u30b3\u30c4\u300d \u690d\u6728\u3000\u667a\u5fd7\uff1a\u6f14\u8005\u300c\u708e\u75c7\u6027\u8996\u795e\u7d4c\u75be\u60a3\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\u306e\u30b3\u30c4\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b5\u30d6\u30b9\u30da\u30b7\u30e3\u30ea\u30c6\u30a3\u30b5\u30f3\u30c7\u30fc8\u3011<\/p>\n<ul>\n<li>\u300c\u7dd1\u5185\u969c\uff1a\u8a3a\u65ad\u306e\u30b3\u30c4\u300d \u6802\u91ce\u3000\u54f2\u54c9\uff1a\u6f14\u8005\u300c\u773c\u5727\u6e2c\u5b9a\u306e\u30b3\u30c4\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2021\u5e74<\/h3>\n<p><u>\u7b2c75\u56de\u3000\u65e5\u672c\u81e8\u5e8a\u773c\u79d1\u5b66\u4f1a\u3000\u798f\u5ca1\u30002021.10.28\uff5e31<\/u><\/p>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b9\u3011<\/p>\n<ul>\n<li>\u300c\u7dd1\u5185\u969c\u30c1\u30e5\u30fc\u30d6\u30b7\u30e3\u30f3\u30c8\u624b\u8853\u30a2\u30c3\u30d7\u30c7\u30fc\u30c82021\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u30ed\u30f3\u30b0\u30c1\u30e5\u30fc\u30d6\u30b7\u30e3\u30f3\u30c8\u624b\u8853\u306e\u5408\u4f75\u75c7\u5bfe\u7b56\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5b89\u85e4 \u62d3\u6d77, \u4ed6\uff1a\u6bdb\u69d8\u4f53\u816b\u8139\u306b\u3088\u308a\u7d9a\u767a\u9589\u585e\u9685\u89d2\u75c7\u3092\u751f\u3058\u305fBDUMP\u306e\u4e00\u4f8b.<\/li>\n<\/ul>\n<p>\u3010\u5b66\u8853\u5c55\u793a\u3011<\/p>\n<ul>\n<li>\u4e0a\u7530\u3000\u6075\u7406\u5b50\uff0c\u4ed6\uff1a\u785d\u5b50\u4f53\u7db2\u819c\u30ea\u30f3\u30d1\u816b\u306e\u751f\u691c\u5f8c\u306e\u691c\u8a0e\u3000VRL\u751f\u691c\u5f8c\u306e\u7d4c\u904e<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c32\u56de\u3000\u65e5\u672c\u7dd1\u5185\u969c\u5b66\u4f1a\u3000\u4eac\u90fd\u30002021.9.10\uff5e12<\/u><\/p>\n<p>\u3010JGS special session 3\u3011<\/p>\n<ul>\n<li>\u300c\u65e5\u672c\u306e\u7dd1\u5185\u969c\u6cbb\u7642\u306e\u73fe\u72b6\u3068\u8ab2\u984c\u300d \u798f\u5730\u3000\u5065\u90ce\uff1a\u7dd1\u5185\u969c\u9577\u671f\u7ba1\u7406\u306e\u73fe\u72b6\uff1a\u7b2c1\u56de\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\u7d50\u679c\u304b\u3089<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e07\u3011<\/p>\n<ul>\n<li>\u300cCan we discriminate glaucomatous optic neuropathy from myopic optic neuropathy?\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u30fb\u5ea7\u9577\u300cVascular changes in myopia and glaucoma\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u98ef\u5ddd\u3000\u9f8d, \u4ed6\uff1a\u30de\u30a4\u30af\u30ed\u30d1\u30eb\u30b9\u6bdb\u69d8\u4f53\u5149\u51dd\u56fa\u8853\u3067\u9ad8\u5ea6\u306e\u8853\u5f8c\u708e\u75c7\u3092\u751f\u3058\u3001\u539f\u56e0\u4e0d\u660e\u306e\u8996\u529b\u4f4e\u4e0b\u3092\u304d\u305f\u3057\u305f1\u4f8b.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c38\u56de\u3000\u65e5\u672c\u773c\u816b\u760d\u5b66\u4f1a\u3000\u798f\u5ca1\u30002021.9.4\uff5e5<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5927\u6e4a\u3000\u7d62, \u4ed6\uff1a\u4e21\u773c\u9ad8\u306b\u75c5\u5909\u3092\u751f\u3058\u305fErdheim-Chester\u75c5\u306e\u4e00\u4f8b.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c10\u56de\u3000\u65e5\u672c\u8996\u91ce\u753b\u50cf\u5b66\u4f1a\u3000Web\u30002021.4.24\uff5e25<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e02\u3011<\/p>\n<ul>\n<li>\u300c\u8fd1\u8996\u306e\u69cb\u9020\u3068\u6a5f\u80fd\u306e\u67b6\u3051\u6a4b\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u8996\u795e\u7d4c\u4e73\u982d\u6df1\u90e8\u306e\u8840\u6d41\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e03\u3011<\/p>\n<ul>\n<li>\u300c\u7db2\u819c\u75be\u60a3\u306e\u69cb\u9020\u3068\u6a5f\u80fd\u306e\u67b6\u3051\u6a4b.\u300d \u5bfa\u5cf6\u3000\u6d69\u5b50\uff1a\u6f14\u8005\u300c\u9ec4\u6591\u75be\u60a3\u306b\u5bfe\u3059\u308b\u5185\u5883\u754c\u819c\u5265\u96e2\u8853\u524d\u5f8c\u306e\u69cb\u9020\u5909\u5316\u3068\u8996\u91ce\u5909\u5316\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c125\u56de\u3000\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000\u5927\u962a\u30002021.4.8\uff5e11 <\/u><\/p>\n<p>\u3010\u30b5\u30d6\u30b9\u30da\u30b7\u30e3\u30eb\u30c6\u30a3\u30fc\u30b5\u30f3\u30c7\u30fc\u3011<\/p>\n<ul>\n<li>\u300c\u65e5\u5e38\u81e8\u5e8a\u3092\u5909\u9769\u3057\u3046\u308b\u65b0\u3057\u3044\u7dd1\u5185\u969c\u691c\u67fb\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u30fb\u5ea7\u9577\u300c\u773c\u5e95\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e06\u3011<\/p>\n<ul>\n<li>\u300c\u8996\u6a5f\u80fd\u3092\u8003\u3048\u305f\u9ec4\u6591\u75be\u60a3\u6cbb\u7642\u6226\u7565\u300d \u5bfa\u5cf6\u3000\u6d69\u5b50\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u3092\u6709\u3059\u308b\u9ec4\u6591\u75be\u60a3\u75c7\u4f8b\u306e\u6cbb\u7642\u300d<\/li>\n<\/ul>\n<p>\u3010\u6559\u80b2\u30bb\u30df\u30ca\u30fc3\u3011<\/p>\n<ul>\n<li>\u81e8\u5e8a\u3067\u77e5\u3063\u3066\u304a\u304f\u3079\u304dOCT\u6240\u898b\u306e\u898b\u65b9 \u6802\u91ce\u3000\u54f2\u54c9\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u8a3a\u7642\u306b\u304a\u3051\u308bOCT\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u5742\u4e0a\u3000\u60a0\u592a, \u4ed6\uff1a\u4e73\u982d\u9ec4\u6591\u9818\u57df\u8996\u91ce\u969c\u5bb3\u306e\u3042\u308b\u5e83\u7fa9\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30c8\u30e9\u30d9\u30af\u30ec\u30af\u30c8\u30df\u30fc.<\/li>\n<li>2). \u4e2d\u91ce\u3000\u91cc\u7d75\u5b50, \u4ed6\uff1a\u5e83\u7fa9\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u60a3\u8005\u306e\u30b3\u30f3\u30c8\u30e9\u30b9\u30c8\u611f\u5ea6\u3068VFQ-25\u30e9\u30b7\u30e5\u30b9\u30b3\u30a2\u306e\u76f8\u95a2.<\/li>\n<li>3). \u7530\u6ca2\u3000\u7dbe\u5b50, \u4ed6\uff1a\u65b0\u6f5f\u770c\u306b\u304a\u3051\u308b\u904e\u53bb10\u5e74\u306e\u7dd1\u5185\u969c\u306b\u3088\u308b\u8996\u899a\u969c\u5bb3\u8005\u8a8d\u5b9a\u72b6\u6cc1\u306e\u7d71\u8a08\u7684\u691c\u8a0e.<\/li>\n<li>4). \u938c\u7530\u3000\u7d79\u5b50, \u4ed6\uff1a\u5e83\u7fa9POAG\u773c\u306e\u6a5f\u80fd\u7684\u304a\u3088\u3073\u5f62\u614b\u7684\u4e2d\u5fc3\u7aa9\u969c\u5bb3\u3068\u8996\u529b\u3001\u4e2d\u5fc3\u7aa9\u95be\u5024.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2020\u5e74<\/h3>\n<p><u>\u7b2c59\u56de\u3000\u65e5\u672c\u7db2\u819c\u785d\u5b50\u4f53\u5b66\u4f1a\u3000\u798f\u5ca1\u30fbWeb\u30002020.11.27\uff5e29<\/u><\/p>\n<p>\u3010\u5b66\u8853\u5c55\u793a\u3011<\/p>\n<ul>\n<li>\u9577\u8c37\u90e8 \u65e5, \u4ed6\uff1a\u7279\u767a\u6027\u9ec4\u6591\u5186\u5b54\u9589\u9396\u5f8c\u306b\u6b8b\u5b58\u3059\u308bfluid cuff\u306e\u7d4c\u904e<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u5bfa\u5cf6 \u6d69\u5b50, \u4ed6\uff1a\u7db2\u819c\u9759\u8108\u5206\u679d\u9589\u585e\u75c7\u306e\u9ec4\u6591\u90e8\u7121\u704c\u6d41\u9818\u57df\u306b\u5bfe\u3059\u308bOCT angiography\u3068\u7db2\u819c\u611f\u5ea6<\/li>\n<li>2). \u5409\u7530 \u535a\u5149, \u4ed6\uff1a\u7279\u767a\u6027\u9ec4\u6591\u5186\u5b54\u306b\u5bfe\u3059\u308b\u4e2d\u5fc3\u7aa9\u6e29\u5b58\u5185\u5883\u754c\u819c\u5265\u96e2\u306e\u8853\u5f8c\u9ec4\u6591\u5f62\u614b\u306e\u8a55\u4fa1<\/li>\n<li>3). \u5b89\u85e4 \u62d3\u6d77, \u4ed6\uff1a\u7279\u767a\u6027\u9ec4\u6591\u5186\u5b54\u8853\u524d\u5f8c\u306e\u4e2d\u5fc3\u7aa9\u7121\u8840\u7ba1\u57df\u3068\u8996\u6a5f\u80fd\u3068\u306e\u95a2\u9023<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c74\u56de\u3000\u65e5\u672c\u81e8\u5e8a\u773c\u79d1\u5b66\u4f1a\u3000Web\u30002020.11.5\uff5e25<\/u><\/p>\n<p>\u3010\u7279\u5225\u8b1b\u6f14\u3011<\/p>\n<ul>\n<li>\u798f\u5730\u3000\u5065\u90ce\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u304b\u3089QOL\u3092\u5b88\u308b\u305f\u3081\u306e\u30b9\u30c8\u30e9\u30c6\u30b8\u30fc\u3000\uff0dEBM\u304b\u3089PCM\u300d\u3078\uff0d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3011<\/p>\n<ul>\n<li>\u300c\u8fd1\u8996\u773c\u306e\u7dd1\u5185\u969c\u6027\u8996\u795e\u7d4c\u969c\u5bb3\u3092\u79d1\u5b66\u3059\u308b\u2015\u8fd1\u8996\u6027\u304b\u7dd1\u5185\u969c\u6027\u304b\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u7dd1\u5185\u969c\u3092\u4f34\u3046\u8fd1\u8996\u773c\u306eOCTA\u6240\u898b\u300d<\/li>\n<\/ul>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b9\u3011<\/p>\n<ul>\n<li>\u300c\u7dd1\u5185\u969c\u30ed\u30f3\u30b0\u30c1\u30e5\u30fc\u30d6\u30b7\u30e3\u30f3\u30c8\u306e\u9069\u5fdc\u30fb\u6210\u7e3e\u30fb\u5408\u4f75\u75c7\u3068\u305d\u306e\u5bfe\u7b56\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u30a4\u30f3\u30d7\u30e9\u30f3\u30c8\u306e\u9732\u51fa\u30fb\u611f\u67d3\u5bfe\u7b56\u3068\u4fdd\u5b58\u5f37\u819c\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5bfa\u5cf6 \u6d69\u5b50, \u4ed6\uff1a\u7db2\u819c\u9759\u8108\u5206\u679d\u9589\u585e\u75c7\u306b\u5bfe\u3059\u308b\u521d\u56de\u6cbb\u7642\u5f8c\u306eOCT\u6240\u898b\u306b\u3088\u308b\u6cbb\u7642\u4e88\u6e2c<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c31\u56de\u3000\u65e5\u672c\u7dd1\u5185\u969c\u5b66\u4f1a\u3000Web\u30002020.10.2\uff5e4<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3011<\/p>\n<ul>\n<li>\u300c\u624b\u8853\u6cbb\u7642\u306e\u9032\u6b69\u3068\u8a55\u4fa1\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u8853\u5f8c\u306e\u30b7\u30e5\u30ec\u30e0\u6c0f\u7ba1\u5f8c\u65b9\u7d44\u7e54\u5909\u5316\u306e\u753b\u50cf\u5316\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e06\u3011<\/p>\n<ul>\n<li>\u300c\u7dd1\u5185\u969c10\u5e74\u4ee5\u4e0a\u306e\u9577\u671f\u7d4c\u904e\u3092\u30d2\u30e2\u89e3\u304f\u300d \u5742\u4e0a\u3000\u60a0\u592a\uff1a\u6f14\u8005\u300c\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u306e10\u5e74\u4ee5\u4e0a\u306e\u9577\u671f\u7d4c\u904e\u3068\u9032\u884c\u306e\u5371\u967a\u56e0\u5b50\u300d<\/li>\n<\/ul>\n<p>\u3010\u6559\u80b2\u30bb\u30df\u30ca\u30fc2\u3011<\/p>\n<ul>\n<li>\u7dd1\u5185\u969c\u60a3\u8005\u306eQOL\u3092\u77e5\u308b \u6802\u91ce\u3000\u54f2\u54c9\uff1a\u6f14\u8005\u300c\u8996\u91ce\u3068QOL\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u6802\u91ce\u3000\u54f2\u54c9, \u4ed6\uff1a\u6e2c\u5b9a\u5024\u9593\u306e\u56e0\u679c\u95a2\u4fc2\u3092\u8003\u616e\u3057\u305f\u9685\u89d2\u5f62\u614b\u30e2\u30c7\u30ea\u30f3\u30b0<\/li>\n<li>2). \u9ad8\u91ce\u3000\u5e78\u7a42, \u4ed6\uff1a\u5e83\u7fa9\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u306b\u304a\u3044\u3066\u89d2\u819c\u30d2\u30b9\u30c6\u30ea\u30b7\u30b9\u306b\u5de6\u53f3\u5dee\u304c\u307f\u3089\u308c\u305f\u75c7\u4f8b\u306e\u691c\u8a0e<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c53\u56de\u3000\u773c\u79d1\u81e8\u5e8a\u75c5\u7406\u7d44\u7e54\u7814\u7a76\u4f1a\uff08\u7b2c90\u56de\u4e5d\u5dde\u773c\u79d1\u5b66\u4f1a\uff09\u3000Web\u30002020.7.1\uff5e31<\/u><\/p>\n<p>\u3010\u4e5d\u5dde\u30d6\u30ed\u30c3\u30af\u773c\u79d1\u8b1b\u7fd2\u4f1a\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u8a3a\u7642\u306b\u304a\u3051\u308bOCT\u30fbOCTA\u306e\u6d3b\u7528\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5927\u6e4a\u3000\u7d62, \u4ed6\uff1a\u4e73\u304c\u3093\u306e\u8ee2\u79fb\u304c\u7591\u308f\u308c\u305f\u773c\u7aaf\u816b\u760d\u306e\u4e00\u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c21\u56de\u3000\u65e5\u672c\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u5b66\u4f1a\u3000Web\u30002020.7.3\uff5e12<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5e02\u6751\u3000\u7f8e\u9999, \u4ed6\uff1a\u8996\u91ce\u969c\u5bb32\u7d1a\u306e\u8aad\u66f8\u80fd\u529b\u3000\u2015\u7dd1\u5185\u969c\u3068\u7db2\u819c\u8272\u7d20\u5909\u6027\u306e\u6bd4\u8f03\u2015<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c9\u56de\u3000\u65e5\u672c\u8996\u91ce\u753b\u50cf\u5b66\u4f1a\u3000Web\u3000 2020.5.22-23<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3011<\/p>\n<ul>\n<li>\u300c\u773c\u79d1\u624b\u8853\u3068\u8996\u91ce\u30fb\u753b\u50cf\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u624b\u8853-\u524d\u773c\u90e8OCTA\u306e\u6d3b\u7528\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c124\u56de\u3000\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000Web\u30002020.4.16\uff5e19<\/u><\/p>\n<p>\u3010\u30b5\u30d6\u30b9\u30da\u30b7\u30e3\u30ea\u30c6\u30a3\u30b5\u30f3\u30c7\u30fc2\u3011<\/p>\n<ul>\n<li>\u300c\u6700\u65b0\u306e\u7dd1\u5185\u969c\u8a3a\u65ad\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300cOCT\u30fbOCTA\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b5\u30d6\u30b9\u30da\u30b7\u30e3\u30ea\u30c6\u30a3\u30b5\u30f3\u30c7\u30fc 10\u3011<\/p>\n<ul>\n<li>\u300c\u3053\u3053\u307e\u3067\u3067\u304d\u308b\u773c\u816b\u760d\u8a3a\u7642\u306e\u30dd\u30a4\u30f3\u30c8\u300d \u5927\u6e4a\u3000\u7d62\uff1a\u6f14\u8005\u300c\u773c\u9ad8\u816b\u760d\u8a3a\u7642\u306e\u30dd\u30a4\u30f3\u30c8\uff5e\u75c7\u72b6\u304b\u3089\u8a3a\u65ad\u306b\u5230\u308b\u307e\u3067\uff5e\u300d<\/li>\n<\/ul>\n<p>\u3010\u6559\u80b2\u30bb\u30df\u30ca\u30fc10\u3011<\/p>\n<ul>\n<li>\u300cOCT\u3067\u3053\u3053\u307e\u3067\u308f\u304b\u308b\u7dd1\u5185\u969c\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u8a3a\u7642\u306b\u304a\u3051\u308bOCTA\u306e\u6d3b\u7528\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u4e94\u5341\u5d50\u3000\u907c\u5b50, \u4ed6\uff1a\u5e83\u7fa9\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u773c\u306b\u304a\u3051\u308bmicrovasculature dropout\u306e\u89b3\u5bdf<\/li>\n<\/ul>\n<p>\u3010\u5b66\u8853\u5c55\u793a20\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u5fe0\u9053\uff1a\uff08\u5ea7\u9577\uff09\u7dd1\u5185\u969c\u624b\u8853<\/li>\n<li>\u5742\u4e0a\u3000\u60a0\u592a, \u4ed6\uff1aThe relationship between mean deviation slope in 10\u00b0 and intraocular pressure<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c43\u56de\u3000\u65e5\u672c\u773c\u79d1\u624b\u8853\u5b66\u4f1a\u3000\u6771\u4eac\u30002020.1.24\uff5e26<\/u><\/p>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b91\u3011<\/p>\n<ul>\n<li>\u300c\u7db2\u819c\u5265\u96e2\u306e\u521d\u56de\u785d\u5b50\u4f53\u624b\u8853\uff1a\u5b9f\u8df5\u7de8\u300d \u9577\u8c37\u90e8 \u65e5\uff1a\u8b1b\u5e2b\u3000\u300c\u8853\u4e2d\u8853\u5f8c\u5408\u4f75\u75c7\u300d<\/li>\n<\/ul>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b9\u3011<\/p>\n<ul>\n<li>\u300c\u4e0a\u9054\u3078\u306e\u8fd1\u9053\uff01\u773c\u5f62\u6210\u624b\u8853\u306e\u57fa\u672c\u624b\u6280\u30d7\u30e9\u30b9\u03b12020\u300d \u5f35\u3000\u5927\u884c\uff1a\u8b1b\u5e2b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2019\u5e74<\/h3>\n<p><u>\u7b2c58\u56de\u3000\u65e5\u672c\u7db2\u819c\u785d\u5b50\u4f53\u5b66\u4f1a\u3000\u9577\u5d0e\u30002019.12.6-8<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u9577\u8c37\u90e8\u3000\u65e5, \u4ed6\uff1a\u7279\u767a\u6027\u9ec4\u6591\u5186\u5b54\u9589\u9396\u5f8c\u8996\u529b\u4e88\u5f8c\u826f\u597d\u7fa4\u306e\u8853\u5f8c\u8996\u529b\u7d4c\u904e\u306e\u7279\u5fb4.<\/li>\n<li>2). \u5bfa\u5cf6\u3000\u6d69\u5b50, \u4ed6\uff1a\u7dd1\u5185\u969c\u5408\u4f75\u9ec4\u6591\u4e0a\u819c\u306b\u5bfe\u3059\u308b\u5185\u5883\u754c\u819c\u5265\u96e2\u306e\u9ec4\u6591\u8996\u6a5f\u80fd\u306b\u53ca\u307c\u3059\u5f71\u97ff<\/li>\n<li>3). \u5409\u7530\u3000\u535a\u5149, \u4ed6\uff1a\u7279\u767a\u6027\u7db2\u819c\u524d\u819c\u306b\u304a\u3051\u308b\u4e2d\u5fc3\u7aa9\u7121\u8840\u7ba1\u91ce\u3068\u9ec4\u6591\u5f62\u614b\u3068\u8996\u6a5f\u80fd\u306e\u95a2\u9023\u6027<\/li>\n<\/ul>\n<p>\u3010\u5b66\u8853\u5c55\u793a\u3011<\/p>\n<ul>\n<li>\u677e\u5ca1\u3000\u5c1a\u6c17, \u4ed6\uff1a\u30de\u30a4\u30af\u30ed\u30da\u30ea\u30e1\u30c8\u30ea\u30fc\u306b\u3088\u308b\u8853\u524d\u7db2\u819c\u611f\u5ea6\u3092\u5229\u7528\u3057\u305f\u9ec4\u6591\u5186\u5b54\u306e\u8853\u5f8c\u8996\u529b\u4e88\u6e2c.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c60\u56de\u3000\u65e5\u672c\u8996\u80fd\u77ef\u6b63\u5b66\u4f1a\u3000\u798f\u5ca1\u30002019.11.30-12.1<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u5e02\u6751\u3000\u7f8e\u9999, \u4ed6\uff1a\u5c0f\u5150\u306b\u304a\u3051\u308b\u30b9\u30dd\u30c3\u30c8\u30d3\u30b8\u30e7\u30f3\u30b9\u30af\u30ea\u30fc\u30ca\u30fc\u306e\u518d\u73fe\u6027\u306e\u691c\u8a3c.<\/li>\n<li>2). \u5fd7\u7530\u3000\u6b69\u5922, \u4ed6\uff1aHumphrey\u8996\u91ce\u6e2c\u5b9a\u306b\u304a\u3051\u308b\u4fe1\u983c\u5ea6\u4fc2\u6570\u4f4e\u4e0b\u306e\u8981\u56e0\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c34\u56de\u3000\u65e5\u672c\u773c\u7aa9\u75be\u60a3\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3000\u65b0\u6f5f\u30002019.11.9<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u5c3e\u5c71\u3000\u5fb3\u79c0, \u4ed6\uff1a\u5916\u50b7\u6027\u773c\u7aa9\u5185\u640d\u50b7\u306e2\u4f8b<\/li>\n<li>2). \u5f35\u3000\u5927\u884c, \u4ed6\uff1a\u80ba\u708e\u7403\u83cc\u306b\u3088\u308b\u773c\u7aa9\u81bf\u760d\u306e\u4e00\u4f8b.<\/li>\n<li>3). \u5927\u6e4a\u3000\u7d62, \u4ed6\uff1a\u526f\u9f3b\u8154\u708e\u306b\u5408\u4f75\u3057\u305f\u773c\u7aa9\u9aa8\u819c\u4e0b\u8840\u816b\u7591\u3044\u306e2\u4f8b.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c73\u56de\u3000\u65e5\u672c\u81e8\u5e8a\u773c\u79d1\u5b66\u4f1a\u3000\u4eac\u90fd\u30002019.10.24-27<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e020\u3011<\/p>\n<ul>\n<li>\u300c\u753b\u50cf\u691c\u67fb\u306e\u9032\u6b69\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u306e\u753b\u50cf\u691c\u67fb\u306e\u9032\u6b69\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u798f\u5730 \u5065\u90ce, \u4ed6\uff1a\u65b0\u898f\u30d6\u30ea\u30e2\u30cb\u30b8\u30f3\uff0f\u30c1\u30e2\u30ed\u30fc\u30eb\u914d\u5408\u70b9\u773c\u5264\u306e\u7b2c III \u76f8\u9577\u671f\u6295\u4e0e\u8a66\u9a13<\/li>\n<li>2). \u5bfa\u5cf6\u3000\u6d69\u5b50, \u4ed6\uff1a\u8fd1\u8996\u6027\u7db2\u819c\u5206\u96e2\u75c7\u306b\u5bfe\u3059\u308bfovea sparing ILM peeling\u306e\u624b\u8853\u6210\u7e3e<\/li>\n<li>3). \u677e\u7530\u3000\u82f1\u4f38, \u4ed6\uff1a\u30b5\u30a4\u30c8\u30e1\u30ac\u30ed\u30a6\u30a4\u30eb\u30b9\u8679\u5f69\u6bdb\u69d8\u4f53\u5185\u76ae\u708e\u306e\u81e8\u5e8a\u7684\u7279\u5fb4\u306e\u691c\u8a0e<\/li>\n<li>4). \u677e\u5ca1\u3000\u5c1a\u6c17, \u4ed6\uff1a\u7279\u767a\u6027\u9ec4\u6591\u5186\u5b54\u6cbb\u7642\u306b\u304a\u3051\u308b\u5185\u5883\u754c\u819c\u5265\u96e2\u7bc4\u56f2\u306e\u7d4c\u6642\u7684\u5909\u5316<\/li>\n<li>5). \u5927\u6e4a\u3000\u7d62, \u4ed6\uff1a\u725b\u773c\u75c7\u306b\u776b\u6bdb\u5185\u53cd\u75c7\u3092\u4f75\u767a\u3057\u305f\u4e00\u4f8b<\/li>\n<li>6). \u4e2d\u91ce\u3000\u82f1\u4e4b, \u4ed6\uff1a\u5f37\u5ea6\u8fd1\u8996\u9ec4\u6591\u5186\u5b54\u7db2\u819c\u5265\u96e2\u306b\u5bfe\u3059\u308bInverted ILM flap tech\u00adnique\u3092\u7528\u3044\u305f\u785d\u5b50\u4f53\u624b\u8853<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c37\u56de\u3000\u65e5\u672c\u773c\u816b\u760d\u5b66\u4f1a\u3000\u6771\u4eac\u30002019.9.28-29<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5927\u6e4a\u3000\u7d62, \u4ed6\uff1a\u82e5\u5e74\u8005\u306b\u751f\u3058\u305f\u773c\u7aa9\u9650\u5c40\u578b\u591a\u767a\u8840\u7ba1\u708e\u6027\u8089\u82bd\u816b\u75c7\u306e\u4e00\u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c30\u56de\u3000\u65e5\u672c\u7dd1\u5185\u969c\u5b66\u4f1a\u3000\u718a\u672c\u30002019.9.6-8<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3011<\/p>\n<ul>\n<li>\u300c\u7dd1\u5185\u969c\u306b\u304a\u3051\u308bOCT\u691c\u67fb\u306e\u9769\u65b0\u3068\u9032\u6b69\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u30fb\u5ea7\u9577\u300c\u524d\u773c\u90e8OCTA\u306b\u3088\u3063\u3066\u898b\u3048\u3066\u304d\u305f\u3082\u306e\uff08\u7dda\u7dad\u67f1\u5e2f\u4ee5\u964d\u306e\u623f\u6c34\u6d41\u51fa\u8def\u306e\u975e\u4fb5\u8972\u7684\u53ef\u8996\u5316\uff09\u300d<\/li>\n<\/ul>\n<p>\u3010\u6559\u80b2\u8b1b\u6f14\u3011<\/p>\n<ul>\n<li>\u300c\u65b0\u3057\u3044\u6a5f\u5668\u3092\u4f7f\u3044\u3053\u306a\u3059\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300cOCTA\u3092\u4f7f\u3044\u3053\u306a\u3059\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u6802\u91ce\u3000\u54f2\u54c9, \u4ed6\uff1a\u4e73\u982d\u5468\u56f2\u7db2\u819c\u795e\u7d4c\u7dda\u7dad\u5c64\u539a\u6e2c\u5b9a\u539a\u306e\u6e2c\u5b9a\u5909\u52d5\u3068\u30c8\u30ec\u30f3\u30c9\u89e3\u6790\u306b\u3088\u308b\u9032\u884c\u691c\u51fa\u529b<\/li>\n<li>2). \u98ef\u5ddd\u3000\u9f8d, \u4ed6\uff1a\u8853\u5f8c3\u65e5\u76ee\u306b\u767a\u75c7\u3057\u305f\u30c8\u30e9\u30d9\u30af\u30ec\u30af\u30c8\u30df\u30fc\u8853\u5f8c\u65e9\u671f\u773c\u5185\u708e\u306e\u4e00\u4f8b<\/li>\n<li>3). \u591a\u3005\u826f\u3000\u3075\u3046\u5b50, \u4ed6\uff1a\u30a2\u30a4\u30c8\u30e9\u30c3\u30ad\u30f3\u30b0\u642d\u8f09\u30c9\u30e9\u30a4\u30d3\u30f3\u30b0\u30b7\u30df\u30e5\u30ec\uff0d\u30bf (ETDS) \u306b\u3088\u308b\u7dd1\u5185\u969c\u60a3\u8005\u306e\u8996\u91ce\u3068\u904b\u8ee2.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c36\u56de\u3000\u65e5\u672c\u773c\u5faa\u74b0\u5b66\u4f1a\u3000\u672d\u5e4c\u30002019.7.19-20<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e02\u3011<\/p>\n<ul>\n<li>\u300c\u8996\u795e\u7d4c\u4e73\u982d\u5faa\u74b0update\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u773c\u306b\u304a\u3051\u308b\u8996\u795e\u7d4c\u4e73\u982d\u5faa\u74b0\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u4eac\u90fd\u773c\u79d1\u5b66\u4f1a\u3000\u4eac\u90fd\u30002019.6.9<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u5fe0\u9053, \u4ed6\uff1a\u30c1\u30e5\u30fc\u30d6\u30b7\u30e3\u30f3\u30c8\u624b\u8853\u5f8c\u306b\u30a4\u30f3\u30d7\u30e9\u30f3\u30c8\u9732\u51fa\u3092\uff12\u56de\u751f\u3058\u305f\u7d9a\u767a\u7dd1\u5185\u969c\u306e\uff11\u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c89\u56de\u3000\u4e5d\u5dde\u773c\u79d1\u5b66\u4f1a \uff08\u5927\u5206\uff092019.5.31-6.2<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5927\u6e4a\u3000\u7d62\uff1a\u773c\u90e8\u306b\u751f\u3058\u305fInflammatory myofibroblastic tumor\u306e\u4e00\u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c20\u56de\u3000\u65e5\u672c\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u5b66\u4f1a\u3000\u6771\u4eac\u30002019.5.24-26<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u9593\u3000\u8061\u7f8e, \u4ed6\uff1a\u512a\u4f4d\u773c\u5074\u306e\u4ea4\u4ee3\u306b\u3088\u308a\u8aad\u66f8\u80fd\u529b\u306e\u4f4e\u4e0b\u3092\u304d\u305f\u3057\u305f\u7dd1\u5185\u969c\u60a3\u80053 \u75c7\u4f8b\u306e\u691c\u8a0e.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c8\u56de\u3000\u65e5\u672c\u8996\u91ce\u753b\u50cf\u5b66\u4f1a\u3000\u5927\u962a\u30002019.5.18-19<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e03\u3011<\/p>\n<ul>\n<li>\u300c\u8996\u91ce\u3068\u751f\u6d3b\u3092\u8a9e\u308b\u300d\u798f\u5730\u3000\u5065\u90ce\uff1a\u30aa\u30fc\u30ac\u30ca\u30a4\u30b6\u30fc<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c123\u56de\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000\u6771\u4eac\u30002019.4.18-21<\/u><\/p>\n<p>\u3010\u30b5\u30d6\u30b9\u30da\u30b7\u30e3\u30ea\u30c6\u30a3\u30b5\u30f3\u30c7\u30fc5\u3011<\/p>\n<ul>\n<li>\u300c\u8a3a\u65ad\u3068\u6cbb\u7642\u306e\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u3000\u539f\u767a\u7dd1\u5185\u969c\u300d \u798f\u5730\u3000\u5065\u90ce\uff1a\u6f14\u8005\u300c\u524d\u8996\u91ce\u7dd1\u5185\u969c\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3011<\/p>\n<ul>\n<li>\u300c\u753b\u50cf\u691c\u67fb\u306e\u9032\u6b69\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u306e\u753b\u50cf\u691c\u67fb\u306e\u9032\u6b69\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b5\u30d6\u30b9\u30da\u30b7\u30e3\u30ea\u30c6\u30a3\u30b5\u30f3\u30c7\u30fc2\u3011<\/p>\n<ul>\n<li>\u300c\u65e5\u5e38\u81e8\u5e8a\u3092\u5909\u9769\u3057\u3046\u308b\u65b0\u3057\u3044\u7dd1\u5185\u969c\u691c\u67fb\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u300c\u65e5\u5e38\u81e8\u5e8a\u3092\u5909\u9769\u3057\u3046\u308b\u7dd1\u5185\u969c\u773c\u5e95\u691c\u67fb\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u3000\u5fe0\u9053, \u4ed6\uff1a2 \u56de\u306e\u7dd1\u5185\u969c\u30a4\u30f3\u30d7\u30e9\u30f3\u30c8\u9732\u51fa\u306b\u30a4\u30f3\u30d7\u30e9\u30f3\u30c8\u6458\u51fa\u30fb\u518d\u7559 \u7f6e\u8853\u3092\u8981\u3057\u305f\u7d9a\u767a\u7dd1\u5185\u969c\u306e\uff11\u4f8b<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c42\u56de\u3000\u65e5\u672c\u773c\u79d1\u624b\u8853\u5b66\u4f1a\u3000\u6a2a\u6d5c\u30002019.2.1-3<\/u><\/p>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b9\u3011<\/p>\n<ul>\n<li>\u300c\u7db2\u819c\u5265\u96e2\u306e\u521d\u56de\u785d\u5b50\u4f53\u624b\u8853\uff1a\u5b9f\u8df5\u7de8\u300d \u9577\u8c37\u90e8\u3000\u65e5\uff1a\u6f14\u8005\u300c\u8853\u4e2d\u8853\u5f8c\u5408\u4f75\u75c7\u300d<\/li>\n<li>\u5f35\u3000\u5927\u884c \u300c\u4e0a\u9054\u3078\u306e\u8fd1\u9053\uff01\u773c\u5f62\u6210\u624b\u8853\u306e\u57fa\u672c\u624b\u6280\u30d7\u30e9\u30b9\u03b12019\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2018\u5e74<\/h3>\n<p><u>\u7b2c56\u56de\u3000\u65e5\u672c\u795e\u7d4c\u773c\u79d1\u5b66\u4f1a\u3000\u795e\u6238\u30002018.12.14-5<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3011<\/p>\n<ul>\n<li>\u5fb9\u5e95\u8a0e\u8ad6\uff01Visual pathway disorder \u690d\u6728\u3000\u667a\u5fd7\uff1a\u6f14\u8005\u300c\u6297\u30a2\u30af\u30a2\u30dd\u30ea\u30f3 4 \u6297\u4f53\u967d\u6027\u8996\u795e\u7d4c\u708e\u306e\u75c5\u614b\u3068\u81e8\u5e8a\u50cf\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c57\u56de\u3000\u65e5\u672c\u7db2\u819c\u785d\u5b50\u4f53\u5b66\u4f1a\u3000\u4eac\u90fd\u30002018.12.7-9<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u5bfa\u5cf6\u3000\u6d69\u5b50, \u4ed6\uff1a\u9ec4\u6591\u4e0a\u819c\u306b\u304a\u3051\u308b\u7db2\u819c\u5185\u5c64\u69cb\u9020\u3068\u8853\u5f8c\u8996\u6a5f\u80fd\u3068\u306e\u95a2\u9023.<\/li>\n<li>2). \u4e2d\u91ce\u3000\u82f1\u4e4b, \u4ed6\uff1aSwept-source OCT en face\u753b\u50cf\u306b\u3088\u308b\u7cd6\u5c3f\u75c5\u7db2\u819c\u75c7\u3067\u306e\u8108\u7d61\u819c\u8840\u7ba1\u8a55\u4fa1.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c36\u56de\u3000\u65e5\u672c\u773c\u816b\u760d\u5b66\u4f1a\u3000\u91d1\u6ca2\u30002018.11.3-4<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u5927\u6e4a\u3000\u7d62, \u4ed6\uff1a\u773c\u9699\u539f\u767a\u6307\u817a\u764c\u304a\u3088\u3073\u6247\u5e73\u4e0a\u76ae\u764c\u306e\u5c40\u6240\u518d\u767a\u7387\u3068\u30ea\u30f3\u30d1\u7bc0\u8ee2\u79fb\u7387\u306e\u691c\u8a0e.<\/li>\n<li>2). \u4e2d\u91ce\u3000\u91cc\u7d75\u5b50, \u4ed6\uff1a\u30de\u30a4\u30c8\u30de\u30a4\u30b7\u30f3C\u70b9\u773c\u52a0\u7642\u304c\u6709\u52b9\u3067\u3042\u3063\u305f\u773c\u77bc\u7d50\u819c\u60aa\u6027\u816b\u760d\u306e2\u4f8b.\u3000<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c72\u56de\u3000\u65e5\u672c\u81e8\u5e8a\u773c\u79d1\u5b66\u4f1a\u3000\u6771\u4eac\u30002018.10.11-14<\/u><\/p>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b923\u3011<\/p>\n<ul>\n<li>\u300c\u5897\u6b96\u7cd6\u5c3f\u75c5\u7db2\u819c\u75c7\u306b\u5bfe\u3059\u308b\u785d\u5b50\u4f53\u624b\u8853\u300d \u9577\u8c37\u90e8\u3000\u65e5\uff1a\u6f14\u8005\u300cPDR\u306b\u5bfe\u3059\u308b\u785d\u5b50\u4f53\u624b\u8853\u306e\u8853\u4e2d\u8853\u5f8c\u5408\u4f75\u75c7\u3068\u305d\u306e\u5bfe\u7b56\u300d<\/li>\n<\/ul>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b9\u3011<\/p>\n<ul>\n<li>\u300c\u7dd1\u5185\u969c\u8a3a\u65ad\u30fb\u624b\u8853\u306e\u65b0\u3057\u3044\u6f6e\u6d41\uff5eMIGS,\u6bdb\u69d8\u4f53\u5149\u51dd\u56fa,\u524d\u773c\u90e8OCT,OCTA\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u623f\u6c34\u6d41\u51fa\u8def\u306e\u53ef\u8996\u5316\u306e\u8a66\u307f\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u798f\u5730\u3000\u5065\u90ce, \u4ed6\uff1a\u7dd1\u5185\u969c\u306e\u69cb\u9020\u30fb\u8996\u91ce\u306b\u95a2\u3059\u308b\u524d\u5411\u304d\u89b3\u5bdf\u7814\u7a76\u306b\u304a\u3051\u308b\u30af\u30e9\u30b9\u30bf\u5225\u8996\u91ce\u9032\u884c\u3068\u4e73\u982d\u51fa\u8840.<\/li>\n<li>2). \u677e\u7530\u3000\u82f1\u4f38, \u4ed6\uff1a\u3076\u3069\u3046\u819c\u708e\u306b\u4f34\u3046\u7d9a\u767a\u7dd1\u5185\u969c\u306e\u691c\u8a0e.<\/li>\n<li>3). \u5bfa\u5cf6 \u6d69\u5b50, \u4ed6\uff1aOCT angiography \u306b\u3088\u308b\u7db2\u819c\u9759\u8108\u5206\u679d\u9589\u585e\u75c7\u306e\u9ec4\u6591\u90e8\u865a\u8840\u7d4c\u6642\u7684\u5909\u5316\u3068\u81e8\u5e8a\u8a55\u4fa1.<\/li>\n<li>4). \u6802\u91ce \u54f2\u54c9, \u4ed6\uff1a\u7dd1\u5185\u969c\u773c\u306b\u304a\u3051\u308b\u30af\u30e9\u30b9\u30bf\u5316\u5e73\u5747\u8996\u91ce\u611f\u5ea6\u306e\u6e2c\u5b9a\u9593\u5909\u52d5.<\/li>\n<li>5). \u677e\u5ca1 \u5c1a\u6c17, \u4ed6\uff1a\u50da\u773c\u306b\u3082\u767a\u75c7\u3057\u305f\u7279\u767a\u6027\u9ec4\u6591\u5186\u5b54\u75c7\u4f8b\u306e\u7279\u5fb4.<\/li>\n<li>6). \u4f50\u3005\u6728\u3000\u4eae, \u4ed6\uff1a\u5897\u6b96\u7cd6\u5c3f\u75c5\u7db2\u819c\u75c7\u306b\u3088\u308b\u8840\u7ba1\u65b0\u751f\u7dd1\u5185\u969c\u306e\u624b\u8853\u6cbb\u7642\u6210\u7e3e.<\/li>\n<li>7). \u5927\u6e4a\u3000\u7d62, \u4ed6\uff1a\u773c\u77ad\u30e1\u30eb\u30b1\u30eb\u7d30\u80de\u764c\u306b\u5bfe\u3059\u308b\u30a4\u30f3\u30bf\u30fc\u30d5\u30a7\u30ed\u30f3\u03b2\u8853\u5f8c\u88dc\u52a9\u7642\u6cd5\u306e\u7d4c\u904e.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c29\u56de\u3000\u65e5\u672c\u7dd1\u5185\u969c\u5b66\u4f1a\u3000\u65b0\u6f5f\u30002018.9.14-16<\/u><\/p>\n<p>\u3010Asia-Japan symposium\u3011<\/p>\n<ul>\n<li>\u201cNew Insights of Glaucoma\u201d Tetsuya Togano\uff1a\u6f14\u8005\u300cMacular function in glaucoma patients.\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e01\u3011<\/p>\n<ul>\n<li>\u300c\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u304b\u3089\u8003\u3048\u308b\u7dd1\u5185\u969c\u8996\u795e\u7d4c\u75c7\u30fb\u7db2\u819c\u795e\u7d4c\u7dda\u7dad\u300d \u98ef\u5ddd\u3000\u9f8d\uff1a\u6f14\u8005\u300cOCT\u3067\u6349\u3048\u308b\u7db2\u819c\u795e\u7d4c\u7dda\u7dad\u5c64\u306e\u75c5\u614b\u3068\u7dd1\u5185\u969c\u6027\u8996\u795e\u7d4c\u75c7\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e06\u3011<\/p>\n<ul>\n<li>\u300c\u7dd1\u5185\u969c\u773c\u5727\u4e0b\u964d\u6cbb\u7642\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u300d \u5742\u4e0a\u3000\u60a0\u592a\uff1a\u6f14\u8005\u300c\u9ec4\u6591\u90e8\u8996\u91ce\u969c\u5bb3\u3068\u773c\u5727\u4e0b\u964d\u6cbb\u7642\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e09\u3011<\/p>\n<ul>\n<li>\u300c\u7dd1\u5185\u969c\u306e\u773c\u5727\u975e\u4f9d\u5b58\u56e0\u5b50\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u30fb\u5ea7\u9577\u300c\u8fd1\u8996\u3068\u7dd1\u5185\u969c\u306e\u95a2\u4fc2\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e011\u3011\u3000<\/p>\n<ul>\n<li>\u300c\u57fa\u790e\u7814\u7a76\u30fb\u85ac\u7406\uff1a\u5275\u85ac\u306e\u82bd\u300d \u4e94\u5341\u5d50\u3000\u907c\u5b50\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u3068\u30de\u30a4\u30c8\u30d5\u30a1\u30b8\u30fc\u300d<\/li>\n<\/ul>\n<p>\u3010\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u3011<\/p>\n<ul>\n<li>\u8d64\u6728\u3000\u5fe0\u9053\uff1a\u30c7\u30a3\u30b9\u30ab\u30c3\u30b5\u30f3\u30c8\u300c\u305d\u3057\u3066\u672a\u6765\u3078\u7dd1\u5185\u969c\u3092\u3064\u306a\u3050\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u8d64\u6728\u3000\u5fe0\u9053, \u4ed6\uff1a\u6b63\u5e38\u773c\u306b\u304a\u3051\u308b\u524d\u773c\u90e8OCT\u30a2\u30f3\u30ae\u30aa\u30b0\u30e9\u30d5\u30a3\u30fc\u3092\u7528\u3044\u305f\u5f37\u819c\u5185\u8840\u6d41\u8a55\u4fa1<\/li>\n<li>2). \u91ce\u3005\u6751\u3000\u7d79\u5b50, \u4ed6\uff1a\u30d7\u30ed\u30b9\u30bf\u30b0\u30e9\u30f3\u30b8\u30f3\u95a2\u9023\u85ac\u306b\u3088\u308b\u7dd1\u5185\u969c\u6cbb\u7642\u7d4c\u904e\u4e2d\u306b\u56a2\u80de\u69d8\u9ec4\u6591\u6d6e\u816b\u3092\u751f\u3058\u305f\uff11\u4f8b.<\/li>\n<li>3). \u5bae\u672c\u3000\u3075\u3046\u5b50, \u4ed6\uff1a\u5f8c\u671f\u7dd1\u5185\u969c\u60a3\u8005\u3078\u306e\u30a2\u30a4\u30c8\u30e9\u30c3\u30ad\u30f3\u30b0\u642d\u8f09\u30c9\u30e9\u30a4\u30d4\u30f3\u30b0\u30b7\u30df\u30e5\u30ec\u30fc\u30bf\u306e\u8a66\u307f.<\/li>\n<li>4). \u9593\u3000\u8061\u7f8e, \u4ed6\uff1a\u7dd1\u5185\u969c\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30c9\u30e9\u30a4\u30d3\u30f3\u30b0\u30b7\u30e5\u30df\u30ec\u30fc\u30bf\u65bd\u884c\u5f8c6\u5e74\u306e\u904b\u8ee2\u5b9f\u614b\u8abf\u67fb.<\/li>\n<li>5). \u6751\u7530\u3000\u61b2\u7ae0, \u4ed6\uff1a\u7dd1\u5185\u969c\u60a3\u8005\u306e\u8aad\u66f8\u80fd\u529b\u3068Humphrey\u8996\u91ce10-2\u30af\u30e9\u30b9\u30bf\u5225\u611f\u5ea6\u306e\u95a2\u4fc2\u6027.<\/li>\n<li>6). \u843d\u5408\u3000\u7ae3, \u4ed6\uff1a\u5e83\u7fa9\u30fb\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u306b\u304a\u3051\u308bOCT-Angiography\u3092\u7528\u3044\u305fmicrovasculature dropout\u306e\u89b3\u5bdf.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c33\u56de\u3000\u65e5\u672c\u773c\u79d1\u75be\u60a3\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3000\u6771\u4eac\u30002018.9.8<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5869\u5d0e\u3000\u76f4\u54c9, \u4ed6\uff1a\u5185\u58c1\u30fb\u4e0b\u58c1\u4e21\u65b9\u3067\u773c\u7aa9\u8102\u80aa\u306e\u7d5e\u627c\u3092\u8a8d\u3081\u305f\u9589\u9396\u578b\u773c\u7aa9\u58c1\u9aa8\u6298\u306e\u4e00\u4f8b.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c74\u56de\u3000\u65e5\u672c\u5f31\u8996\u659c\u8996\u5b66\u4f1a\u3000\u5009\u6577\u30002018.7.6\uff5e7<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5e02\u6751\u3000\u7f8e\u9999, \u4ed6\uff1a\u30b9\u30dd\u30c3\u30c8\u30d3\u30b8\u30e7\u30f3\u30b9\u30af\u30ea\u30fc\u30ca\u30fc\u306b\u3088\u308a\u659c\u8996\u624b\u8853\u5f8c\u306e\u5c48\u6298\u5024\u30fb\u77b3\u5b54\u5f84\u3092\u8a55\u4fa1\u3057\u305f\u659c\u4f4d\u8fd1\u8996\u306e3\u4f8b.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c19\u56de\u3000\u65e5\u672c\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u5b66\u4f1a\u3000\u6771\u4eac\u30002018.6.15\uff5e17<\/u><\/p>\n<ul>\n<li>1). \u843d\u5408\u3000\u7ae3, \u4ed6\uff1a\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u5916\u6765\u3092\u53d7\u8a3a\u3057\u305f\u7dd1\u5185\u969c\u60a3\u8005\u306e\u30cb\u30fc\u30ba\u3068\u8996\u529b\u3001\u8996\u91ce\u306e\u95a2\u4fc2.<\/li>\n<li>2). \u9593\u3000\u8061\u7f8e, \u4ed6\uff1a\u7db2\u819c\u8272\u7d20\u5909\u6027\u60a3\u8005\u306e\u30cb\u30fc\u30ba\u3068\u30ed\u30fc\u30d3\u30b8\u30e7\u30f3\u30b1\u30a2.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c7\u56de\u3000\u65e5\u672c\u8996\u91ce\u5b66\u4f1a\u3000\u91d1\u6ca2\u30002018.5.9-13<\/u><\/p>\n<p>\u3010\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u3011<\/p>\n<ul>\n<li>2018JPS Special Project: \u300c\u57fa\u790e\u304b\u3089\u81e8\u5e8a\u307e\u3067\u5168\u3066\u304c\u3064\u306a\u304c\u308b\u8996\u91ce\u3068\u753b\u50cf\u306e\u6559\u80b2\u30bb\u30df\u30ca\u30fc\uff5e\u3053\u308c\u3067\u3042\u306a\u305f\u3082\u8996\u91ce\u30fb\u753b\u50cf\u30de\u30a4\u30b9\u30bf\u30fc\uff01\uff5e\u300d \u300cSpecial Project 3\u300c\u30de\u30a4\u30b9\u30bf\u30fc\u3078\u306e\u9053\uff1a\u8996\u91ce\u3068OCT\u306e\u9032\u884c\u5224\u5b9a\u7de8\u300d\u300d \u798f\u5730 \u5065\u90ce\u3000\u6f14\u8005\uff1a\u300c\u30cf\u30f3\u30d5\u30ea\u30fc\u8996\u91ce\u6e2c\u5b9a\u3068\u9032\u884c\u5224\u5b9a\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c88\u56de\u3000\u4e5d\u5dde\u773c\u79d1\u5b66\u4f1a\u3000\uff08\u9577\u5d0e\uff09\u30002018.5.25-26<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5927\u6e4a\u3000\u7d62, \u4ed6\uff1a\u773c\u9a13\u539f\u767aclear cell squamous cell carcinoma\u306e\u4e00\u4f8b.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c122\u56de\u3000\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u3000\u5927\u962a\u30002018.4.19-22<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e03\u3011<\/p>\n<ul>\n<li>\u6802\u91ce\u54f2\u54c9.\uff1a\u6f14\u8005\u300c\u7be9\u72b6\u677f\u3068\u7dd1\u5185\u969c\u6027\u8996\u795e\u7d4c\u75c7\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u5742\u4e0a\u3000\u60a0\u592a, \u4ed6\uff1a\u30c8\u30e9\u30d9\u30af\u30ec\u30af\u30c8\u30df\u30fc\u65e2\u5f80\u773c\u306b\u5bfe\u3059\u308b\u767d\u5185\u969c\u30fb\u30cb\u30fc\u30c9\u30ea\u30f3\u30b0\u540c\u6642\u624b\u8853\u306e\u8853\u5f8c\u773c\u5727\u7d4c\u904e.<\/li>\n<li>2). \u98ef\u5ddd\u3000\u9f8d, \u4ed6\uff1aSS-OCT En-face\u753b\u50cf\u3068\u4e2d\u5fc3\u88d4\u95be\u5024\u30fb\u7db2\u819c\u5185\u5c64\u539a\u3068\u306e\u95a2\u9023.<\/li>\n<\/ul>\n<p>\u3010\u5b66\u8853\u5c55\u793a\u3011<\/p>\n<ul>\n<li>\u5c0f\u6797 \u5927\u609f, \u4ed6\uff1a\u8fd1\u8996\u6027\u7db2\u819c\u5206\u96e2\u75c7\u306b\u5bfe\u3059\u308bfovea sparing ILM peeling\u3092\u7528\u3044\u305f\u785d\u5b50\u4f53\u624b\u8853\u6210\u7e3e<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c43\u56de\u3000\u65e5\u672c\u5c0f\u5150\u773c\u79d1\u5b66\u4f1a\u3000\u540d\u53e4\u5c4b\u30002018.3.2-3<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5b89\u85e4 \u62d3\u6d77, \u4ed6\uff1a\u7db2\u819c\u96fb\u56f3\u306b\u3066\u8a3a\u65ad\u3057\u305f\u687f\u4f53\u4e00\u8272\u899a\u306e2\u4f8b.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c41\u56de\u3000\u65e5\u672c\u773c\u79d1\u624b\u8853\u5b66\u4f1a\u3000\u4eac\u90fd\u30002018.1.26-28<\/u><\/p>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b9\u3011<\/p>\n<ul>\n<li>\u300c\u7db2\u819c\u5265\u96e2\u306e\u521d\u56de\u785d\u5b50\u4f53\u624b\u8853\uff1a\u5b9f\u8df5\u7de8\u300d \u9577\u8c37\u90e8 \u65e5\uff1a\u8b1b\u5e2b\u300c\u8853\u4e2d\u8853\u5f8c\u5408\u4f75\u75c7\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>2017\u5e74<\/h3>\n<p><u>\u7b2c56\u56de\u3000\u65e5\u672c\u7db2\u819c\u785d\u5b50\u4f53\u5b66\u4f1a\u7dcf\u4f1a\u3000\u6771\u4eac\u30002017.12.1-3<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u9577\u8c37\u90e8\u3000\u65e5, \u4ed6\uff1a\u9ec4\u6591\u5186\u5b54\u3092\uff12\u56de\u518d\u767a\u3057\u5185\u5883\u754c\u819c\u81ea\u5bb6\u79fb\u690d\u304c\u884c\u308f\u308c\u305f\u5f37\u5ea6\u8fd1\u8996\u306e\uff11\u4f8b.<\/li>\n<li>2). \u5bfa\u5cf6\u3000\u6d69\u5b50, \u4ed6\uff1a\u9ec4\u6591\u5186\u5b54\u30fb\u9ec4\u6591\u4e0a\u819c\u306e\u5185\u5883\u754c\u819c\u5265\u96e2\u4f75\u7528\u8853\u5f8c\u306e\u8996\u91ce\u611f\u5ea6\u3068\u795e\u7d4c\u7bc0\u7d30\u80de\u8907\u5408\u4f53\u306e\u8a55\u4fa1.<\/li>\n<li>3). \u677e\u5ca1\u3000\u5c1a\u6c17, \u4ed6\uff1a\u9ec4\u6591\u5186\u5b54\u773c\u3068\u9ec4\u6591\u4e0a\u819c\u773c\u306e\u9818\u57df\u5225\u8108\u7d61\u819c\u539a\u306e\u691c\u8a0e.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c55\u56de\u3000\u65e5\u672c\u795e\u7d4c\u773c\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000\u6a2a\u6d5c\u30002017.11.10-11<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u798f\u6b66 \u6148, \u4ed6\uff1a\u5f31\u8996\u3068\u9451\u5225\u3092\u8981\u3057\u5149\u5e72\u6e09\u65ad\u5c64\u8a08\u691c\u67fb\u306b\u3088\u308a\u8a3a\u65ad\u306b\u81f3\u3063\u305f\u7db2\u819c\u4f4e\u5f62\u6210\u306e 1 \u4f8b.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c58\u56de\u3000\u65e5\u672c\u8996\u80fd\u77ef\u6b63\u5b66\u4f1a\u3000\u4ed9\u53f0\u30002017.10.28-29<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u5bae\u672c\u3000\u3075\u3046\u5b50, \u4ed6\uff1a\u7db2\u819c\u8272\u7d20\u5909\u6027\u60a3\u8005\u306e\u8996\u91ce\u969c\u5bb3\u3068\u8aad\u66f8\u30d1\u30bf\u30fc\u30f3\u306e\u95a2\u4fc2.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c71\u56de\u3000\u65e5\u672c\u81e8\u5e8a\u773c\u79d1\u5b66\u4f1a\u3000\u6771\u4eac\u30002017.10.12-15<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e01\u3011<\/p>\n<ul>\n<li>\u300c\u8996\u91ce\u3092\u5e83\u3052\u3088\u3046\u300d \u798f\u5730\u3000\u5065\u90ce\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u60a3\u8005\u306e\u8996\u91ce\u3068QOL \u3092\u7406\u89e3\u3059\u308b.\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e06\u3011<\/p>\n<ul>\n<li>\u300c\u8840\u6d41\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u773c\u306eOCT angiography\u3067\u5206\u304b\u308b\u3053\u3068\u300d<\/li>\n<\/ul>\n<p>\u3010\u30a4\u30f3\u30b9\u30c8\u30e9\u30af\u30b7\u30e7\u30f3\u30b3\u30fc\u30b948\u3011<\/p>\n<ul>\n<li>\u300c\u5897\u6b96\u7cd6\u5c3f\u75c5\u7db2\u819c\u75c7\u306b\u5bfe\u3059\u308b\u785d\u5b50\u4f53\u624b\u8853\u300d \u9577\u8c37\u90e8\u3000\u65e5\uff1a\u6f14\u8005\u300c\u727d\u5f15\u6027\u7db2\u819c\u5265\u96e2\u3078\u306e\u5bfe\u51e6.\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u798f\u5730\u3000\u5065\u90ce, \u4ed6\uff1a\u7dd1\u5185\u969c\u306e\u69cb\u9020\u30fb\u8996\u91ce\u306b\u95a2\u3059\u308b\u524d\u5411\u304d\u89b3\u5bdf\u7814\u7a76\u306b\u304a\u3051\u308b\u30af\u30e9\u30b9\u30bf\u5225\u8996\u91ce\u9032\u884c\u3068\u4e73\u982d\u51fa\u8840.<\/li>\n<li>2). \u8d64\u6728\u3000\u5fe0\u9053, \u4ed6\uff1a\u7dd1\u5185\u969c\u773c\u306b\u304a\u3051\u308b\u4e73\u982d\u51fa\u8840\u767a\u75c7\u6642\u671f\u3068\u7db2\u819c\u795e\u7d4c\u7dda\u7dad\u5c64\u83f2\u8584\u5316\u901f\u5ea6\u306e\u95a2\u4fc2<\/li>\n<li>3). \u5bfa\u5cf6\u3000\u6d69\u5b50, \u4ed6\uff1a\u7db2\u819c\u9759\u8108\u5206\u679d\u9589\u585e\u75c7\u306e\u9ec4\u6591\u90e8\u7121\u704c\u6d41\u9818\u57df\u306b\u5bfe\u3059\u308bOCT angiography\u3068\u8996\u91ce\u611f\u5ea6.<\/li>\n<li>4). \u9152\u4e95\u3000\u5eb7\u5f18, \u4ed6\uff1a\u3076\u3069\u3046\u819c\u708e\u304b\u3089\u767a\u898b\u3055\u308c\u305f\u7b2c\uff12\u671f\u6885\u6bd2\u306e\u4e00\u4f8b.<\/li>\n<li>5). \u4f50\u85e4\u3000\u5f25\u751f, \u4ed6\uff1a\u8996\u529b\u826f\u597d\u306a\u6ef2\u51fa\u578b\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u306b\u5bfe\u3059\u308b\u6297VEGF\u7642\u6cd5\u306e1\u5e74\u6210\u7e3e.<\/li>\n<li>6). \u4f50\u3005\u6728\u3000\u4eae, \u4ed6\uff1a\u8840\u7ba1\u65b0\u751f\u7dd1\u5185\u969c\u306b\u5bfe\u3059\u308b\u30d0\u30eb\u30d9\u30eb\u30c8\u7dd1\u5185\u969c\u30a4\u30f3\u30d7\u30e9\u30f3\u30c8\u306e\u624b\u8853\u6210\u7e3e.<\/li>\n<li>7). \u672c\u9593\u3000\u53cb\u91cc\u6075, \u4ed6\uff1a\u65e9\u671f\u7dd1\u5185\u969c\u60a3\u8005\u306e\u4e2d\u5fc310\u00b0\u8996\u91ce\u969c\u5bb3\u306e\u51fa\u73fe\u983b\u5ea6\u3068\u305d\u306e\u6027\u72b6\u3001\u4e0a\u4e0b\u534a\u8996\u91ce\u5225\u30af\u30e9\u30b9\u30bf\u5225\u691c\u8a0e.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c28\u56de\u3000\u65e5\u672c\u7dd1\u5185\u969c\u5b66\u4f1a\u3000\u5e83\u5cf6\u30002017.9.29-10.1<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e03\u3011<\/p>\n<ul>\n<li>\u300cAsia-Japan Imaging in glaucoma.\u300d \u5ea7\u9577\uff1a\u798f\u5730\u3000\u5065\u90ce<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e04\u3011<\/p>\n<ul>\n<li>\u300cStructure-Function\u300d \u98ef\u5ddd\u3000\u9f8d\uff1a\u6f14\u8005\u300cOCT\u306b\u3088\u308b\u9ec4\u6591\u90e8\u306e\u89b3\u5bdf\u3068\u8996\u529b\u30fb\u8996\u91ce\u300d<\/li>\n<\/ul>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e06\u3011<\/p>\n<ul>\n<li>\u300c\u8840\u6d41\u300d \u8d64\u6728\u3000\u5fe0\u9053\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u773c\u306eOCT angiography\u3067\u5206\u304b\u308b\u3053\u3068\u300d \u4e94\u5341\u5d50\u3000\u907c\u5b50\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u306b\u304a\u3051\u308b\u9ec4\u6591\u90e8\u8840\u6d41\u3068\u8996\u91ce\u306e\u89e3\u6790\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u8d64\u6728\u3000\u5fe0\u9053, \u4ed6: Optical Coherence Tomography Angiography Microvasculature Dropout inside the Optic Disc in Glaucoma Eyes<\/li>\n<li>2). \u843d\u5408\u3000\u7ae3, \u4ed6\uff1a\u5e83\u7fa9\u30fb\u539f\u767a\u958b\u653e\u9685\u89d2\u7dd1\u5185\u969c\u773c\u306b\u304a\u3051\u308bOCT-Angiography\u3092\u7528\u3044\u305f\u4e2d\u5fc3\u5d69\u7121\u8840\u7ba1\u9818\u57df\u3068\u7db2\u819c\u5185\u5c64\u539a\u304a\u3088\u3073\u8996\u91ce\u3068\u306e\u95a2\u4fc2.<\/li>\n<li>3). \u5bae\u672c\u3000\u5927\u8f1d, \u4ed6\uff1aOcular Response Analyzer \u00ae\u3092\u7528\u3044\u305f\u7dd1\u5185\u969c\u75c5\u578b\u5225\u3067\u306e\u89d2\u819c\u30d2\u30b9\u30c6\u30ea\u30b7\u30b9\u306e\u691c\u8a0e.<\/li>\n<li>4). \u672b\u6b66\u3000\u4e9c\u7d00, \u4ed6\uff1a\u6c34\u6676\u4f53\u4e9c\u8131\u81fc\u30fb\u773c\u5185\u30ec\u30f3\u30ba\u4e9c\u8131\u81fc\u3092\u5408\u4f75\u3057\u305f\u843d\u5c51\u7dd1\u5185\u969c\u773c \u306b\u5bfe\u3059\u308b\u6cbb\u7642\u6210\u7e3e.<\/li>\n<li>5). \u9577\u8c37\u5ddd\u3000\u53cb\u52a0\u91cc, \u4ed6\uff1a\u7dd1\u5185\u969c\u52a0\u7642\u4e2d\u306b\u982d\u84cb\u5185\u75be\u60a3\u306e\u5408\u4f75\u304c\u660e\u3089\u304b\u306b\u306a\u3063\u305f4\u4f8b.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c35\u56de \u65e5\u672c\u773c\u816b\u760d\u5b66\u4f1a\u3000\u6771\u4eac\u30002017.9.23-24<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u5927\u6e4a\u3000\u7d62, \u4ed6\uff1al gG4\u95a2\u9023\u75be\u60a3\u306b\u5408\u4f75\u3057\u305f Adult Orbital Xanthogranulomatous Disease \u306e\u4e00\u4f8b.<\/li>\n<li>2). \u5869\u5d0e\u3000\u76f4\u54c9, \u4ed6\uff1a\u6d99\u56a2\u539f\u767a\u817a\u764c\u306e\u4e00\u4f8b.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c73\u56de \u65e5\u672c\u5f31\u8996\u659c\u8996\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u7b2c42\u56de \u65e5\u672c\u5c0f\u5150\u773c\u79d1\u5b66\u4f1a\u7dcf\u4f1a \u5408\u540c\u5b66\u4f1a\u3000\u91d1\u6ca22017.6.16-17<\/u><\/p>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>1). \u7fbd\u5165\u3000\u8cb4\u5b50, \u4ed6\uff1a\u5c0f\u5150\u306e\u8996\u795e\u7d4c\u81a0\u816b5\u4f8b\u306e\u81e8\u5e8a\u50cf.<\/li>\n<li>2). \u5e02\u6751\u3000\u7f8e\u9999, \u4ed6\uff1a\u5148\u5929\u773c\u632f\u75c7\u4f8b\u306enull zone\u3092\u63a8\u5b9a\u3059\u308b\u30b4\u30fc\u30eb\u30c9\u30de\u30f3\u8996\u91ce\u8a08\u3092\u7528\u3044\u305f\u65b0\u305f\u306a\u65b9\u6cd5.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c5\u56de\u3000\u65e5\u672c\u773c\u5f62\u6210\u518d\u5efa\u5916\u79d1\u5b66\u4f1a\u3000\u798f\u5ca1\u30002017.6.3-4<\/u><\/p>\n<ul>\n<li>\u5927\u6e4a\u3000\u7d62, \u4ed6\uff1a\u773c\u77bc\u5f8c\u9000\u306b\u5bfe\u3059\u308b\u751f\u4f53\u5438\u53ce\u6027\u30b9\u30d9\u30fc\u30b5\u30fc\uff08tarSys\u00ae\uff09\u3092\u7528\u3044\u305f\u5f8c\u8449\u5ef6\u9577\u8853.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c121\u56de\u3000\u65e5\u672c\u773c\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000\u6771\u4eac\u30002017.4.6-9<\/u><\/p>\n<p>\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e010\u3011<\/p>\n<ul>\n<li>\u300c\u7dd1\u5185\u969c\u306e\u8996\u91ce\uff1a\u4eca\u5f8c\u306e\u5c55\u958b\u300d \u5742\u4e0a\u3000\u60a0\u592a\uff1a\u6f14\u8005\u300c\u7dd1\u5185\u969c\u306b\u304a\u3051\u308b\u9ec4\u6591\u90e8\u8996\u91ce\u306e\u8a55\u4fa1\u300d<\/li>\n<\/ul>\n<p>\u3010\u4e00\u822c\u53e3\u6f14\u3011<\/p>\n<ul>\n<li>\u98ef\u5ddd\u3000\u9f8d, \u4ed6\uff1aSS-OCT En-face\u30a4\u30e1\u30fc\u30b8\u306b\u3088\u308b\u4e2d\u5fc310\u00b0\u63a8\u5b9a\u8996\u91ce\u3068HFA10-2\u306e\u6bd4\u8f03<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><u>\u7b2c40\u56de\u3000\u65e5\u672c\u773c\u79d1\u624b\u8853\u5b66\u4f1a\u3000\u6771\u4eac\u30002017.1.27-29<\/u><\/p>\n<p>\u3010\u7dcf\u4f1a\u9577\u4f01\u753b1\u3000\u624b\u8853\u6559\u80b2\u3011<\/p>\n<ul>\n<li>\u798f\u5730\u3000\u5065\u90ce\uff1a\u6f14\u8005\u300cGlaucoma surgeon\u3092\u30d7\u30ed\u30c7\u30e5\u30fc\u30b9\u3059\u308b\u300d \u9577\u8c37\u90e8\u3000\u65e5\uff1a\u6f14\u8005\u300c\u6307\u5c0e\u533b\u3082legacy\u3067\u306f\u30c0\u30e1\uff01\u672a\u6765\u306b\u3064\u306a\u304c\u308b\u624b\u8853\u6559\u80b2\u3092\u300d<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>\u82f1\u6587\u8ad6\u6587\u3000\u3000\u548c\u6587\u8ad6\u6587\u3000\u3000\u56fd\u969b\u5b66\u4f1a\u767a\u8868\u3000\u3000\u56fd\u5185\u5b66\u4f1a\u767a\u8868 \u82f1\u6587\u8ad6\u6587 2025\u5e74 Tadanobu Sato, Taro Kuramoto Diagnostic Performance of ChatGPT-4o in Cla [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":12,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-176","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.med.niigata-u.ac.jp\/oph\/wp-json\/wp\/v2\/pages\/176","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.niigata-u.ac.jp\/oph\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.med.niigata-u.ac.jp\/oph\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.niigata-u.ac.jp\/oph\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.niigata-u.ac.jp\/oph\/wp-json\/wp\/v2\/comments?post=176"}],"version-history":[{"count":90,"href":"https:\/\/www.med.niigata-u.ac.jp\/oph\/wp-json\/wp\/v2\/pages\/176\/revisions"}],"predecessor-version":[{"id":3095,"href":"https:\/\/www.med.niigata-u.ac.jp\/oph\/wp-json\/wp\/v2\/pages\/176\/revisions\/3095"}],"up":[{"embeddable":true,"href":"https:\/\/www.med.niigata-u.ac.jp\/oph\/wp-json\/wp\/v2\/pages\/12"}],"wp:attachment":[{"href":"https:\/\/www.med.niigata-u.ac.jp\/oph\/wp-json\/wp\/v2\/media?parent=176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}